subset
stringclasses 6
values | context
stringlengths 16
17.7k
| context_tokens
sequence | qid
stringlengths 32
32
| question
stringlengths 1
717
| question_tokens
sequence | detected_answers
sequence | answers
sequencelengths 1
25
|
---|---|---|---|---|---|---|---|
SQuAD | In empirical therapy, a patient has proven or suspected infection, but the responsible microorganism is not yet unidentified. While the microorgainsim is being identified the doctor will usually administer the best choice of antibiotic that will be most active against the likely cause of infection usually a broad spectrum antibiotic. Empirical therapy is usually initiated before the doctor knows the exact identification of microorgansim causing the infection as the identification process make take several days in the laboratory. | {
"tokens": [
"In",
"empirical",
"therapy",
",",
"a",
"patient",
"has",
"proven",
"or",
"suspected",
"infection",
",",
"but",
"the",
"responsible",
"microorganism",
"is",
"not",
"yet",
"unidentified",
".",
"While",
"the",
"microorgainsim",
"is",
"being",
"identified",
"the",
"doctor",
"will",
"usually",
"administer",
"the",
"best",
"choice",
"of",
"antibiotic",
"that",
"will",
"be",
"most",
"active",
"against",
"the",
"likely",
"cause",
"of",
"infection",
"usually",
"a",
"broad",
"spectrum",
"antibiotic",
".",
"Empirical",
"therapy",
"is",
"usually",
"initiated",
"before",
"the",
"doctor",
"knows",
"the",
"exact",
"identification",
"of",
"microorgansim",
"causing",
"the",
"infection",
"as",
"the",
"identification",
"process",
"make",
"take",
"several",
"days",
"in",
"the",
"laboratory",
"."
],
"offsets": [
0,
3,
13,
20,
22,
24,
32,
36,
43,
46,
56,
65,
67,
71,
75,
87,
101,
104,
108,
112,
124,
126,
132,
136,
151,
154,
160,
171,
175,
182,
187,
195,
206,
210,
215,
222,
225,
236,
241,
246,
249,
254,
261,
269,
273,
280,
286,
289,
299,
307,
309,
315,
324,
334,
336,
346,
354,
357,
365,
375,
382,
386,
393,
399,
403,
409,
424,
427,
441,
449,
453,
463,
466,
470,
485,
493,
498,
503,
511,
516,
519,
523,
533
]
} | 8600d7cab9384ab19f8bff3bd08389a7 | What happens when a doctor doesn't know the microorganism yet? | {
"tokens": [
"What",
"happens",
"when",
"a",
"doctor",
"does",
"n't",
"know",
"the",
"microorganism",
"yet",
"?"
],
"offsets": [
0,
5,
13,
18,
20,
27,
31,
35,
40,
44,
58,
61
]
} | {
"text": [
"broad spectrum antibiotic"
],
"char_spans": [
{
"start": [
309
],
"end": [
333
]
}
],
"token_spans": [
{
"start": [
50
],
"end": [
52
]
}
]
} | [
"broad spectrum antibiotic"
] |
SQuAD | In empirical therapy, a patient has proven or suspected infection, but the responsible microorganism is not yet unidentified. While the microorgainsim is being identified the doctor will usually administer the best choice of antibiotic that will be most active against the likely cause of infection usually a broad spectrum antibiotic. Empirical therapy is usually initiated before the doctor knows the exact identification of microorgansim causing the infection as the identification process make take several days in the laboratory. | {
"tokens": [
"In",
"empirical",
"therapy",
",",
"a",
"patient",
"has",
"proven",
"or",
"suspected",
"infection",
",",
"but",
"the",
"responsible",
"microorganism",
"is",
"not",
"yet",
"unidentified",
".",
"While",
"the",
"microorgainsim",
"is",
"being",
"identified",
"the",
"doctor",
"will",
"usually",
"administer",
"the",
"best",
"choice",
"of",
"antibiotic",
"that",
"will",
"be",
"most",
"active",
"against",
"the",
"likely",
"cause",
"of",
"infection",
"usually",
"a",
"broad",
"spectrum",
"antibiotic",
".",
"Empirical",
"therapy",
"is",
"usually",
"initiated",
"before",
"the",
"doctor",
"knows",
"the",
"exact",
"identification",
"of",
"microorgansim",
"causing",
"the",
"infection",
"as",
"the",
"identification",
"process",
"make",
"take",
"several",
"days",
"in",
"the",
"laboratory",
"."
],
"offsets": [
0,
3,
13,
20,
22,
24,
32,
36,
43,
46,
56,
65,
67,
71,
75,
87,
101,
104,
108,
112,
124,
126,
132,
136,
151,
154,
160,
171,
175,
182,
187,
195,
206,
210,
215,
222,
225,
236,
241,
246,
249,
254,
261,
269,
273,
280,
286,
289,
299,
307,
309,
315,
324,
334,
336,
346,
354,
357,
365,
375,
382,
386,
393,
399,
403,
409,
424,
427,
441,
449,
453,
463,
466,
470,
485,
493,
498,
503,
511,
516,
519,
523,
533
]
} | 58473f842ad940769adb7273a75c2a92 | What happens in empirical therapy? | {
"tokens": [
"What",
"happens",
"in",
"empirical",
"therapy",
"?"
],
"offsets": [
0,
5,
13,
16,
26,
33
]
} | {
"text": [
"a patient has proven or suspected infection, but the responsible microorganism is not yet unidentified"
],
"char_spans": [
{
"start": [
22
],
"end": [
123
]
}
],
"token_spans": [
{
"start": [
4
],
"end": [
19
]
}
]
} | [
"a patient has proven or suspected infection, but the responsible microorganism is not yet unidentified"
] |
SQuAD | In empirical therapy, a patient has proven or suspected infection, but the responsible microorganism is not yet unidentified. While the microorgainsim is being identified the doctor will usually administer the best choice of antibiotic that will be most active against the likely cause of infection usually a broad spectrum antibiotic. Empirical therapy is usually initiated before the doctor knows the exact identification of microorgansim causing the infection as the identification process make take several days in the laboratory. | {
"tokens": [
"In",
"empirical",
"therapy",
",",
"a",
"patient",
"has",
"proven",
"or",
"suspected",
"infection",
",",
"but",
"the",
"responsible",
"microorganism",
"is",
"not",
"yet",
"unidentified",
".",
"While",
"the",
"microorgainsim",
"is",
"being",
"identified",
"the",
"doctor",
"will",
"usually",
"administer",
"the",
"best",
"choice",
"of",
"antibiotic",
"that",
"will",
"be",
"most",
"active",
"against",
"the",
"likely",
"cause",
"of",
"infection",
"usually",
"a",
"broad",
"spectrum",
"antibiotic",
".",
"Empirical",
"therapy",
"is",
"usually",
"initiated",
"before",
"the",
"doctor",
"knows",
"the",
"exact",
"identification",
"of",
"microorgansim",
"causing",
"the",
"infection",
"as",
"the",
"identification",
"process",
"make",
"take",
"several",
"days",
"in",
"the",
"laboratory",
"."
],
"offsets": [
0,
3,
13,
20,
22,
24,
32,
36,
43,
46,
56,
65,
67,
71,
75,
87,
101,
104,
108,
112,
124,
126,
132,
136,
151,
154,
160,
171,
175,
182,
187,
195,
206,
210,
215,
222,
225,
236,
241,
246,
249,
254,
261,
269,
273,
280,
286,
289,
299,
307,
309,
315,
324,
334,
336,
346,
354,
357,
365,
375,
382,
386,
393,
399,
403,
409,
424,
427,
441,
449,
453,
463,
466,
470,
485,
493,
498,
503,
511,
516,
519,
523,
533
]
} | 5f66ec4113ca45b088c855be81360a58 | When is empirical started? | {
"tokens": [
"When",
"is",
"empirical",
"started",
"?"
],
"offsets": [
0,
5,
8,
18,
25
]
} | {
"text": [
"before the doctor knows the exact identification of microorgansim"
],
"char_spans": [
{
"start": [
375
],
"end": [
439
]
}
],
"token_spans": [
{
"start": [
59
],
"end": [
67
]
}
]
} | [
"before the doctor knows the exact identification of microorgansim"
] |
SQuAD | With advances in medicinal chemistry, most modern antibacterials are semisynthetic modifications of various natural compounds. These include, for example, the beta-lactam antibiotics, which include the penicillins (produced by fungi in the genus Penicillium), the cephalosporins, and the carbapenems. Compounds that are still isolated from living organisms are the aminoglycosides, whereas other antibacterials—for example, the sulfonamides, the quinolones, and the oxazolidinones—are produced solely by chemical synthesis. Many antibacterial compounds are relatively small molecules with a molecular weight of less than 2000 atomic mass units.[citation needed] | {
"tokens": [
"With",
"advances",
"in",
"medicinal",
"chemistry",
",",
"most",
"modern",
"antibacterials",
"are",
"semisynthetic",
"modifications",
"of",
"various",
"natural",
"compounds",
".",
"These",
"include",
",",
"for",
"example",
",",
"the",
"beta",
"-",
"lactam",
"antibiotics",
",",
"which",
"include",
"the",
"penicillins",
"(",
"produced",
"by",
"fungi",
"in",
"the",
"genus",
"Penicillium",
")",
",",
"the",
"cephalosporins",
",",
"and",
"the",
"carbapenems",
".",
"Compounds",
"that",
"are",
"still",
"isolated",
"from",
"living",
"organisms",
"are",
"the",
"aminoglycosides",
",",
"whereas",
"other",
"antibacterials",
"—",
"for",
"example",
",",
"the",
"sulfonamides",
",",
"the",
"quinolones",
",",
"and",
"the",
"oxazolidinones",
"—",
"are",
"produced",
"solely",
"by",
"chemical",
"synthesis",
".",
"Many",
"antibacterial",
"compounds",
"are",
"relatively",
"small",
"molecules",
"with",
"a",
"molecular",
"weight",
"of",
"less",
"than",
"2000",
"atomic",
"mass",
"units.[citation",
"needed",
"]"
],
"offsets": [
0,
5,
14,
17,
27,
36,
38,
43,
50,
65,
69,
83,
97,
100,
108,
116,
125,
127,
133,
140,
142,
146,
153,
155,
159,
163,
164,
171,
182,
184,
190,
198,
202,
214,
215,
224,
227,
233,
236,
240,
246,
257,
258,
260,
264,
278,
280,
284,
288,
299,
301,
311,
316,
320,
326,
335,
340,
347,
357,
361,
365,
380,
382,
390,
396,
410,
411,
415,
422,
424,
428,
440,
442,
446,
456,
458,
462,
466,
480,
481,
485,
494,
501,
504,
513,
522,
524,
529,
543,
553,
557,
568,
574,
584,
589,
591,
601,
608,
611,
616,
621,
626,
633,
638,
654,
660
]
} | 4b7f1a4bb67c48a7a6cc0834db4d53e7 | What are antibiotics in chemical terms? | {
"tokens": [
"What",
"are",
"antibiotics",
"in",
"chemical",
"terms",
"?"
],
"offsets": [
0,
5,
9,
21,
24,
33,
38
]
} | {
"text": [
"semisynthetic modifications"
],
"char_spans": [
{
"start": [
69
],
"end": [
95
]
}
],
"token_spans": [
{
"start": [
10
],
"end": [
11
]
}
]
} | [
"semisynthetic modifications"
] |
SQuAD | With advances in medicinal chemistry, most modern antibacterials are semisynthetic modifications of various natural compounds. These include, for example, the beta-lactam antibiotics, which include the penicillins (produced by fungi in the genus Penicillium), the cephalosporins, and the carbapenems. Compounds that are still isolated from living organisms are the aminoglycosides, whereas other antibacterials—for example, the sulfonamides, the quinolones, and the oxazolidinones—are produced solely by chemical synthesis. Many antibacterial compounds are relatively small molecules with a molecular weight of less than 2000 atomic mass units.[citation needed] | {
"tokens": [
"With",
"advances",
"in",
"medicinal",
"chemistry",
",",
"most",
"modern",
"antibacterials",
"are",
"semisynthetic",
"modifications",
"of",
"various",
"natural",
"compounds",
".",
"These",
"include",
",",
"for",
"example",
",",
"the",
"beta",
"-",
"lactam",
"antibiotics",
",",
"which",
"include",
"the",
"penicillins",
"(",
"produced",
"by",
"fungi",
"in",
"the",
"genus",
"Penicillium",
")",
",",
"the",
"cephalosporins",
",",
"and",
"the",
"carbapenems",
".",
"Compounds",
"that",
"are",
"still",
"isolated",
"from",
"living",
"organisms",
"are",
"the",
"aminoglycosides",
",",
"whereas",
"other",
"antibacterials",
"—",
"for",
"example",
",",
"the",
"sulfonamides",
",",
"the",
"quinolones",
",",
"and",
"the",
"oxazolidinones",
"—",
"are",
"produced",
"solely",
"by",
"chemical",
"synthesis",
".",
"Many",
"antibacterial",
"compounds",
"are",
"relatively",
"small",
"molecules",
"with",
"a",
"molecular",
"weight",
"of",
"less",
"than",
"2000",
"atomic",
"mass",
"units.[citation",
"needed",
"]"
],
"offsets": [
0,
5,
14,
17,
27,
36,
38,
43,
50,
65,
69,
83,
97,
100,
108,
116,
125,
127,
133,
140,
142,
146,
153,
155,
159,
163,
164,
171,
182,
184,
190,
198,
202,
214,
215,
224,
227,
233,
236,
240,
246,
257,
258,
260,
264,
278,
280,
284,
288,
299,
301,
311,
316,
320,
326,
335,
340,
347,
357,
361,
365,
380,
382,
390,
396,
410,
411,
415,
422,
424,
428,
440,
442,
446,
456,
458,
462,
466,
480,
481,
485,
494,
501,
504,
513,
522,
524,
529,
543,
553,
557,
568,
574,
584,
589,
591,
601,
608,
611,
616,
621,
626,
633,
638,
654,
660
]
} | a2756009e9894ccfa93333aa8b9579d9 | What type of antibiotics include penicilin? | {
"tokens": [
"What",
"type",
"of",
"antibiotics",
"include",
"penicilin",
"?"
],
"offsets": [
0,
5,
10,
13,
25,
33,
42
]
} | {
"text": [
"beta-lactam antibiotics"
],
"char_spans": [
{
"start": [
159
],
"end": [
181
]
}
],
"token_spans": [
{
"start": [
24
],
"end": [
27
]
}
]
} | [
"beta-lactam antibiotics"
] |
SQuAD | With advances in medicinal chemistry, most modern antibacterials are semisynthetic modifications of various natural compounds. These include, for example, the beta-lactam antibiotics, which include the penicillins (produced by fungi in the genus Penicillium), the cephalosporins, and the carbapenems. Compounds that are still isolated from living organisms are the aminoglycosides, whereas other antibacterials—for example, the sulfonamides, the quinolones, and the oxazolidinones—are produced solely by chemical synthesis. Many antibacterial compounds are relatively small molecules with a molecular weight of less than 2000 atomic mass units.[citation needed] | {
"tokens": [
"With",
"advances",
"in",
"medicinal",
"chemistry",
",",
"most",
"modern",
"antibacterials",
"are",
"semisynthetic",
"modifications",
"of",
"various",
"natural",
"compounds",
".",
"These",
"include",
",",
"for",
"example",
",",
"the",
"beta",
"-",
"lactam",
"antibiotics",
",",
"which",
"include",
"the",
"penicillins",
"(",
"produced",
"by",
"fungi",
"in",
"the",
"genus",
"Penicillium",
")",
",",
"the",
"cephalosporins",
",",
"and",
"the",
"carbapenems",
".",
"Compounds",
"that",
"are",
"still",
"isolated",
"from",
"living",
"organisms",
"are",
"the",
"aminoglycosides",
",",
"whereas",
"other",
"antibacterials",
"—",
"for",
"example",
",",
"the",
"sulfonamides",
",",
"the",
"quinolones",
",",
"and",
"the",
"oxazolidinones",
"—",
"are",
"produced",
"solely",
"by",
"chemical",
"synthesis",
".",
"Many",
"antibacterial",
"compounds",
"are",
"relatively",
"small",
"molecules",
"with",
"a",
"molecular",
"weight",
"of",
"less",
"than",
"2000",
"atomic",
"mass",
"units.[citation",
"needed",
"]"
],
"offsets": [
0,
5,
14,
17,
27,
36,
38,
43,
50,
65,
69,
83,
97,
100,
108,
116,
125,
127,
133,
140,
142,
146,
153,
155,
159,
163,
164,
171,
182,
184,
190,
198,
202,
214,
215,
224,
227,
233,
236,
240,
246,
257,
258,
260,
264,
278,
280,
284,
288,
299,
301,
311,
316,
320,
326,
335,
340,
347,
357,
361,
365,
380,
382,
390,
396,
410,
411,
415,
422,
424,
428,
440,
442,
446,
456,
458,
462,
466,
480,
481,
485,
494,
501,
504,
513,
522,
524,
529,
543,
553,
557,
568,
574,
584,
589,
591,
601,
608,
611,
616,
621,
626,
633,
638,
654,
660
]
} | 5cbfb77ba3754663b2f823683c02bd4f | What are the type of antibiotics which are taken from still living things? | {
"tokens": [
"What",
"are",
"the",
"type",
"of",
"antibiotics",
"which",
"are",
"taken",
"from",
"still",
"living",
"things",
"?"
],
"offsets": [
0,
5,
9,
13,
18,
21,
33,
39,
43,
49,
54,
60,
67,
73
]
} | {
"text": [
"aminoglycosides"
],
"char_spans": [
{
"start": [
365
],
"end": [
379
]
}
],
"token_spans": [
{
"start": [
60
],
"end": [
60
]
}
]
} | [
"aminoglycosides"
] |
SQuAD | With advances in medicinal chemistry, most modern antibacterials are semisynthetic modifications of various natural compounds. These include, for example, the beta-lactam antibiotics, which include the penicillins (produced by fungi in the genus Penicillium), the cephalosporins, and the carbapenems. Compounds that are still isolated from living organisms are the aminoglycosides, whereas other antibacterials—for example, the sulfonamides, the quinolones, and the oxazolidinones—are produced solely by chemical synthesis. Many antibacterial compounds are relatively small molecules with a molecular weight of less than 2000 atomic mass units.[citation needed] | {
"tokens": [
"With",
"advances",
"in",
"medicinal",
"chemistry",
",",
"most",
"modern",
"antibacterials",
"are",
"semisynthetic",
"modifications",
"of",
"various",
"natural",
"compounds",
".",
"These",
"include",
",",
"for",
"example",
",",
"the",
"beta",
"-",
"lactam",
"antibiotics",
",",
"which",
"include",
"the",
"penicillins",
"(",
"produced",
"by",
"fungi",
"in",
"the",
"genus",
"Penicillium",
")",
",",
"the",
"cephalosporins",
",",
"and",
"the",
"carbapenems",
".",
"Compounds",
"that",
"are",
"still",
"isolated",
"from",
"living",
"organisms",
"are",
"the",
"aminoglycosides",
",",
"whereas",
"other",
"antibacterials",
"—",
"for",
"example",
",",
"the",
"sulfonamides",
",",
"the",
"quinolones",
",",
"and",
"the",
"oxazolidinones",
"—",
"are",
"produced",
"solely",
"by",
"chemical",
"synthesis",
".",
"Many",
"antibacterial",
"compounds",
"are",
"relatively",
"small",
"molecules",
"with",
"a",
"molecular",
"weight",
"of",
"less",
"than",
"2000",
"atomic",
"mass",
"units.[citation",
"needed",
"]"
],
"offsets": [
0,
5,
14,
17,
27,
36,
38,
43,
50,
65,
69,
83,
97,
100,
108,
116,
125,
127,
133,
140,
142,
146,
153,
155,
159,
163,
164,
171,
182,
184,
190,
198,
202,
214,
215,
224,
227,
233,
236,
240,
246,
257,
258,
260,
264,
278,
280,
284,
288,
299,
301,
311,
316,
320,
326,
335,
340,
347,
357,
361,
365,
380,
382,
390,
396,
410,
411,
415,
422,
424,
428,
440,
442,
446,
456,
458,
462,
466,
480,
481,
485,
494,
501,
504,
513,
522,
524,
529,
543,
553,
557,
568,
574,
584,
589,
591,
601,
608,
611,
616,
621,
626,
633,
638,
654,
660
]
} | 926b1648f4854bb1b867a98476826516 | How are the slufonamides,quinolones, and oxazolidinones created? | {
"tokens": [
"How",
"are",
"the",
"slufonamides",
",",
"quinolones",
",",
"and",
"oxazolidinones",
"created",
"?"
],
"offsets": [
0,
4,
8,
12,
24,
25,
35,
37,
41,
56,
63
]
} | {
"text": [
"synthesis"
],
"char_spans": [
{
"start": [
513
],
"end": [
521
]
}
],
"token_spans": [
{
"start": [
84
],
"end": [
84
]
}
]
} | [
"synthesis"
] |
SQuAD | With advances in medicinal chemistry, most modern antibacterials are semisynthetic modifications of various natural compounds. These include, for example, the beta-lactam antibiotics, which include the penicillins (produced by fungi in the genus Penicillium), the cephalosporins, and the carbapenems. Compounds that are still isolated from living organisms are the aminoglycosides, whereas other antibacterials—for example, the sulfonamides, the quinolones, and the oxazolidinones—are produced solely by chemical synthesis. Many antibacterial compounds are relatively small molecules with a molecular weight of less than 2000 atomic mass units.[citation needed] | {
"tokens": [
"With",
"advances",
"in",
"medicinal",
"chemistry",
",",
"most",
"modern",
"antibacterials",
"are",
"semisynthetic",
"modifications",
"of",
"various",
"natural",
"compounds",
".",
"These",
"include",
",",
"for",
"example",
",",
"the",
"beta",
"-",
"lactam",
"antibiotics",
",",
"which",
"include",
"the",
"penicillins",
"(",
"produced",
"by",
"fungi",
"in",
"the",
"genus",
"Penicillium",
")",
",",
"the",
"cephalosporins",
",",
"and",
"the",
"carbapenems",
".",
"Compounds",
"that",
"are",
"still",
"isolated",
"from",
"living",
"organisms",
"are",
"the",
"aminoglycosides",
",",
"whereas",
"other",
"antibacterials",
"—",
"for",
"example",
",",
"the",
"sulfonamides",
",",
"the",
"quinolones",
",",
"and",
"the",
"oxazolidinones",
"—",
"are",
"produced",
"solely",
"by",
"chemical",
"synthesis",
".",
"Many",
"antibacterial",
"compounds",
"are",
"relatively",
"small",
"molecules",
"with",
"a",
"molecular",
"weight",
"of",
"less",
"than",
"2000",
"atomic",
"mass",
"units.[citation",
"needed",
"]"
],
"offsets": [
0,
5,
14,
17,
27,
36,
38,
43,
50,
65,
69,
83,
97,
100,
108,
116,
125,
127,
133,
140,
142,
146,
153,
155,
159,
163,
164,
171,
182,
184,
190,
198,
202,
214,
215,
224,
227,
233,
236,
240,
246,
257,
258,
260,
264,
278,
280,
284,
288,
299,
301,
311,
316,
320,
326,
335,
340,
347,
357,
361,
365,
380,
382,
390,
396,
410,
411,
415,
422,
424,
428,
440,
442,
446,
456,
458,
462,
466,
480,
481,
485,
494,
501,
504,
513,
522,
524,
529,
543,
553,
557,
568,
574,
584,
589,
591,
601,
608,
611,
616,
621,
626,
633,
638,
654,
660
]
} | df6c2af362d64136a69263d0b8a06f52 | Besides semisytetic modifications, what advances in medicinal chemistry regarding antibacterials? | {
"tokens": [
"Besides",
"semisytetic",
"modifications",
",",
"what",
"advances",
"in",
"medicinal",
"chemistry",
"regarding",
"antibacterials",
"?"
],
"offsets": [
0,
8,
20,
33,
35,
40,
49,
52,
62,
72,
82,
96
]
} | {
"text": [
"various natural compounds"
],
"char_spans": [
{
"start": [
100
],
"end": [
124
]
}
],
"token_spans": [
{
"start": [
13
],
"end": [
15
]
}
]
} | [
"various natural compounds"
] |
SQuAD | With advances in medicinal chemistry, most modern antibacterials are semisynthetic modifications of various natural compounds. These include, for example, the beta-lactam antibiotics, which include the penicillins (produced by fungi in the genus Penicillium), the cephalosporins, and the carbapenems. Compounds that are still isolated from living organisms are the aminoglycosides, whereas other antibacterials—for example, the sulfonamides, the quinolones, and the oxazolidinones—are produced solely by chemical synthesis. Many antibacterial compounds are relatively small molecules with a molecular weight of less than 2000 atomic mass units.[citation needed] | {
"tokens": [
"With",
"advances",
"in",
"medicinal",
"chemistry",
",",
"most",
"modern",
"antibacterials",
"are",
"semisynthetic",
"modifications",
"of",
"various",
"natural",
"compounds",
".",
"These",
"include",
",",
"for",
"example",
",",
"the",
"beta",
"-",
"lactam",
"antibiotics",
",",
"which",
"include",
"the",
"penicillins",
"(",
"produced",
"by",
"fungi",
"in",
"the",
"genus",
"Penicillium",
")",
",",
"the",
"cephalosporins",
",",
"and",
"the",
"carbapenems",
".",
"Compounds",
"that",
"are",
"still",
"isolated",
"from",
"living",
"organisms",
"are",
"the",
"aminoglycosides",
",",
"whereas",
"other",
"antibacterials",
"—",
"for",
"example",
",",
"the",
"sulfonamides",
",",
"the",
"quinolones",
",",
"and",
"the",
"oxazolidinones",
"—",
"are",
"produced",
"solely",
"by",
"chemical",
"synthesis",
".",
"Many",
"antibacterial",
"compounds",
"are",
"relatively",
"small",
"molecules",
"with",
"a",
"molecular",
"weight",
"of",
"less",
"than",
"2000",
"atomic",
"mass",
"units.[citation",
"needed",
"]"
],
"offsets": [
0,
5,
14,
17,
27,
36,
38,
43,
50,
65,
69,
83,
97,
100,
108,
116,
125,
127,
133,
140,
142,
146,
153,
155,
159,
163,
164,
171,
182,
184,
190,
198,
202,
214,
215,
224,
227,
233,
236,
240,
246,
257,
258,
260,
264,
278,
280,
284,
288,
299,
301,
311,
316,
320,
326,
335,
340,
347,
357,
361,
365,
380,
382,
390,
396,
410,
411,
415,
422,
424,
428,
440,
442,
446,
456,
458,
462,
466,
480,
481,
485,
494,
501,
504,
513,
522,
524,
529,
543,
553,
557,
568,
574,
584,
589,
591,
601,
608,
611,
616,
621,
626,
633,
638,
654,
660
]
} | 0e6aee774a0b4937a65c4a54175968fd | What is included in the beta-lactam antibiotics? | {
"tokens": [
"What",
"is",
"included",
"in",
"the",
"beta",
"-",
"lactam",
"antibiotics",
"?"
],
"offsets": [
0,
5,
8,
17,
20,
24,
28,
29,
36,
47
]
} | {
"text": [
"penicillins"
],
"char_spans": [
{
"start": [
202
],
"end": [
212
]
}
],
"token_spans": [
{
"start": [
32
],
"end": [
32
]
}
]
} | [
"penicillins"
] |
SQuAD | With advances in medicinal chemistry, most modern antibacterials are semisynthetic modifications of various natural compounds. These include, for example, the beta-lactam antibiotics, which include the penicillins (produced by fungi in the genus Penicillium), the cephalosporins, and the carbapenems. Compounds that are still isolated from living organisms are the aminoglycosides, whereas other antibacterials—for example, the sulfonamides, the quinolones, and the oxazolidinones—are produced solely by chemical synthesis. Many antibacterial compounds are relatively small molecules with a molecular weight of less than 2000 atomic mass units.[citation needed] | {
"tokens": [
"With",
"advances",
"in",
"medicinal",
"chemistry",
",",
"most",
"modern",
"antibacterials",
"are",
"semisynthetic",
"modifications",
"of",
"various",
"natural",
"compounds",
".",
"These",
"include",
",",
"for",
"example",
",",
"the",
"beta",
"-",
"lactam",
"antibiotics",
",",
"which",
"include",
"the",
"penicillins",
"(",
"produced",
"by",
"fungi",
"in",
"the",
"genus",
"Penicillium",
")",
",",
"the",
"cephalosporins",
",",
"and",
"the",
"carbapenems",
".",
"Compounds",
"that",
"are",
"still",
"isolated",
"from",
"living",
"organisms",
"are",
"the",
"aminoglycosides",
",",
"whereas",
"other",
"antibacterials",
"—",
"for",
"example",
",",
"the",
"sulfonamides",
",",
"the",
"quinolones",
",",
"and",
"the",
"oxazolidinones",
"—",
"are",
"produced",
"solely",
"by",
"chemical",
"synthesis",
".",
"Many",
"antibacterial",
"compounds",
"are",
"relatively",
"small",
"molecules",
"with",
"a",
"molecular",
"weight",
"of",
"less",
"than",
"2000",
"atomic",
"mass",
"units.[citation",
"needed",
"]"
],
"offsets": [
0,
5,
14,
17,
27,
36,
38,
43,
50,
65,
69,
83,
97,
100,
108,
116,
125,
127,
133,
140,
142,
146,
153,
155,
159,
163,
164,
171,
182,
184,
190,
198,
202,
214,
215,
224,
227,
233,
236,
240,
246,
257,
258,
260,
264,
278,
280,
284,
288,
299,
301,
311,
316,
320,
326,
335,
340,
347,
357,
361,
365,
380,
382,
390,
396,
410,
411,
415,
422,
424,
428,
440,
442,
446,
456,
458,
462,
466,
480,
481,
485,
494,
501,
504,
513,
522,
524,
529,
543,
553,
557,
568,
574,
584,
589,
591,
601,
608,
611,
616,
621,
626,
633,
638,
654,
660
]
} | ac11e227e8d3474f8174dfdb35ce6dcf | What is penicillins produced by? | {
"tokens": [
"What",
"is",
"penicillins",
"produced",
"by",
"?"
],
"offsets": [
0,
5,
8,
20,
29,
31
]
} | {
"text": [
"fungi"
],
"char_spans": [
{
"start": [
227
],
"end": [
231
]
}
],
"token_spans": [
{
"start": [
36
],
"end": [
36
]
}
]
} | [
"fungi"
] |
SQuAD | The successful outcome of antimicrobial therapy with antibacterial compounds depends on several factors. These include host defense mechanisms, the location of infection, and the pharmacokinetic and pharmacodynamic properties of the antibacterial. A bactericidal activity of antibacterials may depend on the bacterial growth phase, and it often requires ongoing metabolic activity and division of bacterial cells. These findings are based on laboratory studies, and in clinical settings have also been shown to eliminate bacterial infection. Since the activity of antibacterials depends frequently on its concentration, in vitro characterization of antibacterial activity commonly includes the determination of the minimum inhibitory concentration and minimum bactericidal concentration of an antibacterial. To predict clinical outcome, the antimicrobial activity of an antibacterial is usually combined with its pharmacokinetic profile, and several pharmacological parameters are used as markers of drug efficacy. | {
"tokens": [
"The",
"successful",
"outcome",
"of",
"antimicrobial",
"therapy",
"with",
"antibacterial",
"compounds",
"depends",
"on",
"several",
"factors",
".",
"These",
"include",
"host",
"defense",
"mechanisms",
",",
"the",
"location",
"of",
"infection",
",",
"and",
"the",
"pharmacokinetic",
"and",
"pharmacodynamic",
"properties",
"of",
"the",
"antibacterial",
".",
"A",
"bactericidal",
"activity",
"of",
"antibacterials",
"may",
"depend",
"on",
"the",
"bacterial",
"growth",
"phase",
",",
"and",
"it",
"often",
"requires",
"ongoing",
"metabolic",
"activity",
"and",
"division",
"of",
"bacterial",
"cells",
".",
"These",
"findings",
"are",
"based",
"on",
"laboratory",
"studies",
",",
"and",
"in",
"clinical",
"settings",
"have",
"also",
"been",
"shown",
"to",
"eliminate",
"bacterial",
"infection",
".",
"Since",
"the",
"activity",
"of",
"antibacterials",
"depends",
"frequently",
"on",
"its",
"concentration",
",",
"in",
"vitro",
"characterization",
"of",
"antibacterial",
"activity",
"commonly",
"includes",
"the",
"determination",
"of",
"the",
"minimum",
"inhibitory",
"concentration",
"and",
"minimum",
"bactericidal",
"concentration",
"of",
"an",
"antibacterial",
".",
"To",
"predict",
"clinical",
"outcome",
",",
"the",
"antimicrobial",
"activity",
"of",
"an",
"antibacterial",
"is",
"usually",
"combined",
"with",
"its",
"pharmacokinetic",
"profile",
",",
"and",
"several",
"pharmacological",
"parameters",
"are",
"used",
"as",
"markers",
"of",
"drug",
"efficacy",
"."
],
"offsets": [
0,
4,
15,
23,
26,
40,
48,
53,
67,
77,
85,
88,
96,
103,
105,
111,
119,
124,
132,
142,
144,
148,
157,
160,
169,
171,
175,
179,
195,
199,
215,
226,
229,
233,
246,
248,
250,
263,
272,
275,
290,
294,
301,
304,
308,
318,
325,
330,
332,
336,
339,
345,
354,
362,
372,
381,
385,
394,
397,
407,
412,
414,
420,
429,
433,
439,
442,
453,
460,
462,
466,
469,
478,
487,
492,
497,
502,
508,
511,
521,
531,
540,
542,
548,
552,
561,
564,
579,
587,
598,
601,
605,
618,
620,
623,
629,
646,
649,
663,
672,
681,
690,
694,
708,
711,
715,
723,
734,
748,
752,
760,
773,
787,
790,
793,
806,
808,
811,
819,
828,
835,
837,
841,
855,
864,
867,
870,
884,
887,
895,
904,
909,
913,
929,
936,
938,
942,
950,
966,
977,
981,
986,
989,
997,
1000,
1005,
1013
]
} | 42a6f253cbf343af8c9db919376fc6fe | What does the potency of antibacterials depend upon? | {
"tokens": [
"What",
"does",
"the",
"potency",
"of",
"antibacterials",
"depend",
"upon",
"?"
],
"offsets": [
0,
5,
10,
14,
22,
25,
40,
47,
51
]
} | {
"text": [
"concentration"
],
"char_spans": [
{
"start": [
605
],
"end": [
617
]
}
],
"token_spans": [
{
"start": [
91
],
"end": [
91
]
}
]
} | [
"concentration"
] |
SQuAD | The successful outcome of antimicrobial therapy with antibacterial compounds depends on several factors. These include host defense mechanisms, the location of infection, and the pharmacokinetic and pharmacodynamic properties of the antibacterial. A bactericidal activity of antibacterials may depend on the bacterial growth phase, and it often requires ongoing metabolic activity and division of bacterial cells. These findings are based on laboratory studies, and in clinical settings have also been shown to eliminate bacterial infection. Since the activity of antibacterials depends frequently on its concentration, in vitro characterization of antibacterial activity commonly includes the determination of the minimum inhibitory concentration and minimum bactericidal concentration of an antibacterial. To predict clinical outcome, the antimicrobial activity of an antibacterial is usually combined with its pharmacokinetic profile, and several pharmacological parameters are used as markers of drug efficacy. | {
"tokens": [
"The",
"successful",
"outcome",
"of",
"antimicrobial",
"therapy",
"with",
"antibacterial",
"compounds",
"depends",
"on",
"several",
"factors",
".",
"These",
"include",
"host",
"defense",
"mechanisms",
",",
"the",
"location",
"of",
"infection",
",",
"and",
"the",
"pharmacokinetic",
"and",
"pharmacodynamic",
"properties",
"of",
"the",
"antibacterial",
".",
"A",
"bactericidal",
"activity",
"of",
"antibacterials",
"may",
"depend",
"on",
"the",
"bacterial",
"growth",
"phase",
",",
"and",
"it",
"often",
"requires",
"ongoing",
"metabolic",
"activity",
"and",
"division",
"of",
"bacterial",
"cells",
".",
"These",
"findings",
"are",
"based",
"on",
"laboratory",
"studies",
",",
"and",
"in",
"clinical",
"settings",
"have",
"also",
"been",
"shown",
"to",
"eliminate",
"bacterial",
"infection",
".",
"Since",
"the",
"activity",
"of",
"antibacterials",
"depends",
"frequently",
"on",
"its",
"concentration",
",",
"in",
"vitro",
"characterization",
"of",
"antibacterial",
"activity",
"commonly",
"includes",
"the",
"determination",
"of",
"the",
"minimum",
"inhibitory",
"concentration",
"and",
"minimum",
"bactericidal",
"concentration",
"of",
"an",
"antibacterial",
".",
"To",
"predict",
"clinical",
"outcome",
",",
"the",
"antimicrobial",
"activity",
"of",
"an",
"antibacterial",
"is",
"usually",
"combined",
"with",
"its",
"pharmacokinetic",
"profile",
",",
"and",
"several",
"pharmacological",
"parameters",
"are",
"used",
"as",
"markers",
"of",
"drug",
"efficacy",
"."
],
"offsets": [
0,
4,
15,
23,
26,
40,
48,
53,
67,
77,
85,
88,
96,
103,
105,
111,
119,
124,
132,
142,
144,
148,
157,
160,
169,
171,
175,
179,
195,
199,
215,
226,
229,
233,
246,
248,
250,
263,
272,
275,
290,
294,
301,
304,
308,
318,
325,
330,
332,
336,
339,
345,
354,
362,
372,
381,
385,
394,
397,
407,
412,
414,
420,
429,
433,
439,
442,
453,
460,
462,
466,
469,
478,
487,
492,
497,
502,
508,
511,
521,
531,
540,
542,
548,
552,
561,
564,
579,
587,
598,
601,
605,
618,
620,
623,
629,
646,
649,
663,
672,
681,
690,
694,
708,
711,
715,
723,
734,
748,
752,
760,
773,
787,
790,
793,
806,
808,
811,
819,
828,
835,
837,
841,
855,
864,
867,
870,
884,
887,
895,
904,
909,
913,
929,
936,
938,
942,
950,
966,
977,
981,
986,
989,
997,
1000,
1005,
1013
]
} | 5755d5c0dc93471f81c31a123b7e04cd | What does this eliminate? | {
"tokens": [
"What",
"does",
"this",
"eliminate",
"?"
],
"offsets": [
0,
5,
10,
15,
24
]
} | {
"text": [
"bacterial infection"
],
"char_spans": [
{
"start": [
521
],
"end": [
539
]
}
],
"token_spans": [
{
"start": [
79
],
"end": [
80
]
}
]
} | [
"bacterial infection"
] |
SQuAD | The successful outcome of antimicrobial therapy with antibacterial compounds depends on several factors. These include host defense mechanisms, the location of infection, and the pharmacokinetic and pharmacodynamic properties of the antibacterial. A bactericidal activity of antibacterials may depend on the bacterial growth phase, and it often requires ongoing metabolic activity and division of bacterial cells. These findings are based on laboratory studies, and in clinical settings have also been shown to eliminate bacterial infection. Since the activity of antibacterials depends frequently on its concentration, in vitro characterization of antibacterial activity commonly includes the determination of the minimum inhibitory concentration and minimum bactericidal concentration of an antibacterial. To predict clinical outcome, the antimicrobial activity of an antibacterial is usually combined with its pharmacokinetic profile, and several pharmacological parameters are used as markers of drug efficacy. | {
"tokens": [
"The",
"successful",
"outcome",
"of",
"antimicrobial",
"therapy",
"with",
"antibacterial",
"compounds",
"depends",
"on",
"several",
"factors",
".",
"These",
"include",
"host",
"defense",
"mechanisms",
",",
"the",
"location",
"of",
"infection",
",",
"and",
"the",
"pharmacokinetic",
"and",
"pharmacodynamic",
"properties",
"of",
"the",
"antibacterial",
".",
"A",
"bactericidal",
"activity",
"of",
"antibacterials",
"may",
"depend",
"on",
"the",
"bacterial",
"growth",
"phase",
",",
"and",
"it",
"often",
"requires",
"ongoing",
"metabolic",
"activity",
"and",
"division",
"of",
"bacterial",
"cells",
".",
"These",
"findings",
"are",
"based",
"on",
"laboratory",
"studies",
",",
"and",
"in",
"clinical",
"settings",
"have",
"also",
"been",
"shown",
"to",
"eliminate",
"bacterial",
"infection",
".",
"Since",
"the",
"activity",
"of",
"antibacterials",
"depends",
"frequently",
"on",
"its",
"concentration",
",",
"in",
"vitro",
"characterization",
"of",
"antibacterial",
"activity",
"commonly",
"includes",
"the",
"determination",
"of",
"the",
"minimum",
"inhibitory",
"concentration",
"and",
"minimum",
"bactericidal",
"concentration",
"of",
"an",
"antibacterial",
".",
"To",
"predict",
"clinical",
"outcome",
",",
"the",
"antimicrobial",
"activity",
"of",
"an",
"antibacterial",
"is",
"usually",
"combined",
"with",
"its",
"pharmacokinetic",
"profile",
",",
"and",
"several",
"pharmacological",
"parameters",
"are",
"used",
"as",
"markers",
"of",
"drug",
"efficacy",
"."
],
"offsets": [
0,
4,
15,
23,
26,
40,
48,
53,
67,
77,
85,
88,
96,
103,
105,
111,
119,
124,
132,
142,
144,
148,
157,
160,
169,
171,
175,
179,
195,
199,
215,
226,
229,
233,
246,
248,
250,
263,
272,
275,
290,
294,
301,
304,
308,
318,
325,
330,
332,
336,
339,
345,
354,
362,
372,
381,
385,
394,
397,
407,
412,
414,
420,
429,
433,
439,
442,
453,
460,
462,
466,
469,
478,
487,
492,
497,
502,
508,
511,
521,
531,
540,
542,
548,
552,
561,
564,
579,
587,
598,
601,
605,
618,
620,
623,
629,
646,
649,
663,
672,
681,
690,
694,
708,
711,
715,
723,
734,
748,
752,
760,
773,
787,
790,
793,
806,
808,
811,
819,
828,
835,
837,
841,
855,
864,
867,
870,
884,
887,
895,
904,
909,
913,
929,
936,
938,
942,
950,
966,
977,
981,
986,
989,
997,
1000,
1005,
1013
]
} | 42aad83d0037434eb3c2cd582df0d9e3 | What does the bactericidal activitty of antibacterials depend on what? | {
"tokens": [
"What",
"does",
"the",
"bactericidal",
"activitty",
"of",
"antibacterials",
"depend",
"on",
"what",
"?"
],
"offsets": [
0,
5,
10,
14,
27,
37,
40,
55,
62,
65,
69
]
} | {
"text": [
"bacterial growth phase"
],
"char_spans": [
{
"start": [
308
],
"end": [
329
]
}
],
"token_spans": [
{
"start": [
44
],
"end": [
46
]
}
]
} | [
"bacterial growth phase"
] |
SQuAD | The successful outcome of antimicrobial therapy with antibacterial compounds depends on several factors. These include host defense mechanisms, the location of infection, and the pharmacokinetic and pharmacodynamic properties of the antibacterial. A bactericidal activity of antibacterials may depend on the bacterial growth phase, and it often requires ongoing metabolic activity and division of bacterial cells. These findings are based on laboratory studies, and in clinical settings have also been shown to eliminate bacterial infection. Since the activity of antibacterials depends frequently on its concentration, in vitro characterization of antibacterial activity commonly includes the determination of the minimum inhibitory concentration and minimum bactericidal concentration of an antibacterial. To predict clinical outcome, the antimicrobial activity of an antibacterial is usually combined with its pharmacokinetic profile, and several pharmacological parameters are used as markers of drug efficacy. | {
"tokens": [
"The",
"successful",
"outcome",
"of",
"antimicrobial",
"therapy",
"with",
"antibacterial",
"compounds",
"depends",
"on",
"several",
"factors",
".",
"These",
"include",
"host",
"defense",
"mechanisms",
",",
"the",
"location",
"of",
"infection",
",",
"and",
"the",
"pharmacokinetic",
"and",
"pharmacodynamic",
"properties",
"of",
"the",
"antibacterial",
".",
"A",
"bactericidal",
"activity",
"of",
"antibacterials",
"may",
"depend",
"on",
"the",
"bacterial",
"growth",
"phase",
",",
"and",
"it",
"often",
"requires",
"ongoing",
"metabolic",
"activity",
"and",
"division",
"of",
"bacterial",
"cells",
".",
"These",
"findings",
"are",
"based",
"on",
"laboratory",
"studies",
",",
"and",
"in",
"clinical",
"settings",
"have",
"also",
"been",
"shown",
"to",
"eliminate",
"bacterial",
"infection",
".",
"Since",
"the",
"activity",
"of",
"antibacterials",
"depends",
"frequently",
"on",
"its",
"concentration",
",",
"in",
"vitro",
"characterization",
"of",
"antibacterial",
"activity",
"commonly",
"includes",
"the",
"determination",
"of",
"the",
"minimum",
"inhibitory",
"concentration",
"and",
"minimum",
"bactericidal",
"concentration",
"of",
"an",
"antibacterial",
".",
"To",
"predict",
"clinical",
"outcome",
",",
"the",
"antimicrobial",
"activity",
"of",
"an",
"antibacterial",
"is",
"usually",
"combined",
"with",
"its",
"pharmacokinetic",
"profile",
",",
"and",
"several",
"pharmacological",
"parameters",
"are",
"used",
"as",
"markers",
"of",
"drug",
"efficacy",
"."
],
"offsets": [
0,
4,
15,
23,
26,
40,
48,
53,
67,
77,
85,
88,
96,
103,
105,
111,
119,
124,
132,
142,
144,
148,
157,
160,
169,
171,
175,
179,
195,
199,
215,
226,
229,
233,
246,
248,
250,
263,
272,
275,
290,
294,
301,
304,
308,
318,
325,
330,
332,
336,
339,
345,
354,
362,
372,
381,
385,
394,
397,
407,
412,
414,
420,
429,
433,
439,
442,
453,
460,
462,
466,
469,
478,
487,
492,
497,
502,
508,
511,
521,
531,
540,
542,
548,
552,
561,
564,
579,
587,
598,
601,
605,
618,
620,
623,
629,
646,
649,
663,
672,
681,
690,
694,
708,
711,
715,
723,
734,
748,
752,
760,
773,
787,
790,
793,
806,
808,
811,
819,
828,
835,
837,
841,
855,
864,
867,
870,
884,
887,
895,
904,
909,
913,
929,
936,
938,
942,
950,
966,
977,
981,
986,
989,
997,
1000,
1005,
1013
]
} | 925bd74725c54734a5dd43e633d8d775 | What besides ongoing metabolic activity is required in bactericidal activity? | {
"tokens": [
"What",
"besides",
"ongoing",
"metabolic",
"activity",
"is",
"required",
"in",
"bactericidal",
"activity",
"?"
],
"offsets": [
0,
5,
13,
21,
31,
40,
43,
52,
55,
68,
76
]
} | {
"text": [
"division of bacterial cells"
],
"char_spans": [
{
"start": [
385
],
"end": [
411
]
}
],
"token_spans": [
{
"start": [
56
],
"end": [
59
]
}
]
} | [
"division of bacterial cells"
] |
SQuAD | The successful outcome of antimicrobial therapy with antibacterial compounds depends on several factors. These include host defense mechanisms, the location of infection, and the pharmacokinetic and pharmacodynamic properties of the antibacterial. A bactericidal activity of antibacterials may depend on the bacterial growth phase, and it often requires ongoing metabolic activity and division of bacterial cells. These findings are based on laboratory studies, and in clinical settings have also been shown to eliminate bacterial infection. Since the activity of antibacterials depends frequently on its concentration, in vitro characterization of antibacterial activity commonly includes the determination of the minimum inhibitory concentration and minimum bactericidal concentration of an antibacterial. To predict clinical outcome, the antimicrobial activity of an antibacterial is usually combined with its pharmacokinetic profile, and several pharmacological parameters are used as markers of drug efficacy. | {
"tokens": [
"The",
"successful",
"outcome",
"of",
"antimicrobial",
"therapy",
"with",
"antibacterial",
"compounds",
"depends",
"on",
"several",
"factors",
".",
"These",
"include",
"host",
"defense",
"mechanisms",
",",
"the",
"location",
"of",
"infection",
",",
"and",
"the",
"pharmacokinetic",
"and",
"pharmacodynamic",
"properties",
"of",
"the",
"antibacterial",
".",
"A",
"bactericidal",
"activity",
"of",
"antibacterials",
"may",
"depend",
"on",
"the",
"bacterial",
"growth",
"phase",
",",
"and",
"it",
"often",
"requires",
"ongoing",
"metabolic",
"activity",
"and",
"division",
"of",
"bacterial",
"cells",
".",
"These",
"findings",
"are",
"based",
"on",
"laboratory",
"studies",
",",
"and",
"in",
"clinical",
"settings",
"have",
"also",
"been",
"shown",
"to",
"eliminate",
"bacterial",
"infection",
".",
"Since",
"the",
"activity",
"of",
"antibacterials",
"depends",
"frequently",
"on",
"its",
"concentration",
",",
"in",
"vitro",
"characterization",
"of",
"antibacterial",
"activity",
"commonly",
"includes",
"the",
"determination",
"of",
"the",
"minimum",
"inhibitory",
"concentration",
"and",
"minimum",
"bactericidal",
"concentration",
"of",
"an",
"antibacterial",
".",
"To",
"predict",
"clinical",
"outcome",
",",
"the",
"antimicrobial",
"activity",
"of",
"an",
"antibacterial",
"is",
"usually",
"combined",
"with",
"its",
"pharmacokinetic",
"profile",
",",
"and",
"several",
"pharmacological",
"parameters",
"are",
"used",
"as",
"markers",
"of",
"drug",
"efficacy",
"."
],
"offsets": [
0,
4,
15,
23,
26,
40,
48,
53,
67,
77,
85,
88,
96,
103,
105,
111,
119,
124,
132,
142,
144,
148,
157,
160,
169,
171,
175,
179,
195,
199,
215,
226,
229,
233,
246,
248,
250,
263,
272,
275,
290,
294,
301,
304,
308,
318,
325,
330,
332,
336,
339,
345,
354,
362,
372,
381,
385,
394,
397,
407,
412,
414,
420,
429,
433,
439,
442,
453,
460,
462,
466,
469,
478,
487,
492,
497,
502,
508,
511,
521,
531,
540,
542,
548,
552,
561,
564,
579,
587,
598,
601,
605,
618,
620,
623,
629,
646,
649,
663,
672,
681,
690,
694,
708,
711,
715,
723,
734,
748,
752,
760,
773,
787,
790,
793,
806,
808,
811,
819,
828,
835,
837,
841,
855,
864,
867,
870,
884,
887,
895,
904,
909,
913,
929,
936,
938,
942,
950,
966,
977,
981,
986,
989,
997,
1000,
1005,
1013
]
} | 642dd4bedb9e44c597fc1adcd66e61f4 | What does the activity of antibacterials depends on? | {
"tokens": [
"What",
"does",
"the",
"activity",
"of",
"antibacterials",
"depends",
"on",
"?"
],
"offsets": [
0,
5,
10,
14,
23,
26,
41,
49,
51
]
} | {
"text": [
"concentration"
],
"char_spans": [
{
"start": [
605
],
"end": [
617
]
}
],
"token_spans": [
{
"start": [
91
],
"end": [
91
]
}
]
} | [
"concentration"
] |
SQuAD | The successful outcome of antimicrobial therapy with antibacterial compounds depends on several factors. These include host defense mechanisms, the location of infection, and the pharmacokinetic and pharmacodynamic properties of the antibacterial. A bactericidal activity of antibacterials may depend on the bacterial growth phase, and it often requires ongoing metabolic activity and division of bacterial cells. These findings are based on laboratory studies, and in clinical settings have also been shown to eliminate bacterial infection. Since the activity of antibacterials depends frequently on its concentration, in vitro characterization of antibacterial activity commonly includes the determination of the minimum inhibitory concentration and minimum bactericidal concentration of an antibacterial. To predict clinical outcome, the antimicrobial activity of an antibacterial is usually combined with its pharmacokinetic profile, and several pharmacological parameters are used as markers of drug efficacy. | {
"tokens": [
"The",
"successful",
"outcome",
"of",
"antimicrobial",
"therapy",
"with",
"antibacterial",
"compounds",
"depends",
"on",
"several",
"factors",
".",
"These",
"include",
"host",
"defense",
"mechanisms",
",",
"the",
"location",
"of",
"infection",
",",
"and",
"the",
"pharmacokinetic",
"and",
"pharmacodynamic",
"properties",
"of",
"the",
"antibacterial",
".",
"A",
"bactericidal",
"activity",
"of",
"antibacterials",
"may",
"depend",
"on",
"the",
"bacterial",
"growth",
"phase",
",",
"and",
"it",
"often",
"requires",
"ongoing",
"metabolic",
"activity",
"and",
"division",
"of",
"bacterial",
"cells",
".",
"These",
"findings",
"are",
"based",
"on",
"laboratory",
"studies",
",",
"and",
"in",
"clinical",
"settings",
"have",
"also",
"been",
"shown",
"to",
"eliminate",
"bacterial",
"infection",
".",
"Since",
"the",
"activity",
"of",
"antibacterials",
"depends",
"frequently",
"on",
"its",
"concentration",
",",
"in",
"vitro",
"characterization",
"of",
"antibacterial",
"activity",
"commonly",
"includes",
"the",
"determination",
"of",
"the",
"minimum",
"inhibitory",
"concentration",
"and",
"minimum",
"bactericidal",
"concentration",
"of",
"an",
"antibacterial",
".",
"To",
"predict",
"clinical",
"outcome",
",",
"the",
"antimicrobial",
"activity",
"of",
"an",
"antibacterial",
"is",
"usually",
"combined",
"with",
"its",
"pharmacokinetic",
"profile",
",",
"and",
"several",
"pharmacological",
"parameters",
"are",
"used",
"as",
"markers",
"of",
"drug",
"efficacy",
"."
],
"offsets": [
0,
4,
15,
23,
26,
40,
48,
53,
67,
77,
85,
88,
96,
103,
105,
111,
119,
124,
132,
142,
144,
148,
157,
160,
169,
171,
175,
179,
195,
199,
215,
226,
229,
233,
246,
248,
250,
263,
272,
275,
290,
294,
301,
304,
308,
318,
325,
330,
332,
336,
339,
345,
354,
362,
372,
381,
385,
394,
397,
407,
412,
414,
420,
429,
433,
439,
442,
453,
460,
462,
466,
469,
478,
487,
492,
497,
502,
508,
511,
521,
531,
540,
542,
548,
552,
561,
564,
579,
587,
598,
601,
605,
618,
620,
623,
629,
646,
649,
663,
672,
681,
690,
694,
708,
711,
715,
723,
734,
748,
752,
760,
773,
787,
790,
793,
806,
808,
811,
819,
828,
835,
837,
841,
855,
864,
867,
870,
884,
887,
895,
904,
909,
913,
929,
936,
938,
942,
950,
966,
977,
981,
986,
989,
997,
1000,
1005,
1013
]
} | 4e82f1f74c0f4c398c0f9aa867aca074 | What does a successful treatment using antibiotics entail? | {
"tokens": [
"What",
"does",
"a",
"successful",
"treatment",
"using",
"antibiotics",
"entail",
"?"
],
"offsets": [
0,
5,
10,
12,
23,
33,
39,
51,
57
]
} | {
"text": [
"host defense mechanisms, the location of infection, and the pharmacokinetic and pharmacodynamic properties of the antibacterial"
],
"char_spans": [
{
"start": [
119
],
"end": [
245
]
}
],
"token_spans": [
{
"start": [
16
],
"end": [
33
]
}
]
} | [
"host defense mechanisms, the location of infection, and the pharmacokinetic and pharmacodynamic properties of the antibacterial"
] |
SQuAD | The successful outcome of antimicrobial therapy with antibacterial compounds depends on several factors. These include host defense mechanisms, the location of infection, and the pharmacokinetic and pharmacodynamic properties of the antibacterial. A bactericidal activity of antibacterials may depend on the bacterial growth phase, and it often requires ongoing metabolic activity and division of bacterial cells. These findings are based on laboratory studies, and in clinical settings have also been shown to eliminate bacterial infection. Since the activity of antibacterials depends frequently on its concentration, in vitro characterization of antibacterial activity commonly includes the determination of the minimum inhibitory concentration and minimum bactericidal concentration of an antibacterial. To predict clinical outcome, the antimicrobial activity of an antibacterial is usually combined with its pharmacokinetic profile, and several pharmacological parameters are used as markers of drug efficacy. | {
"tokens": [
"The",
"successful",
"outcome",
"of",
"antimicrobial",
"therapy",
"with",
"antibacterial",
"compounds",
"depends",
"on",
"several",
"factors",
".",
"These",
"include",
"host",
"defense",
"mechanisms",
",",
"the",
"location",
"of",
"infection",
",",
"and",
"the",
"pharmacokinetic",
"and",
"pharmacodynamic",
"properties",
"of",
"the",
"antibacterial",
".",
"A",
"bactericidal",
"activity",
"of",
"antibacterials",
"may",
"depend",
"on",
"the",
"bacterial",
"growth",
"phase",
",",
"and",
"it",
"often",
"requires",
"ongoing",
"metabolic",
"activity",
"and",
"division",
"of",
"bacterial",
"cells",
".",
"These",
"findings",
"are",
"based",
"on",
"laboratory",
"studies",
",",
"and",
"in",
"clinical",
"settings",
"have",
"also",
"been",
"shown",
"to",
"eliminate",
"bacterial",
"infection",
".",
"Since",
"the",
"activity",
"of",
"antibacterials",
"depends",
"frequently",
"on",
"its",
"concentration",
",",
"in",
"vitro",
"characterization",
"of",
"antibacterial",
"activity",
"commonly",
"includes",
"the",
"determination",
"of",
"the",
"minimum",
"inhibitory",
"concentration",
"and",
"minimum",
"bactericidal",
"concentration",
"of",
"an",
"antibacterial",
".",
"To",
"predict",
"clinical",
"outcome",
",",
"the",
"antimicrobial",
"activity",
"of",
"an",
"antibacterial",
"is",
"usually",
"combined",
"with",
"its",
"pharmacokinetic",
"profile",
",",
"and",
"several",
"pharmacological",
"parameters",
"are",
"used",
"as",
"markers",
"of",
"drug",
"efficacy",
"."
],
"offsets": [
0,
4,
15,
23,
26,
40,
48,
53,
67,
77,
85,
88,
96,
103,
105,
111,
119,
124,
132,
142,
144,
148,
157,
160,
169,
171,
175,
179,
195,
199,
215,
226,
229,
233,
246,
248,
250,
263,
272,
275,
290,
294,
301,
304,
308,
318,
325,
330,
332,
336,
339,
345,
354,
362,
372,
381,
385,
394,
397,
407,
412,
414,
420,
429,
433,
439,
442,
453,
460,
462,
466,
469,
478,
487,
492,
497,
502,
508,
511,
521,
531,
540,
542,
548,
552,
561,
564,
579,
587,
598,
601,
605,
618,
620,
623,
629,
646,
649,
663,
672,
681,
690,
694,
708,
711,
715,
723,
734,
748,
752,
760,
773,
787,
790,
793,
806,
808,
811,
819,
828,
835,
837,
841,
855,
864,
867,
870,
884,
887,
895,
904,
909,
913,
929,
936,
938,
942,
950,
966,
977,
981,
986,
989,
997,
1000,
1005,
1013
]
} | 8110da6157f0417fa1fbc357488d2429 | How do you predict the clinical result? | {
"tokens": [
"How",
"do",
"you",
"predict",
"the",
"clinical",
"result",
"?"
],
"offsets": [
0,
4,
7,
11,
19,
23,
32,
38
]
} | {
"text": [
"several pharmacological parameters are used as markers of drug efficacy"
],
"char_spans": [
{
"start": [
942
],
"end": [
1012
]
}
],
"token_spans": [
{
"start": [
136
],
"end": [
145
]
}
]
} | [
"several pharmacological parameters are used as markers of drug efficacy"
] |
SQuAD | Other authors have focused on the structural conditions leading up to genocide and the psychological and social processes that create an evolution toward genocide. Ervin Staub showed that economic deterioration and political confusion and disorganization were starting points of increasing discrimination and violence in many instances of genocides and mass killing. They lead to scapegoating a group and ideologies that identified that group as an enemy. A history of devaluation of the group that becomes the victim, past violence against the group that becomes the perpetrator leading to psychological wounds, authoritarian cultures and political systems, and the passivity of internal and external witnesses (bystanders) all contribute to the probability that the violence develops into genocide. Intense conflict between groups that is unresolved, becomes intractable and violent can also lead to genocide. The conditions that lead to genocide provide guidance to early prevention, such as humanizing a devalued group, creating ideologies that embrace all groups, and activating bystander responses. There is substantial research to indicate how this can be done, but information is only slowly transformed into action. | {
"tokens": [
"Other",
"authors",
"have",
"focused",
"on",
"the",
"structural",
"conditions",
"leading",
"up",
"to",
"genocide",
"and",
"the",
"psychological",
"and",
"social",
"processes",
"that",
"create",
"an",
"evolution",
"toward",
"genocide",
".",
"Ervin",
"Staub",
"showed",
"that",
"economic",
"deterioration",
"and",
"political",
"confusion",
"and",
"disorganization",
"were",
"starting",
"points",
"of",
"increasing",
"discrimination",
"and",
"violence",
"in",
"many",
"instances",
"of",
"genocides",
"and",
"mass",
"killing",
".",
"They",
"lead",
"to",
"scapegoating",
"a",
"group",
"and",
"ideologies",
"that",
"identified",
"that",
"group",
"as",
"an",
"enemy",
".",
"A",
"history",
"of",
"devaluation",
"of",
"the",
"group",
"that",
"becomes",
"the",
"victim",
",",
"past",
"violence",
"against",
"the",
"group",
"that",
"becomes",
"the",
"perpetrator",
"leading",
"to",
"psychological",
"wounds",
",",
"authoritarian",
"cultures",
"and",
"political",
"systems",
",",
"and",
"the",
"passivity",
"of",
"internal",
"and",
"external",
"witnesses",
"(",
"bystanders",
")",
"all",
"contribute",
"to",
"the",
"probability",
"that",
"the",
"violence",
"develops",
"into",
"genocide",
".",
"Intense",
"conflict",
"between",
"groups",
"that",
"is",
"unresolved",
",",
"becomes",
"intractable",
"and",
"violent",
"can",
"also",
"lead",
"to",
"genocide",
".",
"The",
"conditions",
"that",
"lead",
"to",
"genocide",
"provide",
"guidance",
"to",
"early",
"prevention",
",",
"such",
"as",
"humanizing",
"a",
"devalued",
"group",
",",
"creating",
"ideologies",
"that",
"embrace",
"all",
"groups",
",",
"and",
"activating",
"bystander",
"responses",
".",
"There",
"is",
"substantial",
"research",
"to",
"indicate",
"how",
"this",
"can",
"be",
"done",
",",
"but",
"information",
"is",
"only",
"slowly",
"transformed",
"into",
"action",
"."
],
"offsets": [
0,
6,
14,
19,
27,
30,
34,
45,
56,
64,
67,
70,
79,
83,
87,
101,
105,
112,
122,
127,
134,
137,
147,
154,
162,
164,
170,
176,
183,
188,
197,
211,
215,
225,
235,
239,
255,
260,
269,
276,
279,
290,
305,
309,
318,
321,
326,
336,
339,
349,
353,
358,
365,
367,
372,
377,
380,
393,
395,
401,
405,
416,
421,
432,
437,
443,
446,
449,
454,
456,
458,
466,
469,
481,
484,
488,
494,
499,
507,
511,
517,
519,
524,
533,
541,
545,
551,
556,
564,
568,
580,
588,
591,
605,
611,
613,
627,
636,
640,
650,
657,
659,
663,
667,
677,
680,
689,
693,
702,
712,
713,
723,
725,
729,
740,
743,
747,
759,
764,
768,
777,
786,
791,
799,
801,
809,
818,
826,
833,
838,
841,
851,
853,
861,
873,
877,
885,
889,
894,
899,
902,
910,
912,
916,
927,
932,
937,
940,
949,
957,
966,
969,
975,
985,
987,
992,
995,
1006,
1008,
1017,
1022,
1024,
1033,
1044,
1049,
1057,
1061,
1067,
1069,
1073,
1084,
1094,
1103,
1105,
1111,
1114,
1126,
1135,
1138,
1147,
1151,
1156,
1160,
1163,
1167,
1169,
1173,
1185,
1188,
1193,
1200,
1212,
1217,
1223
]
} | ca251c37b4e749f19006422b73822b53 | In the build-up to genocide, what have other authors focused on? | {
"tokens": [
"In",
"the",
"build",
"-",
"up",
"to",
"genocide",
",",
"what",
"have",
"other",
"authors",
"focused",
"on",
"?"
],
"offsets": [
0,
3,
7,
12,
13,
16,
19,
27,
29,
34,
39,
45,
53,
61,
63
]
} | {
"text": [
"structural conditions"
],
"char_spans": [
{
"start": [
34
],
"end": [
54
]
}
],
"token_spans": [
{
"start": [
6
],
"end": [
7
]
}
]
} | [
"structural conditions"
] |
SQuAD | Other authors have focused on the structural conditions leading up to genocide and the psychological and social processes that create an evolution toward genocide. Ervin Staub showed that economic deterioration and political confusion and disorganization were starting points of increasing discrimination and violence in many instances of genocides and mass killing. They lead to scapegoating a group and ideologies that identified that group as an enemy. A history of devaluation of the group that becomes the victim, past violence against the group that becomes the perpetrator leading to psychological wounds, authoritarian cultures and political systems, and the passivity of internal and external witnesses (bystanders) all contribute to the probability that the violence develops into genocide. Intense conflict between groups that is unresolved, becomes intractable and violent can also lead to genocide. The conditions that lead to genocide provide guidance to early prevention, such as humanizing a devalued group, creating ideologies that embrace all groups, and activating bystander responses. There is substantial research to indicate how this can be done, but information is only slowly transformed into action. | {
"tokens": [
"Other",
"authors",
"have",
"focused",
"on",
"the",
"structural",
"conditions",
"leading",
"up",
"to",
"genocide",
"and",
"the",
"psychological",
"and",
"social",
"processes",
"that",
"create",
"an",
"evolution",
"toward",
"genocide",
".",
"Ervin",
"Staub",
"showed",
"that",
"economic",
"deterioration",
"and",
"political",
"confusion",
"and",
"disorganization",
"were",
"starting",
"points",
"of",
"increasing",
"discrimination",
"and",
"violence",
"in",
"many",
"instances",
"of",
"genocides",
"and",
"mass",
"killing",
".",
"They",
"lead",
"to",
"scapegoating",
"a",
"group",
"and",
"ideologies",
"that",
"identified",
"that",
"group",
"as",
"an",
"enemy",
".",
"A",
"history",
"of",
"devaluation",
"of",
"the",
"group",
"that",
"becomes",
"the",
"victim",
",",
"past",
"violence",
"against",
"the",
"group",
"that",
"becomes",
"the",
"perpetrator",
"leading",
"to",
"psychological",
"wounds",
",",
"authoritarian",
"cultures",
"and",
"political",
"systems",
",",
"and",
"the",
"passivity",
"of",
"internal",
"and",
"external",
"witnesses",
"(",
"bystanders",
")",
"all",
"contribute",
"to",
"the",
"probability",
"that",
"the",
"violence",
"develops",
"into",
"genocide",
".",
"Intense",
"conflict",
"between",
"groups",
"that",
"is",
"unresolved",
",",
"becomes",
"intractable",
"and",
"violent",
"can",
"also",
"lead",
"to",
"genocide",
".",
"The",
"conditions",
"that",
"lead",
"to",
"genocide",
"provide",
"guidance",
"to",
"early",
"prevention",
",",
"such",
"as",
"humanizing",
"a",
"devalued",
"group",
",",
"creating",
"ideologies",
"that",
"embrace",
"all",
"groups",
",",
"and",
"activating",
"bystander",
"responses",
".",
"There",
"is",
"substantial",
"research",
"to",
"indicate",
"how",
"this",
"can",
"be",
"done",
",",
"but",
"information",
"is",
"only",
"slowly",
"transformed",
"into",
"action",
"."
],
"offsets": [
0,
6,
14,
19,
27,
30,
34,
45,
56,
64,
67,
70,
79,
83,
87,
101,
105,
112,
122,
127,
134,
137,
147,
154,
162,
164,
170,
176,
183,
188,
197,
211,
215,
225,
235,
239,
255,
260,
269,
276,
279,
290,
305,
309,
318,
321,
326,
336,
339,
349,
353,
358,
365,
367,
372,
377,
380,
393,
395,
401,
405,
416,
421,
432,
437,
443,
446,
449,
454,
456,
458,
466,
469,
481,
484,
488,
494,
499,
507,
511,
517,
519,
524,
533,
541,
545,
551,
556,
564,
568,
580,
588,
591,
605,
611,
613,
627,
636,
640,
650,
657,
659,
663,
667,
677,
680,
689,
693,
702,
712,
713,
723,
725,
729,
740,
743,
747,
759,
764,
768,
777,
786,
791,
799,
801,
809,
818,
826,
833,
838,
841,
851,
853,
861,
873,
877,
885,
889,
894,
899,
902,
910,
912,
916,
927,
932,
937,
940,
949,
957,
966,
969,
975,
985,
987,
992,
995,
1006,
1008,
1017,
1022,
1024,
1033,
1044,
1049,
1057,
1061,
1067,
1069,
1073,
1084,
1094,
1103,
1105,
1111,
1114,
1126,
1135,
1138,
1147,
1151,
1156,
1160,
1163,
1167,
1169,
1173,
1185,
1188,
1193,
1200,
1212,
1217,
1223
]
} | f79c89a274574a3ab415f6e03a3ad073 | What processes are thought to create an evolution toward genocide? | {
"tokens": [
"What",
"processes",
"are",
"thought",
"to",
"create",
"an",
"evolution",
"toward",
"genocide",
"?"
],
"offsets": [
0,
5,
15,
19,
27,
30,
37,
40,
50,
57,
65
]
} | {
"text": [
"psychological and social"
],
"char_spans": [
{
"start": [
87
],
"end": [
110
]
}
],
"token_spans": [
{
"start": [
14
],
"end": [
16
]
}
]
} | [
"psychological and social"
] |
SQuAD | Other authors have focused on the structural conditions leading up to genocide and the psychological and social processes that create an evolution toward genocide. Ervin Staub showed that economic deterioration and political confusion and disorganization were starting points of increasing discrimination and violence in many instances of genocides and mass killing. They lead to scapegoating a group and ideologies that identified that group as an enemy. A history of devaluation of the group that becomes the victim, past violence against the group that becomes the perpetrator leading to psychological wounds, authoritarian cultures and political systems, and the passivity of internal and external witnesses (bystanders) all contribute to the probability that the violence develops into genocide. Intense conflict between groups that is unresolved, becomes intractable and violent can also lead to genocide. The conditions that lead to genocide provide guidance to early prevention, such as humanizing a devalued group, creating ideologies that embrace all groups, and activating bystander responses. There is substantial research to indicate how this can be done, but information is only slowly transformed into action. | {
"tokens": [
"Other",
"authors",
"have",
"focused",
"on",
"the",
"structural",
"conditions",
"leading",
"up",
"to",
"genocide",
"and",
"the",
"psychological",
"and",
"social",
"processes",
"that",
"create",
"an",
"evolution",
"toward",
"genocide",
".",
"Ervin",
"Staub",
"showed",
"that",
"economic",
"deterioration",
"and",
"political",
"confusion",
"and",
"disorganization",
"were",
"starting",
"points",
"of",
"increasing",
"discrimination",
"and",
"violence",
"in",
"many",
"instances",
"of",
"genocides",
"and",
"mass",
"killing",
".",
"They",
"lead",
"to",
"scapegoating",
"a",
"group",
"and",
"ideologies",
"that",
"identified",
"that",
"group",
"as",
"an",
"enemy",
".",
"A",
"history",
"of",
"devaluation",
"of",
"the",
"group",
"that",
"becomes",
"the",
"victim",
",",
"past",
"violence",
"against",
"the",
"group",
"that",
"becomes",
"the",
"perpetrator",
"leading",
"to",
"psychological",
"wounds",
",",
"authoritarian",
"cultures",
"and",
"political",
"systems",
",",
"and",
"the",
"passivity",
"of",
"internal",
"and",
"external",
"witnesses",
"(",
"bystanders",
")",
"all",
"contribute",
"to",
"the",
"probability",
"that",
"the",
"violence",
"develops",
"into",
"genocide",
".",
"Intense",
"conflict",
"between",
"groups",
"that",
"is",
"unresolved",
",",
"becomes",
"intractable",
"and",
"violent",
"can",
"also",
"lead",
"to",
"genocide",
".",
"The",
"conditions",
"that",
"lead",
"to",
"genocide",
"provide",
"guidance",
"to",
"early",
"prevention",
",",
"such",
"as",
"humanizing",
"a",
"devalued",
"group",
",",
"creating",
"ideologies",
"that",
"embrace",
"all",
"groups",
",",
"and",
"activating",
"bystander",
"responses",
".",
"There",
"is",
"substantial",
"research",
"to",
"indicate",
"how",
"this",
"can",
"be",
"done",
",",
"but",
"information",
"is",
"only",
"slowly",
"transformed",
"into",
"action",
"."
],
"offsets": [
0,
6,
14,
19,
27,
30,
34,
45,
56,
64,
67,
70,
79,
83,
87,
101,
105,
112,
122,
127,
134,
137,
147,
154,
162,
164,
170,
176,
183,
188,
197,
211,
215,
225,
235,
239,
255,
260,
269,
276,
279,
290,
305,
309,
318,
321,
326,
336,
339,
349,
353,
358,
365,
367,
372,
377,
380,
393,
395,
401,
405,
416,
421,
432,
437,
443,
446,
449,
454,
456,
458,
466,
469,
481,
484,
488,
494,
499,
507,
511,
517,
519,
524,
533,
541,
545,
551,
556,
564,
568,
580,
588,
591,
605,
611,
613,
627,
636,
640,
650,
657,
659,
663,
667,
677,
680,
689,
693,
702,
712,
713,
723,
725,
729,
740,
743,
747,
759,
764,
768,
777,
786,
791,
799,
801,
809,
818,
826,
833,
838,
841,
851,
853,
861,
873,
877,
885,
889,
894,
899,
902,
910,
912,
916,
927,
932,
937,
940,
949,
957,
966,
969,
975,
985,
987,
992,
995,
1006,
1008,
1017,
1022,
1024,
1033,
1044,
1049,
1057,
1061,
1067,
1069,
1073,
1084,
1094,
1103,
1105,
1111,
1114,
1126,
1135,
1138,
1147,
1151,
1156,
1160,
1163,
1167,
1169,
1173,
1185,
1188,
1193,
1200,
1212,
1217,
1223
]
} | ce94c0543aca436a95dd9442976595be | Who revealed the starting points of this evolution to be economic deterioration and political confusion? | {
"tokens": [
"Who",
"revealed",
"the",
"starting",
"points",
"of",
"this",
"evolution",
"to",
"be",
"economic",
"deterioration",
"and",
"political",
"confusion",
"?"
],
"offsets": [
0,
4,
13,
17,
26,
33,
36,
41,
51,
54,
57,
66,
80,
84,
94,
103
]
} | {
"text": [
"Ervin Staub"
],
"char_spans": [
{
"start": [
164
],
"end": [
174
]
}
],
"token_spans": [
{
"start": [
25
],
"end": [
26
]
}
]
} | [
"Ervin Staub"
] |
SQuAD | Other authors have focused on the structural conditions leading up to genocide and the psychological and social processes that create an evolution toward genocide. Ervin Staub showed that economic deterioration and political confusion and disorganization were starting points of increasing discrimination and violence in many instances of genocides and mass killing. They lead to scapegoating a group and ideologies that identified that group as an enemy. A history of devaluation of the group that becomes the victim, past violence against the group that becomes the perpetrator leading to psychological wounds, authoritarian cultures and political systems, and the passivity of internal and external witnesses (bystanders) all contribute to the probability that the violence develops into genocide. Intense conflict between groups that is unresolved, becomes intractable and violent can also lead to genocide. The conditions that lead to genocide provide guidance to early prevention, such as humanizing a devalued group, creating ideologies that embrace all groups, and activating bystander responses. There is substantial research to indicate how this can be done, but information is only slowly transformed into action. | {
"tokens": [
"Other",
"authors",
"have",
"focused",
"on",
"the",
"structural",
"conditions",
"leading",
"up",
"to",
"genocide",
"and",
"the",
"psychological",
"and",
"social",
"processes",
"that",
"create",
"an",
"evolution",
"toward",
"genocide",
".",
"Ervin",
"Staub",
"showed",
"that",
"economic",
"deterioration",
"and",
"political",
"confusion",
"and",
"disorganization",
"were",
"starting",
"points",
"of",
"increasing",
"discrimination",
"and",
"violence",
"in",
"many",
"instances",
"of",
"genocides",
"and",
"mass",
"killing",
".",
"They",
"lead",
"to",
"scapegoating",
"a",
"group",
"and",
"ideologies",
"that",
"identified",
"that",
"group",
"as",
"an",
"enemy",
".",
"A",
"history",
"of",
"devaluation",
"of",
"the",
"group",
"that",
"becomes",
"the",
"victim",
",",
"past",
"violence",
"against",
"the",
"group",
"that",
"becomes",
"the",
"perpetrator",
"leading",
"to",
"psychological",
"wounds",
",",
"authoritarian",
"cultures",
"and",
"political",
"systems",
",",
"and",
"the",
"passivity",
"of",
"internal",
"and",
"external",
"witnesses",
"(",
"bystanders",
")",
"all",
"contribute",
"to",
"the",
"probability",
"that",
"the",
"violence",
"develops",
"into",
"genocide",
".",
"Intense",
"conflict",
"between",
"groups",
"that",
"is",
"unresolved",
",",
"becomes",
"intractable",
"and",
"violent",
"can",
"also",
"lead",
"to",
"genocide",
".",
"The",
"conditions",
"that",
"lead",
"to",
"genocide",
"provide",
"guidance",
"to",
"early",
"prevention",
",",
"such",
"as",
"humanizing",
"a",
"devalued",
"group",
",",
"creating",
"ideologies",
"that",
"embrace",
"all",
"groups",
",",
"and",
"activating",
"bystander",
"responses",
".",
"There",
"is",
"substantial",
"research",
"to",
"indicate",
"how",
"this",
"can",
"be",
"done",
",",
"but",
"information",
"is",
"only",
"slowly",
"transformed",
"into",
"action",
"."
],
"offsets": [
0,
6,
14,
19,
27,
30,
34,
45,
56,
64,
67,
70,
79,
83,
87,
101,
105,
112,
122,
127,
134,
137,
147,
154,
162,
164,
170,
176,
183,
188,
197,
211,
215,
225,
235,
239,
255,
260,
269,
276,
279,
290,
305,
309,
318,
321,
326,
336,
339,
349,
353,
358,
365,
367,
372,
377,
380,
393,
395,
401,
405,
416,
421,
432,
437,
443,
446,
449,
454,
456,
458,
466,
469,
481,
484,
488,
494,
499,
507,
511,
517,
519,
524,
533,
541,
545,
551,
556,
564,
568,
580,
588,
591,
605,
611,
613,
627,
636,
640,
650,
657,
659,
663,
667,
677,
680,
689,
693,
702,
712,
713,
723,
725,
729,
740,
743,
747,
759,
764,
768,
777,
786,
791,
799,
801,
809,
818,
826,
833,
838,
841,
851,
853,
861,
873,
877,
885,
889,
894,
899,
902,
910,
912,
916,
927,
932,
937,
940,
949,
957,
966,
969,
975,
985,
987,
992,
995,
1006,
1008,
1017,
1022,
1024,
1033,
1044,
1049,
1057,
1061,
1067,
1069,
1073,
1084,
1094,
1103,
1105,
1111,
1114,
1126,
1135,
1138,
1147,
1151,
1156,
1160,
1163,
1167,
1169,
1173,
1185,
1188,
1193,
1200,
1212,
1217,
1223
]
} | 0f1d6be2312848818bb024e19133785f | A history of what is just one factor that contributes to the probability of violence developing into genocide? | {
"tokens": [
"A",
"history",
"of",
"what",
"is",
"just",
"one",
"factor",
"that",
"contributes",
"to",
"the",
"probability",
"of",
"violence",
"developing",
"into",
"genocide",
"?"
],
"offsets": [
0,
2,
10,
13,
18,
21,
26,
30,
37,
42,
54,
57,
61,
73,
76,
85,
96,
101,
109
]
} | {
"text": [
"devaluation of the group"
],
"char_spans": [
{
"start": [
469
],
"end": [
492
]
}
],
"token_spans": [
{
"start": [
72
],
"end": [
75
]
}
]
} | [
"devaluation of the group"
] |
SQuAD | Other authors have focused on the structural conditions leading up to genocide and the psychological and social processes that create an evolution toward genocide. Ervin Staub showed that economic deterioration and political confusion and disorganization were starting points of increasing discrimination and violence in many instances of genocides and mass killing. They lead to scapegoating a group and ideologies that identified that group as an enemy. A history of devaluation of the group that becomes the victim, past violence against the group that becomes the perpetrator leading to psychological wounds, authoritarian cultures and political systems, and the passivity of internal and external witnesses (bystanders) all contribute to the probability that the violence develops into genocide. Intense conflict between groups that is unresolved, becomes intractable and violent can also lead to genocide. The conditions that lead to genocide provide guidance to early prevention, such as humanizing a devalued group, creating ideologies that embrace all groups, and activating bystander responses. There is substantial research to indicate how this can be done, but information is only slowly transformed into action. | {
"tokens": [
"Other",
"authors",
"have",
"focused",
"on",
"the",
"structural",
"conditions",
"leading",
"up",
"to",
"genocide",
"and",
"the",
"psychological",
"and",
"social",
"processes",
"that",
"create",
"an",
"evolution",
"toward",
"genocide",
".",
"Ervin",
"Staub",
"showed",
"that",
"economic",
"deterioration",
"and",
"political",
"confusion",
"and",
"disorganization",
"were",
"starting",
"points",
"of",
"increasing",
"discrimination",
"and",
"violence",
"in",
"many",
"instances",
"of",
"genocides",
"and",
"mass",
"killing",
".",
"They",
"lead",
"to",
"scapegoating",
"a",
"group",
"and",
"ideologies",
"that",
"identified",
"that",
"group",
"as",
"an",
"enemy",
".",
"A",
"history",
"of",
"devaluation",
"of",
"the",
"group",
"that",
"becomes",
"the",
"victim",
",",
"past",
"violence",
"against",
"the",
"group",
"that",
"becomes",
"the",
"perpetrator",
"leading",
"to",
"psychological",
"wounds",
",",
"authoritarian",
"cultures",
"and",
"political",
"systems",
",",
"and",
"the",
"passivity",
"of",
"internal",
"and",
"external",
"witnesses",
"(",
"bystanders",
")",
"all",
"contribute",
"to",
"the",
"probability",
"that",
"the",
"violence",
"develops",
"into",
"genocide",
".",
"Intense",
"conflict",
"between",
"groups",
"that",
"is",
"unresolved",
",",
"becomes",
"intractable",
"and",
"violent",
"can",
"also",
"lead",
"to",
"genocide",
".",
"The",
"conditions",
"that",
"lead",
"to",
"genocide",
"provide",
"guidance",
"to",
"early",
"prevention",
",",
"such",
"as",
"humanizing",
"a",
"devalued",
"group",
",",
"creating",
"ideologies",
"that",
"embrace",
"all",
"groups",
",",
"and",
"activating",
"bystander",
"responses",
".",
"There",
"is",
"substantial",
"research",
"to",
"indicate",
"how",
"this",
"can",
"be",
"done",
",",
"but",
"information",
"is",
"only",
"slowly",
"transformed",
"into",
"action",
"."
],
"offsets": [
0,
6,
14,
19,
27,
30,
34,
45,
56,
64,
67,
70,
79,
83,
87,
101,
105,
112,
122,
127,
134,
137,
147,
154,
162,
164,
170,
176,
183,
188,
197,
211,
215,
225,
235,
239,
255,
260,
269,
276,
279,
290,
305,
309,
318,
321,
326,
336,
339,
349,
353,
358,
365,
367,
372,
377,
380,
393,
395,
401,
405,
416,
421,
432,
437,
443,
446,
449,
454,
456,
458,
466,
469,
481,
484,
488,
494,
499,
507,
511,
517,
519,
524,
533,
541,
545,
551,
556,
564,
568,
580,
588,
591,
605,
611,
613,
627,
636,
640,
650,
657,
659,
663,
667,
677,
680,
689,
693,
702,
712,
713,
723,
725,
729,
740,
743,
747,
759,
764,
768,
777,
786,
791,
799,
801,
809,
818,
826,
833,
838,
841,
851,
853,
861,
873,
877,
885,
889,
894,
899,
902,
910,
912,
916,
927,
932,
937,
940,
949,
957,
966,
969,
975,
985,
987,
992,
995,
1006,
1008,
1017,
1022,
1024,
1033,
1044,
1049,
1057,
1061,
1067,
1069,
1073,
1084,
1094,
1103,
1105,
1111,
1114,
1126,
1135,
1138,
1147,
1151,
1156,
1160,
1163,
1167,
1169,
1173,
1185,
1188,
1193,
1200,
1212,
1217,
1223
]
} | 77b30db488e54a29bfd248d0d910d3de | What is one preventive effort in circumventing conditions that lead to genocide? | {
"tokens": [
"What",
"is",
"one",
"preventive",
"effort",
"in",
"circumventing",
"conditions",
"that",
"lead",
"to",
"genocide",
"?"
],
"offsets": [
0,
5,
8,
12,
23,
30,
33,
47,
58,
63,
68,
71,
79
]
} | {
"text": [
"humanizing a devalued group"
],
"char_spans": [
{
"start": [
995
],
"end": [
1021
]
}
],
"token_spans": [
{
"start": [
156
],
"end": [
159
]
}
]
} | [
"humanizing a devalued group"
] |
SQuAD | Jonassohn and Björnson postulate that the major reason why no single generally accepted genocide definition has emerged is because academics have adjusted their focus to emphasise different periods and have found it expedient to use slightly different definitions to help them interpret events. For example, Frank Chalk and Kurt Jonassohn studied the whole of human history, while Leo Kuper and R. J. Rummel in their more recent works concentrated on the 20th century, and Helen Fein, Barbara Harff and Ted Gurr have looked at post World War II events. Jonassohn and Björnson are critical of some of these studies, arguing that they are too expansive, and conclude that the academic discipline of genocide studies is too young to have a canon of work on which to build an academic paradigm. | {
"tokens": [
"Jonassohn",
"and",
"Björnson",
"postulate",
"that",
"the",
"major",
"reason",
"why",
"no",
"single",
"generally",
"accepted",
"genocide",
"definition",
"has",
"emerged",
"is",
"because",
"academics",
"have",
"adjusted",
"their",
"focus",
"to",
"emphasise",
"different",
"periods",
"and",
"have",
"found",
"it",
"expedient",
"to",
"use",
"slightly",
"different",
"definitions",
"to",
"help",
"them",
"interpret",
"events",
".",
"For",
"example",
",",
"Frank",
"Chalk",
"and",
"Kurt",
"Jonassohn",
"studied",
"the",
"whole",
"of",
"human",
"history",
",",
"while",
"Leo",
"Kuper",
"and",
"R.",
"J.",
"Rummel",
"in",
"their",
"more",
"recent",
"works",
"concentrated",
"on",
"the",
"20th",
"century",
",",
"and",
"Helen",
"Fein",
",",
"Barbara",
"Harff",
"and",
"Ted",
"Gurr",
"have",
"looked",
"at",
"post",
"World",
"War",
"II",
"events",
".",
"Jonassohn",
"and",
"Björnson",
"are",
"critical",
"of",
"some",
"of",
"these",
"studies",
",",
"arguing",
"that",
"they",
"are",
"too",
"expansive",
",",
"and",
"conclude",
"that",
"the",
"academic",
"discipline",
"of",
"genocide",
"studies",
"is",
"too",
"young",
"to",
"have",
"a",
"canon",
"of",
"work",
"on",
"which",
"to",
"build",
"an",
"academic",
"paradigm",
"."
],
"offsets": [
0,
10,
14,
23,
33,
38,
42,
48,
55,
59,
62,
69,
79,
88,
97,
108,
112,
120,
123,
131,
141,
146,
155,
161,
167,
170,
180,
190,
198,
202,
207,
213,
216,
226,
229,
233,
242,
252,
264,
267,
272,
277,
287,
293,
295,
299,
306,
308,
314,
320,
324,
329,
339,
347,
351,
357,
360,
366,
373,
375,
381,
385,
391,
395,
398,
401,
408,
411,
417,
422,
429,
435,
448,
451,
455,
460,
467,
469,
473,
479,
483,
485,
493,
499,
503,
507,
512,
517,
524,
527,
532,
538,
542,
545,
551,
553,
563,
567,
576,
580,
589,
592,
597,
600,
606,
613,
615,
623,
628,
633,
637,
641,
650,
652,
656,
665,
670,
674,
683,
694,
697,
706,
714,
717,
721,
727,
730,
735,
737,
743,
746,
751,
754,
760,
763,
769,
772,
781,
789
]
} | c83ace4e46044af9a417c9e4b1c2a8c7 | What two writers examined the lack of an accepted and singular definition for genocide? | {
"tokens": [
"What",
"two",
"writers",
"examined",
"the",
"lack",
"of",
"an",
"accepted",
"and",
"singular",
"definition",
"for",
"genocide",
"?"
],
"offsets": [
0,
5,
9,
17,
26,
30,
35,
38,
41,
50,
54,
63,
74,
78,
86
]
} | {
"text": [
"Jonassohn and Björnson"
],
"char_spans": [
{
"start": [
0,
553
],
"end": [
21,
574
]
}
],
"token_spans": [
{
"start": [
0,
95
],
"end": [
2,
97
]
}
]
} | [
"Jonassohn and Björnson"
] |
SQuAD | Jonassohn and Björnson postulate that the major reason why no single generally accepted genocide definition has emerged is because academics have adjusted their focus to emphasise different periods and have found it expedient to use slightly different definitions to help them interpret events. For example, Frank Chalk and Kurt Jonassohn studied the whole of human history, while Leo Kuper and R. J. Rummel in their more recent works concentrated on the 20th century, and Helen Fein, Barbara Harff and Ted Gurr have looked at post World War II events. Jonassohn and Björnson are critical of some of these studies, arguing that they are too expansive, and conclude that the academic discipline of genocide studies is too young to have a canon of work on which to build an academic paradigm. | {
"tokens": [
"Jonassohn",
"and",
"Björnson",
"postulate",
"that",
"the",
"major",
"reason",
"why",
"no",
"single",
"generally",
"accepted",
"genocide",
"definition",
"has",
"emerged",
"is",
"because",
"academics",
"have",
"adjusted",
"their",
"focus",
"to",
"emphasise",
"different",
"periods",
"and",
"have",
"found",
"it",
"expedient",
"to",
"use",
"slightly",
"different",
"definitions",
"to",
"help",
"them",
"interpret",
"events",
".",
"For",
"example",
",",
"Frank",
"Chalk",
"and",
"Kurt",
"Jonassohn",
"studied",
"the",
"whole",
"of",
"human",
"history",
",",
"while",
"Leo",
"Kuper",
"and",
"R.",
"J.",
"Rummel",
"in",
"their",
"more",
"recent",
"works",
"concentrated",
"on",
"the",
"20th",
"century",
",",
"and",
"Helen",
"Fein",
",",
"Barbara",
"Harff",
"and",
"Ted",
"Gurr",
"have",
"looked",
"at",
"post",
"World",
"War",
"II",
"events",
".",
"Jonassohn",
"and",
"Björnson",
"are",
"critical",
"of",
"some",
"of",
"these",
"studies",
",",
"arguing",
"that",
"they",
"are",
"too",
"expansive",
",",
"and",
"conclude",
"that",
"the",
"academic",
"discipline",
"of",
"genocide",
"studies",
"is",
"too",
"young",
"to",
"have",
"a",
"canon",
"of",
"work",
"on",
"which",
"to",
"build",
"an",
"academic",
"paradigm",
"."
],
"offsets": [
0,
10,
14,
23,
33,
38,
42,
48,
55,
59,
62,
69,
79,
88,
97,
108,
112,
120,
123,
131,
141,
146,
155,
161,
167,
170,
180,
190,
198,
202,
207,
213,
216,
226,
229,
233,
242,
252,
264,
267,
272,
277,
287,
293,
295,
299,
306,
308,
314,
320,
324,
329,
339,
347,
351,
357,
360,
366,
373,
375,
381,
385,
391,
395,
398,
401,
408,
411,
417,
422,
429,
435,
448,
451,
455,
460,
467,
469,
473,
479,
483,
485,
493,
499,
503,
507,
512,
517,
524,
527,
532,
538,
542,
545,
551,
553,
563,
567,
576,
580,
589,
592,
597,
600,
606,
613,
615,
623,
628,
633,
637,
641,
650,
652,
656,
665,
670,
674,
683,
694,
697,
706,
714,
717,
721,
727,
730,
735,
737,
743,
746,
751,
754,
760,
763,
769,
772,
781,
789
]
} | 200fb7e4b5ac4aeaad5ddfdb259fdac9 | The two writers suggested that academics adjusted what in their different definitions to assist them in interpreting events? | {
"tokens": [
"The",
"two",
"writers",
"suggested",
"that",
"academics",
"adjusted",
"what",
"in",
"their",
"different",
"definitions",
"to",
"assist",
"them",
"in",
"interpreting",
"events",
"?"
],
"offsets": [
0,
4,
8,
16,
26,
31,
41,
50,
55,
58,
64,
74,
86,
89,
96,
101,
104,
117,
123
]
} | {
"text": [
"their focus"
],
"char_spans": [
{
"start": [
155
],
"end": [
165
]
}
],
"token_spans": [
{
"start": [
22
],
"end": [
23
]
}
]
} | [
"their focus"
] |
SQuAD | Jonassohn and Björnson postulate that the major reason why no single generally accepted genocide definition has emerged is because academics have adjusted their focus to emphasise different periods and have found it expedient to use slightly different definitions to help them interpret events. For example, Frank Chalk and Kurt Jonassohn studied the whole of human history, while Leo Kuper and R. J. Rummel in their more recent works concentrated on the 20th century, and Helen Fein, Barbara Harff and Ted Gurr have looked at post World War II events. Jonassohn and Björnson are critical of some of these studies, arguing that they are too expansive, and conclude that the academic discipline of genocide studies is too young to have a canon of work on which to build an academic paradigm. | {
"tokens": [
"Jonassohn",
"and",
"Björnson",
"postulate",
"that",
"the",
"major",
"reason",
"why",
"no",
"single",
"generally",
"accepted",
"genocide",
"definition",
"has",
"emerged",
"is",
"because",
"academics",
"have",
"adjusted",
"their",
"focus",
"to",
"emphasise",
"different",
"periods",
"and",
"have",
"found",
"it",
"expedient",
"to",
"use",
"slightly",
"different",
"definitions",
"to",
"help",
"them",
"interpret",
"events",
".",
"For",
"example",
",",
"Frank",
"Chalk",
"and",
"Kurt",
"Jonassohn",
"studied",
"the",
"whole",
"of",
"human",
"history",
",",
"while",
"Leo",
"Kuper",
"and",
"R.",
"J.",
"Rummel",
"in",
"their",
"more",
"recent",
"works",
"concentrated",
"on",
"the",
"20th",
"century",
",",
"and",
"Helen",
"Fein",
",",
"Barbara",
"Harff",
"and",
"Ted",
"Gurr",
"have",
"looked",
"at",
"post",
"World",
"War",
"II",
"events",
".",
"Jonassohn",
"and",
"Björnson",
"are",
"critical",
"of",
"some",
"of",
"these",
"studies",
",",
"arguing",
"that",
"they",
"are",
"too",
"expansive",
",",
"and",
"conclude",
"that",
"the",
"academic",
"discipline",
"of",
"genocide",
"studies",
"is",
"too",
"young",
"to",
"have",
"a",
"canon",
"of",
"work",
"on",
"which",
"to",
"build",
"an",
"academic",
"paradigm",
"."
],
"offsets": [
0,
10,
14,
23,
33,
38,
42,
48,
55,
59,
62,
69,
79,
88,
97,
108,
112,
120,
123,
131,
141,
146,
155,
161,
167,
170,
180,
190,
198,
202,
207,
213,
216,
226,
229,
233,
242,
252,
264,
267,
272,
277,
287,
293,
295,
299,
306,
308,
314,
320,
324,
329,
339,
347,
351,
357,
360,
366,
373,
375,
381,
385,
391,
395,
398,
401,
408,
411,
417,
422,
429,
435,
448,
451,
455,
460,
467,
469,
473,
479,
483,
485,
493,
499,
503,
507,
512,
517,
524,
527,
532,
538,
542,
545,
551,
553,
563,
567,
576,
580,
589,
592,
597,
600,
606,
613,
615,
623,
628,
633,
637,
641,
650,
652,
656,
665,
670,
674,
683,
694,
697,
706,
714,
717,
721,
727,
730,
735,
737,
743,
746,
751,
754,
760,
763,
769,
772,
781,
789
]
} | dec13f7df8e44db594808f1d80833178 | What writer joined Jonassohn in the study of the whole of human history? | {
"tokens": [
"What",
"writer",
"joined",
"Jonassohn",
"in",
"the",
"study",
"of",
"the",
"whole",
"of",
"human",
"history",
"?"
],
"offsets": [
0,
5,
12,
19,
29,
32,
36,
42,
45,
49,
55,
58,
64,
71
]
} | {
"text": [
"Frank Chalk"
],
"char_spans": [
{
"start": [
308
],
"end": [
318
]
}
],
"token_spans": [
{
"start": [
47
],
"end": [
48
]
}
]
} | [
"Frank Chalk"
] |
SQuAD | Jonassohn and Björnson postulate that the major reason why no single generally accepted genocide definition has emerged is because academics have adjusted their focus to emphasise different periods and have found it expedient to use slightly different definitions to help them interpret events. For example, Frank Chalk and Kurt Jonassohn studied the whole of human history, while Leo Kuper and R. J. Rummel in their more recent works concentrated on the 20th century, and Helen Fein, Barbara Harff and Ted Gurr have looked at post World War II events. Jonassohn and Björnson are critical of some of these studies, arguing that they are too expansive, and conclude that the academic discipline of genocide studies is too young to have a canon of work on which to build an academic paradigm. | {
"tokens": [
"Jonassohn",
"and",
"Björnson",
"postulate",
"that",
"the",
"major",
"reason",
"why",
"no",
"single",
"generally",
"accepted",
"genocide",
"definition",
"has",
"emerged",
"is",
"because",
"academics",
"have",
"adjusted",
"their",
"focus",
"to",
"emphasise",
"different",
"periods",
"and",
"have",
"found",
"it",
"expedient",
"to",
"use",
"slightly",
"different",
"definitions",
"to",
"help",
"them",
"interpret",
"events",
".",
"For",
"example",
",",
"Frank",
"Chalk",
"and",
"Kurt",
"Jonassohn",
"studied",
"the",
"whole",
"of",
"human",
"history",
",",
"while",
"Leo",
"Kuper",
"and",
"R.",
"J.",
"Rummel",
"in",
"their",
"more",
"recent",
"works",
"concentrated",
"on",
"the",
"20th",
"century",
",",
"and",
"Helen",
"Fein",
",",
"Barbara",
"Harff",
"and",
"Ted",
"Gurr",
"have",
"looked",
"at",
"post",
"World",
"War",
"II",
"events",
".",
"Jonassohn",
"and",
"Björnson",
"are",
"critical",
"of",
"some",
"of",
"these",
"studies",
",",
"arguing",
"that",
"they",
"are",
"too",
"expansive",
",",
"and",
"conclude",
"that",
"the",
"academic",
"discipline",
"of",
"genocide",
"studies",
"is",
"too",
"young",
"to",
"have",
"a",
"canon",
"of",
"work",
"on",
"which",
"to",
"build",
"an",
"academic",
"paradigm",
"."
],
"offsets": [
0,
10,
14,
23,
33,
38,
42,
48,
55,
59,
62,
69,
79,
88,
97,
108,
112,
120,
123,
131,
141,
146,
155,
161,
167,
170,
180,
190,
198,
202,
207,
213,
216,
226,
229,
233,
242,
252,
264,
267,
272,
277,
287,
293,
295,
299,
306,
308,
314,
320,
324,
329,
339,
347,
351,
357,
360,
366,
373,
375,
381,
385,
391,
395,
398,
401,
408,
411,
417,
422,
429,
435,
448,
451,
455,
460,
467,
469,
473,
479,
483,
485,
493,
499,
503,
507,
512,
517,
524,
527,
532,
538,
542,
545,
551,
553,
563,
567,
576,
580,
589,
592,
597,
600,
606,
613,
615,
623,
628,
633,
637,
641,
650,
652,
656,
665,
670,
674,
683,
694,
697,
706,
714,
717,
721,
727,
730,
735,
737,
743,
746,
751,
754,
760,
763,
769,
772,
781,
789
]
} | e4dfbf2638d34766b5371f5012334250 | With whom was Leo Kuper paired in research that focused on 20th century works? | {
"tokens": [
"With",
"whom",
"was",
"Leo",
"Kuper",
"paired",
"in",
"research",
"that",
"focused",
"on",
"20th",
"century",
"works",
"?"
],
"offsets": [
0,
5,
10,
14,
18,
24,
31,
34,
43,
48,
56,
59,
64,
72,
77
]
} | {
"text": [
"R. J. Rummel"
],
"char_spans": [
{
"start": [
395
],
"end": [
406
]
}
],
"token_spans": [
{
"start": [
63
],
"end": [
65
]
}
]
} | [
"R. J. Rummel"
] |
SQuAD | Jonassohn and Björnson postulate that the major reason why no single generally accepted genocide definition has emerged is because academics have adjusted their focus to emphasise different periods and have found it expedient to use slightly different definitions to help them interpret events. For example, Frank Chalk and Kurt Jonassohn studied the whole of human history, while Leo Kuper and R. J. Rummel in their more recent works concentrated on the 20th century, and Helen Fein, Barbara Harff and Ted Gurr have looked at post World War II events. Jonassohn and Björnson are critical of some of these studies, arguing that they are too expansive, and conclude that the academic discipline of genocide studies is too young to have a canon of work on which to build an academic paradigm. | {
"tokens": [
"Jonassohn",
"and",
"Björnson",
"postulate",
"that",
"the",
"major",
"reason",
"why",
"no",
"single",
"generally",
"accepted",
"genocide",
"definition",
"has",
"emerged",
"is",
"because",
"academics",
"have",
"adjusted",
"their",
"focus",
"to",
"emphasise",
"different",
"periods",
"and",
"have",
"found",
"it",
"expedient",
"to",
"use",
"slightly",
"different",
"definitions",
"to",
"help",
"them",
"interpret",
"events",
".",
"For",
"example",
",",
"Frank",
"Chalk",
"and",
"Kurt",
"Jonassohn",
"studied",
"the",
"whole",
"of",
"human",
"history",
",",
"while",
"Leo",
"Kuper",
"and",
"R.",
"J.",
"Rummel",
"in",
"their",
"more",
"recent",
"works",
"concentrated",
"on",
"the",
"20th",
"century",
",",
"and",
"Helen",
"Fein",
",",
"Barbara",
"Harff",
"and",
"Ted",
"Gurr",
"have",
"looked",
"at",
"post",
"World",
"War",
"II",
"events",
".",
"Jonassohn",
"and",
"Björnson",
"are",
"critical",
"of",
"some",
"of",
"these",
"studies",
",",
"arguing",
"that",
"they",
"are",
"too",
"expansive",
",",
"and",
"conclude",
"that",
"the",
"academic",
"discipline",
"of",
"genocide",
"studies",
"is",
"too",
"young",
"to",
"have",
"a",
"canon",
"of",
"work",
"on",
"which",
"to",
"build",
"an",
"academic",
"paradigm",
"."
],
"offsets": [
0,
10,
14,
23,
33,
38,
42,
48,
55,
59,
62,
69,
79,
88,
97,
108,
112,
120,
123,
131,
141,
146,
155,
161,
167,
170,
180,
190,
198,
202,
207,
213,
216,
226,
229,
233,
242,
252,
264,
267,
272,
277,
287,
293,
295,
299,
306,
308,
314,
320,
324,
329,
339,
347,
351,
357,
360,
366,
373,
375,
381,
385,
391,
395,
398,
401,
408,
411,
417,
422,
429,
435,
448,
451,
455,
460,
467,
469,
473,
479,
483,
485,
493,
499,
503,
507,
512,
517,
524,
527,
532,
538,
542,
545,
551,
553,
563,
567,
576,
580,
589,
592,
597,
600,
606,
613,
615,
623,
628,
633,
637,
641,
650,
652,
656,
665,
670,
674,
683,
694,
697,
706,
714,
717,
721,
727,
730,
735,
737,
743,
746,
751,
754,
760,
763,
769,
772,
781,
789
]
} | 67a9a4dfef754bb68731f56bba246b15 | Two women and what man concentrated on post World War II events? | {
"tokens": [
"Two",
"women",
"and",
"what",
"man",
"concentrated",
"on",
"post",
"World",
"War",
"II",
"events",
"?"
],
"offsets": [
0,
4,
10,
14,
19,
23,
36,
39,
44,
50,
54,
57,
63
]
} | {
"text": [
"Ted Gurr"
],
"char_spans": [
{
"start": [
503
],
"end": [
510
]
}
],
"token_spans": [
{
"start": [
84
],
"end": [
85
]
}
]
} | [
"Ted Gurr"
] |
SQuAD | Several molecular mechanisms of antibacterial resistance exist. Intrinsic antibacterial resistance may be part of the genetic makeup of bacterial strains. For example, an antibiotic target may be absent from the bacterial genome. Acquired resistance results from a mutation in the bacterial chromosome or the acquisition of extra-chromosomal DNA. Antibacterial-producing bacteria have evolved resistance mechanisms that have been shown to be similar to, and may have been transferred to, antibacterial-resistant strains. The spread of antibacterial resistance often occurs through vertical transmission of mutations during growth and by genetic recombination of DNA by horizontal genetic exchange. For instance, antibacterial resistance genes can be exchanged between different bacterial strains or species via plasmids that carry these resistance genes. Plasmids that carry several different resistance genes can confer resistance to multiple antibacterials. Cross-resistance to several antibacterials may also occur when a resistance mechanism encoded by a single gene conveys resistance to more than one antibacterial compound. | {
"tokens": [
"Several",
"molecular",
"mechanisms",
"of",
"antibacterial",
"resistance",
"exist",
".",
"Intrinsic",
"antibacterial",
"resistance",
"may",
"be",
"part",
"of",
"the",
"genetic",
"makeup",
"of",
"bacterial",
"strains",
".",
"For",
"example",
",",
"an",
"antibiotic",
"target",
"may",
"be",
"absent",
"from",
"the",
"bacterial",
"genome",
".",
"Acquired",
"resistance",
"results",
"from",
"a",
"mutation",
"in",
"the",
"bacterial",
"chromosome",
"or",
"the",
"acquisition",
"of",
"extra",
"-",
"chromosomal",
"DNA",
".",
"Antibacterial",
"-",
"producing",
"bacteria",
"have",
"evolved",
"resistance",
"mechanisms",
"that",
"have",
"been",
"shown",
"to",
"be",
"similar",
"to",
",",
"and",
"may",
"have",
"been",
"transferred",
"to",
",",
"antibacterial",
"-",
"resistant",
"strains",
".",
"The",
"spread",
"of",
"antibacterial",
"resistance",
"often",
"occurs",
"through",
"vertical",
"transmission",
"of",
"mutations",
"during",
"growth",
"and",
"by",
"genetic",
"recombination",
"of",
"DNA",
"by",
"horizontal",
"genetic",
"exchange",
".",
"For",
"instance",
",",
"antibacterial",
"resistance",
"genes",
"can",
"be",
"exchanged",
"between",
"different",
"bacterial",
"strains",
"or",
"species",
"via",
"plasmids",
"that",
"carry",
"these",
"resistance",
"genes",
".",
"Plasmids",
"that",
"carry",
"several",
"different",
"resistance",
"genes",
"can",
"confer",
"resistance",
"to",
"multiple",
"antibacterials",
".",
"Cross",
"-",
"resistance",
"to",
"several",
"antibacterials",
"may",
"also",
"occur",
"when",
"a",
"resistance",
"mechanism",
"encoded",
"by",
"a",
"single",
"gene",
"conveys",
"resistance",
"to",
"more",
"than",
"one",
"antibacterial",
"compound",
"."
],
"offsets": [
0,
8,
18,
29,
32,
46,
57,
62,
64,
74,
88,
99,
103,
106,
111,
114,
118,
126,
133,
136,
146,
153,
155,
159,
166,
168,
171,
182,
189,
193,
196,
203,
208,
212,
222,
228,
230,
239,
250,
258,
263,
265,
274,
277,
281,
291,
302,
305,
309,
321,
324,
329,
330,
342,
345,
347,
360,
361,
371,
380,
385,
393,
404,
415,
420,
425,
430,
436,
439,
442,
450,
452,
454,
458,
462,
467,
472,
484,
486,
488,
501,
502,
512,
519,
521,
525,
532,
535,
549,
560,
566,
573,
581,
590,
603,
606,
616,
623,
630,
634,
637,
645,
659,
662,
666,
669,
680,
688,
696,
698,
702,
710,
712,
726,
737,
743,
747,
750,
760,
768,
778,
788,
796,
799,
807,
811,
820,
825,
831,
837,
848,
853,
855,
864,
869,
875,
883,
893,
904,
910,
914,
921,
932,
935,
944,
958,
960,
965,
966,
977,
980,
988,
1003,
1007,
1012,
1018,
1023,
1025,
1036,
1046,
1054,
1057,
1059,
1066,
1071,
1079,
1090,
1093,
1098,
1103,
1107,
1121,
1129
]
} | 737eb78050f743b496d9ec95a6843686 | What is part of hje the make up of bacterial strains? | {
"tokens": [
"What",
"is",
"part",
"of",
"hje",
"the",
"make",
"up",
"of",
"bacterial",
"strains",
"?"
],
"offsets": [
0,
5,
8,
13,
16,
20,
24,
29,
32,
35,
45,
52
]
} | {
"text": [
"Intrinsic antibacterial resistance"
],
"char_spans": [
{
"start": [
64
],
"end": [
97
]
}
],
"token_spans": [
{
"start": [
8
],
"end": [
10
]
}
]
} | [
"Intrinsic antibacterial resistance"
] |
SQuAD | Several molecular mechanisms of antibacterial resistance exist. Intrinsic antibacterial resistance may be part of the genetic makeup of bacterial strains. For example, an antibiotic target may be absent from the bacterial genome. Acquired resistance results from a mutation in the bacterial chromosome or the acquisition of extra-chromosomal DNA. Antibacterial-producing bacteria have evolved resistance mechanisms that have been shown to be similar to, and may have been transferred to, antibacterial-resistant strains. The spread of antibacterial resistance often occurs through vertical transmission of mutations during growth and by genetic recombination of DNA by horizontal genetic exchange. For instance, antibacterial resistance genes can be exchanged between different bacterial strains or species via plasmids that carry these resistance genes. Plasmids that carry several different resistance genes can confer resistance to multiple antibacterials. Cross-resistance to several antibacterials may also occur when a resistance mechanism encoded by a single gene conveys resistance to more than one antibacterial compound. | {
"tokens": [
"Several",
"molecular",
"mechanisms",
"of",
"antibacterial",
"resistance",
"exist",
".",
"Intrinsic",
"antibacterial",
"resistance",
"may",
"be",
"part",
"of",
"the",
"genetic",
"makeup",
"of",
"bacterial",
"strains",
".",
"For",
"example",
",",
"an",
"antibiotic",
"target",
"may",
"be",
"absent",
"from",
"the",
"bacterial",
"genome",
".",
"Acquired",
"resistance",
"results",
"from",
"a",
"mutation",
"in",
"the",
"bacterial",
"chromosome",
"or",
"the",
"acquisition",
"of",
"extra",
"-",
"chromosomal",
"DNA",
".",
"Antibacterial",
"-",
"producing",
"bacteria",
"have",
"evolved",
"resistance",
"mechanisms",
"that",
"have",
"been",
"shown",
"to",
"be",
"similar",
"to",
",",
"and",
"may",
"have",
"been",
"transferred",
"to",
",",
"antibacterial",
"-",
"resistant",
"strains",
".",
"The",
"spread",
"of",
"antibacterial",
"resistance",
"often",
"occurs",
"through",
"vertical",
"transmission",
"of",
"mutations",
"during",
"growth",
"and",
"by",
"genetic",
"recombination",
"of",
"DNA",
"by",
"horizontal",
"genetic",
"exchange",
".",
"For",
"instance",
",",
"antibacterial",
"resistance",
"genes",
"can",
"be",
"exchanged",
"between",
"different",
"bacterial",
"strains",
"or",
"species",
"via",
"plasmids",
"that",
"carry",
"these",
"resistance",
"genes",
".",
"Plasmids",
"that",
"carry",
"several",
"different",
"resistance",
"genes",
"can",
"confer",
"resistance",
"to",
"multiple",
"antibacterials",
".",
"Cross",
"-",
"resistance",
"to",
"several",
"antibacterials",
"may",
"also",
"occur",
"when",
"a",
"resistance",
"mechanism",
"encoded",
"by",
"a",
"single",
"gene",
"conveys",
"resistance",
"to",
"more",
"than",
"one",
"antibacterial",
"compound",
"."
],
"offsets": [
0,
8,
18,
29,
32,
46,
57,
62,
64,
74,
88,
99,
103,
106,
111,
114,
118,
126,
133,
136,
146,
153,
155,
159,
166,
168,
171,
182,
189,
193,
196,
203,
208,
212,
222,
228,
230,
239,
250,
258,
263,
265,
274,
277,
281,
291,
302,
305,
309,
321,
324,
329,
330,
342,
345,
347,
360,
361,
371,
380,
385,
393,
404,
415,
420,
425,
430,
436,
439,
442,
450,
452,
454,
458,
462,
467,
472,
484,
486,
488,
501,
502,
512,
519,
521,
525,
532,
535,
549,
560,
566,
573,
581,
590,
603,
606,
616,
623,
630,
634,
637,
645,
659,
662,
666,
669,
680,
688,
696,
698,
702,
710,
712,
726,
737,
743,
747,
750,
760,
768,
778,
788,
796,
799,
807,
811,
820,
825,
831,
837,
848,
853,
855,
864,
869,
875,
883,
893,
904,
910,
914,
921,
932,
935,
944,
958,
960,
965,
966,
977,
980,
988,
1003,
1007,
1012,
1018,
1023,
1025,
1036,
1046,
1054,
1057,
1059,
1066,
1071,
1079,
1090,
1093,
1098,
1103,
1107,
1121,
1129
]
} | 12c3627c318f4c3d839ed4a6643b2280 | What is exchanged between between bacterial strains or species via plasmids that have this resistance? | {
"tokens": [
"What",
"is",
"exchanged",
"between",
"between",
"bacterial",
"strains",
"or",
"species",
"via",
"plasmids",
"that",
"have",
"this",
"resistance",
"?"
],
"offsets": [
0,
5,
8,
18,
26,
34,
44,
52,
55,
63,
67,
76,
81,
86,
91,
101
]
} | {
"text": [
"antibacterial resistance genes"
],
"char_spans": [
{
"start": [
712
],
"end": [
741
]
}
],
"token_spans": [
{
"start": [
112
],
"end": [
114
]
}
]
} | [
"antibacterial resistance genes"
] |
SQuAD | Several molecular mechanisms of antibacterial resistance exist. Intrinsic antibacterial resistance may be part of the genetic makeup of bacterial strains. For example, an antibiotic target may be absent from the bacterial genome. Acquired resistance results from a mutation in the bacterial chromosome or the acquisition of extra-chromosomal DNA. Antibacterial-producing bacteria have evolved resistance mechanisms that have been shown to be similar to, and may have been transferred to, antibacterial-resistant strains. The spread of antibacterial resistance often occurs through vertical transmission of mutations during growth and by genetic recombination of DNA by horizontal genetic exchange. For instance, antibacterial resistance genes can be exchanged between different bacterial strains or species via plasmids that carry these resistance genes. Plasmids that carry several different resistance genes can confer resistance to multiple antibacterials. Cross-resistance to several antibacterials may also occur when a resistance mechanism encoded by a single gene conveys resistance to more than one antibacterial compound. | {
"tokens": [
"Several",
"molecular",
"mechanisms",
"of",
"antibacterial",
"resistance",
"exist",
".",
"Intrinsic",
"antibacterial",
"resistance",
"may",
"be",
"part",
"of",
"the",
"genetic",
"makeup",
"of",
"bacterial",
"strains",
".",
"For",
"example",
",",
"an",
"antibiotic",
"target",
"may",
"be",
"absent",
"from",
"the",
"bacterial",
"genome",
".",
"Acquired",
"resistance",
"results",
"from",
"a",
"mutation",
"in",
"the",
"bacterial",
"chromosome",
"or",
"the",
"acquisition",
"of",
"extra",
"-",
"chromosomal",
"DNA",
".",
"Antibacterial",
"-",
"producing",
"bacteria",
"have",
"evolved",
"resistance",
"mechanisms",
"that",
"have",
"been",
"shown",
"to",
"be",
"similar",
"to",
",",
"and",
"may",
"have",
"been",
"transferred",
"to",
",",
"antibacterial",
"-",
"resistant",
"strains",
".",
"The",
"spread",
"of",
"antibacterial",
"resistance",
"often",
"occurs",
"through",
"vertical",
"transmission",
"of",
"mutations",
"during",
"growth",
"and",
"by",
"genetic",
"recombination",
"of",
"DNA",
"by",
"horizontal",
"genetic",
"exchange",
".",
"For",
"instance",
",",
"antibacterial",
"resistance",
"genes",
"can",
"be",
"exchanged",
"between",
"different",
"bacterial",
"strains",
"or",
"species",
"via",
"plasmids",
"that",
"carry",
"these",
"resistance",
"genes",
".",
"Plasmids",
"that",
"carry",
"several",
"different",
"resistance",
"genes",
"can",
"confer",
"resistance",
"to",
"multiple",
"antibacterials",
".",
"Cross",
"-",
"resistance",
"to",
"several",
"antibacterials",
"may",
"also",
"occur",
"when",
"a",
"resistance",
"mechanism",
"encoded",
"by",
"a",
"single",
"gene",
"conveys",
"resistance",
"to",
"more",
"than",
"one",
"antibacterial",
"compound",
"."
],
"offsets": [
0,
8,
18,
29,
32,
46,
57,
62,
64,
74,
88,
99,
103,
106,
111,
114,
118,
126,
133,
136,
146,
153,
155,
159,
166,
168,
171,
182,
189,
193,
196,
203,
208,
212,
222,
228,
230,
239,
250,
258,
263,
265,
274,
277,
281,
291,
302,
305,
309,
321,
324,
329,
330,
342,
345,
347,
360,
361,
371,
380,
385,
393,
404,
415,
420,
425,
430,
436,
439,
442,
450,
452,
454,
458,
462,
467,
472,
484,
486,
488,
501,
502,
512,
519,
521,
525,
532,
535,
549,
560,
566,
573,
581,
590,
603,
606,
616,
623,
630,
634,
637,
645,
659,
662,
666,
669,
680,
688,
696,
698,
702,
710,
712,
726,
737,
743,
747,
750,
760,
768,
778,
788,
796,
799,
807,
811,
820,
825,
831,
837,
848,
853,
855,
864,
869,
875,
883,
893,
904,
910,
914,
921,
932,
935,
944,
958,
960,
965,
966,
977,
980,
988,
1003,
1007,
1012,
1018,
1023,
1025,
1036,
1046,
1054,
1057,
1059,
1066,
1071,
1079,
1090,
1093,
1098,
1103,
1107,
1121,
1129
]
} | 051c0bfff377470ebb8da0d751d76700 | What can be absent from the bacterial genome? | {
"tokens": [
"What",
"can",
"be",
"absent",
"from",
"the",
"bacterial",
"genome",
"?"
],
"offsets": [
0,
5,
9,
12,
19,
24,
28,
38,
44
]
} | {
"text": [
"antibiotic target"
],
"char_spans": [
{
"start": [
171
],
"end": [
187
]
}
],
"token_spans": [
{
"start": [
26
],
"end": [
27
]
}
]
} | [
"antibiotic target"
] |
SQuAD | Several molecular mechanisms of antibacterial resistance exist. Intrinsic antibacterial resistance may be part of the genetic makeup of bacterial strains. For example, an antibiotic target may be absent from the bacterial genome. Acquired resistance results from a mutation in the bacterial chromosome or the acquisition of extra-chromosomal DNA. Antibacterial-producing bacteria have evolved resistance mechanisms that have been shown to be similar to, and may have been transferred to, antibacterial-resistant strains. The spread of antibacterial resistance often occurs through vertical transmission of mutations during growth and by genetic recombination of DNA by horizontal genetic exchange. For instance, antibacterial resistance genes can be exchanged between different bacterial strains or species via plasmids that carry these resistance genes. Plasmids that carry several different resistance genes can confer resistance to multiple antibacterials. Cross-resistance to several antibacterials may also occur when a resistance mechanism encoded by a single gene conveys resistance to more than one antibacterial compound. | {
"tokens": [
"Several",
"molecular",
"mechanisms",
"of",
"antibacterial",
"resistance",
"exist",
".",
"Intrinsic",
"antibacterial",
"resistance",
"may",
"be",
"part",
"of",
"the",
"genetic",
"makeup",
"of",
"bacterial",
"strains",
".",
"For",
"example",
",",
"an",
"antibiotic",
"target",
"may",
"be",
"absent",
"from",
"the",
"bacterial",
"genome",
".",
"Acquired",
"resistance",
"results",
"from",
"a",
"mutation",
"in",
"the",
"bacterial",
"chromosome",
"or",
"the",
"acquisition",
"of",
"extra",
"-",
"chromosomal",
"DNA",
".",
"Antibacterial",
"-",
"producing",
"bacteria",
"have",
"evolved",
"resistance",
"mechanisms",
"that",
"have",
"been",
"shown",
"to",
"be",
"similar",
"to",
",",
"and",
"may",
"have",
"been",
"transferred",
"to",
",",
"antibacterial",
"-",
"resistant",
"strains",
".",
"The",
"spread",
"of",
"antibacterial",
"resistance",
"often",
"occurs",
"through",
"vertical",
"transmission",
"of",
"mutations",
"during",
"growth",
"and",
"by",
"genetic",
"recombination",
"of",
"DNA",
"by",
"horizontal",
"genetic",
"exchange",
".",
"For",
"instance",
",",
"antibacterial",
"resistance",
"genes",
"can",
"be",
"exchanged",
"between",
"different",
"bacterial",
"strains",
"or",
"species",
"via",
"plasmids",
"that",
"carry",
"these",
"resistance",
"genes",
".",
"Plasmids",
"that",
"carry",
"several",
"different",
"resistance",
"genes",
"can",
"confer",
"resistance",
"to",
"multiple",
"antibacterials",
".",
"Cross",
"-",
"resistance",
"to",
"several",
"antibacterials",
"may",
"also",
"occur",
"when",
"a",
"resistance",
"mechanism",
"encoded",
"by",
"a",
"single",
"gene",
"conveys",
"resistance",
"to",
"more",
"than",
"one",
"antibacterial",
"compound",
"."
],
"offsets": [
0,
8,
18,
29,
32,
46,
57,
62,
64,
74,
88,
99,
103,
106,
111,
114,
118,
126,
133,
136,
146,
153,
155,
159,
166,
168,
171,
182,
189,
193,
196,
203,
208,
212,
222,
228,
230,
239,
250,
258,
263,
265,
274,
277,
281,
291,
302,
305,
309,
321,
324,
329,
330,
342,
345,
347,
360,
361,
371,
380,
385,
393,
404,
415,
420,
425,
430,
436,
439,
442,
450,
452,
454,
458,
462,
467,
472,
484,
486,
488,
501,
502,
512,
519,
521,
525,
532,
535,
549,
560,
566,
573,
581,
590,
603,
606,
616,
623,
630,
634,
637,
645,
659,
662,
666,
669,
680,
688,
696,
698,
702,
710,
712,
726,
737,
743,
747,
750,
760,
768,
778,
788,
796,
799,
807,
811,
820,
825,
831,
837,
848,
853,
855,
864,
869,
875,
883,
893,
904,
910,
914,
921,
932,
935,
944,
958,
960,
965,
966,
977,
980,
988,
1003,
1007,
1012,
1018,
1023,
1025,
1036,
1046,
1054,
1057,
1059,
1066,
1071,
1079,
1090,
1093,
1098,
1103,
1107,
1121,
1129
]
} | 2f6174b696344cf09f38ac47425c1419 | When does the spread of antibacterial resistance frequently occurs/ | {
"tokens": [
"When",
"does",
"the",
"spread",
"of",
"antibacterial",
"resistance",
"frequently",
"occurs/"
],
"offsets": [
0,
5,
10,
14,
21,
24,
38,
49,
60
]
} | {
"text": [
"vertical transmission"
],
"char_spans": [
{
"start": [
581
],
"end": [
601
]
}
],
"token_spans": [
{
"start": [
92
],
"end": [
93
]
}
]
} | [
"vertical transmission"
] |
SQuAD | Several molecular mechanisms of antibacterial resistance exist. Intrinsic antibacterial resistance may be part of the genetic makeup of bacterial strains. For example, an antibiotic target may be absent from the bacterial genome. Acquired resistance results from a mutation in the bacterial chromosome or the acquisition of extra-chromosomal DNA. Antibacterial-producing bacteria have evolved resistance mechanisms that have been shown to be similar to, and may have been transferred to, antibacterial-resistant strains. The spread of antibacterial resistance often occurs through vertical transmission of mutations during growth and by genetic recombination of DNA by horizontal genetic exchange. For instance, antibacterial resistance genes can be exchanged between different bacterial strains or species via plasmids that carry these resistance genes. Plasmids that carry several different resistance genes can confer resistance to multiple antibacterials. Cross-resistance to several antibacterials may also occur when a resistance mechanism encoded by a single gene conveys resistance to more than one antibacterial compound. | {
"tokens": [
"Several",
"molecular",
"mechanisms",
"of",
"antibacterial",
"resistance",
"exist",
".",
"Intrinsic",
"antibacterial",
"resistance",
"may",
"be",
"part",
"of",
"the",
"genetic",
"makeup",
"of",
"bacterial",
"strains",
".",
"For",
"example",
",",
"an",
"antibiotic",
"target",
"may",
"be",
"absent",
"from",
"the",
"bacterial",
"genome",
".",
"Acquired",
"resistance",
"results",
"from",
"a",
"mutation",
"in",
"the",
"bacterial",
"chromosome",
"or",
"the",
"acquisition",
"of",
"extra",
"-",
"chromosomal",
"DNA",
".",
"Antibacterial",
"-",
"producing",
"bacteria",
"have",
"evolved",
"resistance",
"mechanisms",
"that",
"have",
"been",
"shown",
"to",
"be",
"similar",
"to",
",",
"and",
"may",
"have",
"been",
"transferred",
"to",
",",
"antibacterial",
"-",
"resistant",
"strains",
".",
"The",
"spread",
"of",
"antibacterial",
"resistance",
"often",
"occurs",
"through",
"vertical",
"transmission",
"of",
"mutations",
"during",
"growth",
"and",
"by",
"genetic",
"recombination",
"of",
"DNA",
"by",
"horizontal",
"genetic",
"exchange",
".",
"For",
"instance",
",",
"antibacterial",
"resistance",
"genes",
"can",
"be",
"exchanged",
"between",
"different",
"bacterial",
"strains",
"or",
"species",
"via",
"plasmids",
"that",
"carry",
"these",
"resistance",
"genes",
".",
"Plasmids",
"that",
"carry",
"several",
"different",
"resistance",
"genes",
"can",
"confer",
"resistance",
"to",
"multiple",
"antibacterials",
".",
"Cross",
"-",
"resistance",
"to",
"several",
"antibacterials",
"may",
"also",
"occur",
"when",
"a",
"resistance",
"mechanism",
"encoded",
"by",
"a",
"single",
"gene",
"conveys",
"resistance",
"to",
"more",
"than",
"one",
"antibacterial",
"compound",
"."
],
"offsets": [
0,
8,
18,
29,
32,
46,
57,
62,
64,
74,
88,
99,
103,
106,
111,
114,
118,
126,
133,
136,
146,
153,
155,
159,
166,
168,
171,
182,
189,
193,
196,
203,
208,
212,
222,
228,
230,
239,
250,
258,
263,
265,
274,
277,
281,
291,
302,
305,
309,
321,
324,
329,
330,
342,
345,
347,
360,
361,
371,
380,
385,
393,
404,
415,
420,
425,
430,
436,
439,
442,
450,
452,
454,
458,
462,
467,
472,
484,
486,
488,
501,
502,
512,
519,
521,
525,
532,
535,
549,
560,
566,
573,
581,
590,
603,
606,
616,
623,
630,
634,
637,
645,
659,
662,
666,
669,
680,
688,
696,
698,
702,
710,
712,
726,
737,
743,
747,
750,
760,
768,
778,
788,
796,
799,
807,
811,
820,
825,
831,
837,
848,
853,
855,
864,
869,
875,
883,
893,
904,
910,
914,
921,
932,
935,
944,
958,
960,
965,
966,
977,
980,
988,
1003,
1007,
1012,
1018,
1023,
1025,
1036,
1046,
1054,
1057,
1059,
1066,
1071,
1079,
1090,
1093,
1098,
1103,
1107,
1121,
1129
]
} | 91cf767a97174442b8147e0d3d604b97 | What does some resistance come from? | {
"tokens": [
"What",
"does",
"some",
"resistance",
"come",
"from",
"?"
],
"offsets": [
0,
5,
10,
15,
26,
31,
35
]
} | {
"text": [
"mutation"
],
"char_spans": [
{
"start": [
265
],
"end": [
272
]
}
],
"token_spans": [
{
"start": [
41
],
"end": [
41
]
}
]
} | [
"mutation"
] |
SQuAD | Several molecular mechanisms of antibacterial resistance exist. Intrinsic antibacterial resistance may be part of the genetic makeup of bacterial strains. For example, an antibiotic target may be absent from the bacterial genome. Acquired resistance results from a mutation in the bacterial chromosome or the acquisition of extra-chromosomal DNA. Antibacterial-producing bacteria have evolved resistance mechanisms that have been shown to be similar to, and may have been transferred to, antibacterial-resistant strains. The spread of antibacterial resistance often occurs through vertical transmission of mutations during growth and by genetic recombination of DNA by horizontal genetic exchange. For instance, antibacterial resistance genes can be exchanged between different bacterial strains or species via plasmids that carry these resistance genes. Plasmids that carry several different resistance genes can confer resistance to multiple antibacterials. Cross-resistance to several antibacterials may also occur when a resistance mechanism encoded by a single gene conveys resistance to more than one antibacterial compound. | {
"tokens": [
"Several",
"molecular",
"mechanisms",
"of",
"antibacterial",
"resistance",
"exist",
".",
"Intrinsic",
"antibacterial",
"resistance",
"may",
"be",
"part",
"of",
"the",
"genetic",
"makeup",
"of",
"bacterial",
"strains",
".",
"For",
"example",
",",
"an",
"antibiotic",
"target",
"may",
"be",
"absent",
"from",
"the",
"bacterial",
"genome",
".",
"Acquired",
"resistance",
"results",
"from",
"a",
"mutation",
"in",
"the",
"bacterial",
"chromosome",
"or",
"the",
"acquisition",
"of",
"extra",
"-",
"chromosomal",
"DNA",
".",
"Antibacterial",
"-",
"producing",
"bacteria",
"have",
"evolved",
"resistance",
"mechanisms",
"that",
"have",
"been",
"shown",
"to",
"be",
"similar",
"to",
",",
"and",
"may",
"have",
"been",
"transferred",
"to",
",",
"antibacterial",
"-",
"resistant",
"strains",
".",
"The",
"spread",
"of",
"antibacterial",
"resistance",
"often",
"occurs",
"through",
"vertical",
"transmission",
"of",
"mutations",
"during",
"growth",
"and",
"by",
"genetic",
"recombination",
"of",
"DNA",
"by",
"horizontal",
"genetic",
"exchange",
".",
"For",
"instance",
",",
"antibacterial",
"resistance",
"genes",
"can",
"be",
"exchanged",
"between",
"different",
"bacterial",
"strains",
"or",
"species",
"via",
"plasmids",
"that",
"carry",
"these",
"resistance",
"genes",
".",
"Plasmids",
"that",
"carry",
"several",
"different",
"resistance",
"genes",
"can",
"confer",
"resistance",
"to",
"multiple",
"antibacterials",
".",
"Cross",
"-",
"resistance",
"to",
"several",
"antibacterials",
"may",
"also",
"occur",
"when",
"a",
"resistance",
"mechanism",
"encoded",
"by",
"a",
"single",
"gene",
"conveys",
"resistance",
"to",
"more",
"than",
"one",
"antibacterial",
"compound",
"."
],
"offsets": [
0,
8,
18,
29,
32,
46,
57,
62,
64,
74,
88,
99,
103,
106,
111,
114,
118,
126,
133,
136,
146,
153,
155,
159,
166,
168,
171,
182,
189,
193,
196,
203,
208,
212,
222,
228,
230,
239,
250,
258,
263,
265,
274,
277,
281,
291,
302,
305,
309,
321,
324,
329,
330,
342,
345,
347,
360,
361,
371,
380,
385,
393,
404,
415,
420,
425,
430,
436,
439,
442,
450,
452,
454,
458,
462,
467,
472,
484,
486,
488,
501,
502,
512,
519,
521,
525,
532,
535,
549,
560,
566,
573,
581,
590,
603,
606,
616,
623,
630,
634,
637,
645,
659,
662,
666,
669,
680,
688,
696,
698,
702,
710,
712,
726,
737,
743,
747,
750,
760,
768,
778,
788,
796,
799,
807,
811,
820,
825,
831,
837,
848,
853,
855,
864,
869,
875,
883,
893,
904,
910,
914,
921,
932,
935,
944,
958,
960,
965,
966,
977,
980,
988,
1003,
1007,
1012,
1018,
1023,
1025,
1036,
1046,
1054,
1057,
1059,
1066,
1071,
1079,
1090,
1093,
1098,
1103,
1107,
1121,
1129
]
} | e3d6f7864ba847a8adf5c67ee5aefd77 | What method of spread can occur in antibacterial resistance? | {
"tokens": [
"What",
"method",
"of",
"spread",
"can",
"occur",
"in",
"antibacterial",
"resistance",
"?"
],
"offsets": [
0,
5,
12,
15,
22,
26,
32,
35,
49,
59
]
} | {
"text": [
"vertical transmission of mutations"
],
"char_spans": [
{
"start": [
581
],
"end": [
614
]
}
],
"token_spans": [
{
"start": [
92
],
"end": [
95
]
}
]
} | [
"vertical transmission of mutations"
] |
SQuAD | Several molecular mechanisms of antibacterial resistance exist. Intrinsic antibacterial resistance may be part of the genetic makeup of bacterial strains. For example, an antibiotic target may be absent from the bacterial genome. Acquired resistance results from a mutation in the bacterial chromosome or the acquisition of extra-chromosomal DNA. Antibacterial-producing bacteria have evolved resistance mechanisms that have been shown to be similar to, and may have been transferred to, antibacterial-resistant strains. The spread of antibacterial resistance often occurs through vertical transmission of mutations during growth and by genetic recombination of DNA by horizontal genetic exchange. For instance, antibacterial resistance genes can be exchanged between different bacterial strains or species via plasmids that carry these resistance genes. Plasmids that carry several different resistance genes can confer resistance to multiple antibacterials. Cross-resistance to several antibacterials may also occur when a resistance mechanism encoded by a single gene conveys resistance to more than one antibacterial compound. | {
"tokens": [
"Several",
"molecular",
"mechanisms",
"of",
"antibacterial",
"resistance",
"exist",
".",
"Intrinsic",
"antibacterial",
"resistance",
"may",
"be",
"part",
"of",
"the",
"genetic",
"makeup",
"of",
"bacterial",
"strains",
".",
"For",
"example",
",",
"an",
"antibiotic",
"target",
"may",
"be",
"absent",
"from",
"the",
"bacterial",
"genome",
".",
"Acquired",
"resistance",
"results",
"from",
"a",
"mutation",
"in",
"the",
"bacterial",
"chromosome",
"or",
"the",
"acquisition",
"of",
"extra",
"-",
"chromosomal",
"DNA",
".",
"Antibacterial",
"-",
"producing",
"bacteria",
"have",
"evolved",
"resistance",
"mechanisms",
"that",
"have",
"been",
"shown",
"to",
"be",
"similar",
"to",
",",
"and",
"may",
"have",
"been",
"transferred",
"to",
",",
"antibacterial",
"-",
"resistant",
"strains",
".",
"The",
"spread",
"of",
"antibacterial",
"resistance",
"often",
"occurs",
"through",
"vertical",
"transmission",
"of",
"mutations",
"during",
"growth",
"and",
"by",
"genetic",
"recombination",
"of",
"DNA",
"by",
"horizontal",
"genetic",
"exchange",
".",
"For",
"instance",
",",
"antibacterial",
"resistance",
"genes",
"can",
"be",
"exchanged",
"between",
"different",
"bacterial",
"strains",
"or",
"species",
"via",
"plasmids",
"that",
"carry",
"these",
"resistance",
"genes",
".",
"Plasmids",
"that",
"carry",
"several",
"different",
"resistance",
"genes",
"can",
"confer",
"resistance",
"to",
"multiple",
"antibacterials",
".",
"Cross",
"-",
"resistance",
"to",
"several",
"antibacterials",
"may",
"also",
"occur",
"when",
"a",
"resistance",
"mechanism",
"encoded",
"by",
"a",
"single",
"gene",
"conveys",
"resistance",
"to",
"more",
"than",
"one",
"antibacterial",
"compound",
"."
],
"offsets": [
0,
8,
18,
29,
32,
46,
57,
62,
64,
74,
88,
99,
103,
106,
111,
114,
118,
126,
133,
136,
146,
153,
155,
159,
166,
168,
171,
182,
189,
193,
196,
203,
208,
212,
222,
228,
230,
239,
250,
258,
263,
265,
274,
277,
281,
291,
302,
305,
309,
321,
324,
329,
330,
342,
345,
347,
360,
361,
371,
380,
385,
393,
404,
415,
420,
425,
430,
436,
439,
442,
450,
452,
454,
458,
462,
467,
472,
484,
486,
488,
501,
502,
512,
519,
521,
525,
532,
535,
549,
560,
566,
573,
581,
590,
603,
606,
616,
623,
630,
634,
637,
645,
659,
662,
666,
669,
680,
688,
696,
698,
702,
710,
712,
726,
737,
743,
747,
750,
760,
768,
778,
788,
796,
799,
807,
811,
820,
825,
831,
837,
848,
853,
855,
864,
869,
875,
883,
893,
904,
910,
914,
921,
932,
935,
944,
958,
960,
965,
966,
977,
980,
988,
1003,
1007,
1012,
1018,
1023,
1025,
1036,
1046,
1054,
1057,
1059,
1066,
1071,
1079,
1090,
1093,
1098,
1103,
1107,
1121,
1129
]
} | e5327b332767476f983a892e790ad6e7 | What do plasmids do in resistance? | {
"tokens": [
"What",
"do",
"plasmids",
"do",
"in",
"resistance",
"?"
],
"offsets": [
0,
5,
8,
17,
20,
23,
33
]
} | {
"text": [
"carry several different resistance genes"
],
"char_spans": [
{
"start": [
869
],
"end": [
908
]
}
],
"token_spans": [
{
"start": [
134
],
"end": [
138
]
}
]
} | [
"carry several different resistance genes"
] |
SQuAD | The emergence of resistance of bacteria to antibiotics is a common phenomenon. Emergence of resistance often reflects evolutionary processes that take place during antibiotic therapy. The antibiotic treatment may select for bacterial strains with physiologically or genetically enhanced capacity to survive high doses of antibiotics. Under certain conditions, it may result in preferential growth of resistant bacteria, while growth of susceptible bacteria is inhibited by the drug. For example, antibacterial selection for strains having previously acquired antibacterial-resistance genes was demonstrated in 1943 by the Luria–Delbrück experiment. Antibiotics such as penicillin and erythromycin, which used to have a high efficacy against many bacterial species and strains, have become less effective, due to the increased resistance of many bacterial strains. | {
"tokens": [
"The",
"emergence",
"of",
"resistance",
"of",
"bacteria",
"to",
"antibiotics",
"is",
"a",
"common",
"phenomenon",
".",
"Emergence",
"of",
"resistance",
"often",
"reflects",
"evolutionary",
"processes",
"that",
"take",
"place",
"during",
"antibiotic",
"therapy",
".",
"The",
"antibiotic",
"treatment",
"may",
"select",
"for",
"bacterial",
"strains",
"with",
"physiologically",
"or",
"genetically",
"enhanced",
"capacity",
"to",
"survive",
"high",
"doses",
"of",
"antibiotics",
".",
"Under",
"certain",
"conditions",
",",
"it",
"may",
"result",
"in",
"preferential",
"growth",
"of",
"resistant",
"bacteria",
",",
"while",
"growth",
"of",
"susceptible",
"bacteria",
"is",
"inhibited",
"by",
"the",
"drug",
".",
"For",
"example",
",",
"antibacterial",
"selection",
"for",
"strains",
"having",
"previously",
"acquired",
"antibacterial",
"-",
"resistance",
"genes",
"was",
"demonstrated",
"in",
"1943",
"by",
"the",
"Luria",
"–",
"Delbrück",
"experiment",
".",
"Antibiotics",
"such",
"as",
"penicillin",
"and",
"erythromycin",
",",
"which",
"used",
"to",
"have",
"a",
"high",
"efficacy",
"against",
"many",
"bacterial",
"species",
"and",
"strains",
",",
"have",
"become",
"less",
"effective",
",",
"due",
"to",
"the",
"increased",
"resistance",
"of",
"many",
"bacterial",
"strains",
"."
],
"offsets": [
0,
4,
14,
17,
28,
31,
40,
43,
55,
58,
60,
67,
77,
79,
89,
92,
103,
109,
118,
131,
141,
146,
151,
157,
164,
175,
182,
184,
188,
199,
209,
213,
220,
224,
234,
242,
247,
263,
266,
278,
287,
296,
299,
307,
312,
318,
321,
332,
334,
340,
348,
358,
360,
363,
367,
374,
377,
390,
397,
400,
410,
418,
420,
426,
433,
436,
448,
457,
460,
470,
473,
477,
481,
483,
487,
494,
496,
510,
520,
524,
532,
539,
550,
559,
572,
573,
584,
590,
594,
607,
610,
615,
618,
622,
627,
628,
637,
647,
649,
661,
666,
669,
680,
684,
696,
698,
704,
709,
712,
717,
719,
724,
733,
741,
746,
756,
764,
768,
775,
777,
782,
789,
794,
803,
805,
809,
812,
816,
826,
837,
840,
845,
855,
862
]
} | 240f90d1c3224dad86b3f8c5d0e79625 | What is a modern common occurence with antibiotics? | {
"tokens": [
"What",
"is",
"a",
"modern",
"common",
"occurence",
"with",
"antibiotics",
"?"
],
"offsets": [
0,
5,
8,
10,
17,
24,
34,
39,
50
]
} | {
"text": [
"resistance of bacteria"
],
"char_spans": [
{
"start": [
17
],
"end": [
38
]
}
],
"token_spans": [
{
"start": [
3
],
"end": [
5
]
}
]
} | [
"resistance of bacteria"
] |
SQuAD | The emergence of resistance of bacteria to antibiotics is a common phenomenon. Emergence of resistance often reflects evolutionary processes that take place during antibiotic therapy. The antibiotic treatment may select for bacterial strains with physiologically or genetically enhanced capacity to survive high doses of antibiotics. Under certain conditions, it may result in preferential growth of resistant bacteria, while growth of susceptible bacteria is inhibited by the drug. For example, antibacterial selection for strains having previously acquired antibacterial-resistance genes was demonstrated in 1943 by the Luria–Delbrück experiment. Antibiotics such as penicillin and erythromycin, which used to have a high efficacy against many bacterial species and strains, have become less effective, due to the increased resistance of many bacterial strains. | {
"tokens": [
"The",
"emergence",
"of",
"resistance",
"of",
"bacteria",
"to",
"antibiotics",
"is",
"a",
"common",
"phenomenon",
".",
"Emergence",
"of",
"resistance",
"often",
"reflects",
"evolutionary",
"processes",
"that",
"take",
"place",
"during",
"antibiotic",
"therapy",
".",
"The",
"antibiotic",
"treatment",
"may",
"select",
"for",
"bacterial",
"strains",
"with",
"physiologically",
"or",
"genetically",
"enhanced",
"capacity",
"to",
"survive",
"high",
"doses",
"of",
"antibiotics",
".",
"Under",
"certain",
"conditions",
",",
"it",
"may",
"result",
"in",
"preferential",
"growth",
"of",
"resistant",
"bacteria",
",",
"while",
"growth",
"of",
"susceptible",
"bacteria",
"is",
"inhibited",
"by",
"the",
"drug",
".",
"For",
"example",
",",
"antibacterial",
"selection",
"for",
"strains",
"having",
"previously",
"acquired",
"antibacterial",
"-",
"resistance",
"genes",
"was",
"demonstrated",
"in",
"1943",
"by",
"the",
"Luria",
"–",
"Delbrück",
"experiment",
".",
"Antibiotics",
"such",
"as",
"penicillin",
"and",
"erythromycin",
",",
"which",
"used",
"to",
"have",
"a",
"high",
"efficacy",
"against",
"many",
"bacterial",
"species",
"and",
"strains",
",",
"have",
"become",
"less",
"effective",
",",
"due",
"to",
"the",
"increased",
"resistance",
"of",
"many",
"bacterial",
"strains",
"."
],
"offsets": [
0,
4,
14,
17,
28,
31,
40,
43,
55,
58,
60,
67,
77,
79,
89,
92,
103,
109,
118,
131,
141,
146,
151,
157,
164,
175,
182,
184,
188,
199,
209,
213,
220,
224,
234,
242,
247,
263,
266,
278,
287,
296,
299,
307,
312,
318,
321,
332,
334,
340,
348,
358,
360,
363,
367,
374,
377,
390,
397,
400,
410,
418,
420,
426,
433,
436,
448,
457,
460,
470,
473,
477,
481,
483,
487,
494,
496,
510,
520,
524,
532,
539,
550,
559,
572,
573,
584,
590,
594,
607,
610,
615,
618,
622,
627,
628,
637,
647,
649,
661,
666,
669,
680,
684,
696,
698,
704,
709,
712,
717,
719,
724,
733,
741,
746,
756,
764,
768,
775,
777,
782,
789,
794,
803,
805,
809,
812,
816,
826,
837,
840,
845,
855,
862
]
} | 4b5b5f8622cf411cb67119615ed784b2 | When was the Luria-Delbruck experiment? | {
"tokens": [
"When",
"was",
"the",
"Luria",
"-",
"Delbruck",
"experiment",
"?"
],
"offsets": [
0,
5,
9,
13,
18,
19,
28,
38
]
} | {
"text": [
"1943"
],
"char_spans": [
{
"start": [
610
],
"end": [
613
]
}
],
"token_spans": [
{
"start": [
90
],
"end": [
90
]
}
]
} | [
"1943"
] |
SQuAD | The emergence of resistance of bacteria to antibiotics is a common phenomenon. Emergence of resistance often reflects evolutionary processes that take place during antibiotic therapy. The antibiotic treatment may select for bacterial strains with physiologically or genetically enhanced capacity to survive high doses of antibiotics. Under certain conditions, it may result in preferential growth of resistant bacteria, while growth of susceptible bacteria is inhibited by the drug. For example, antibacterial selection for strains having previously acquired antibacterial-resistance genes was demonstrated in 1943 by the Luria–Delbrück experiment. Antibiotics such as penicillin and erythromycin, which used to have a high efficacy against many bacterial species and strains, have become less effective, due to the increased resistance of many bacterial strains. | {
"tokens": [
"The",
"emergence",
"of",
"resistance",
"of",
"bacteria",
"to",
"antibiotics",
"is",
"a",
"common",
"phenomenon",
".",
"Emergence",
"of",
"resistance",
"often",
"reflects",
"evolutionary",
"processes",
"that",
"take",
"place",
"during",
"antibiotic",
"therapy",
".",
"The",
"antibiotic",
"treatment",
"may",
"select",
"for",
"bacterial",
"strains",
"with",
"physiologically",
"or",
"genetically",
"enhanced",
"capacity",
"to",
"survive",
"high",
"doses",
"of",
"antibiotics",
".",
"Under",
"certain",
"conditions",
",",
"it",
"may",
"result",
"in",
"preferential",
"growth",
"of",
"resistant",
"bacteria",
",",
"while",
"growth",
"of",
"susceptible",
"bacteria",
"is",
"inhibited",
"by",
"the",
"drug",
".",
"For",
"example",
",",
"antibacterial",
"selection",
"for",
"strains",
"having",
"previously",
"acquired",
"antibacterial",
"-",
"resistance",
"genes",
"was",
"demonstrated",
"in",
"1943",
"by",
"the",
"Luria",
"–",
"Delbrück",
"experiment",
".",
"Antibiotics",
"such",
"as",
"penicillin",
"and",
"erythromycin",
",",
"which",
"used",
"to",
"have",
"a",
"high",
"efficacy",
"against",
"many",
"bacterial",
"species",
"and",
"strains",
",",
"have",
"become",
"less",
"effective",
",",
"due",
"to",
"the",
"increased",
"resistance",
"of",
"many",
"bacterial",
"strains",
"."
],
"offsets": [
0,
4,
14,
17,
28,
31,
40,
43,
55,
58,
60,
67,
77,
79,
89,
92,
103,
109,
118,
131,
141,
146,
151,
157,
164,
175,
182,
184,
188,
199,
209,
213,
220,
224,
234,
242,
247,
263,
266,
278,
287,
296,
299,
307,
312,
318,
321,
332,
334,
340,
348,
358,
360,
363,
367,
374,
377,
390,
397,
400,
410,
418,
420,
426,
433,
436,
448,
457,
460,
470,
473,
477,
481,
483,
487,
494,
496,
510,
520,
524,
532,
539,
550,
559,
572,
573,
584,
590,
594,
607,
610,
615,
618,
622,
627,
628,
637,
647,
649,
661,
666,
669,
680,
684,
696,
698,
704,
709,
712,
717,
719,
724,
733,
741,
746,
756,
764,
768,
775,
777,
782,
789,
794,
803,
805,
809,
812,
816,
826,
837,
840,
845,
855,
862
]
} | 0e54f565b22d4854be314cc8c25eac32 | Which two antibiotics that have high efficacy are much less useful now? | {
"tokens": [
"Which",
"two",
"antibiotics",
"that",
"have",
"high",
"efficacy",
"are",
"much",
"less",
"useful",
"now",
"?"
],
"offsets": [
0,
6,
10,
22,
27,
32,
37,
46,
50,
55,
60,
67,
70
]
} | {
"text": [
"penicillin and erythromycin"
],
"char_spans": [
{
"start": [
669
],
"end": [
695
]
}
],
"token_spans": [
{
"start": [
101
],
"end": [
103
]
}
]
} | [
"penicillin and erythromycin"
] |
SQuAD | The emergence of resistance of bacteria to antibiotics is a common phenomenon. Emergence of resistance often reflects evolutionary processes that take place during antibiotic therapy. The antibiotic treatment may select for bacterial strains with physiologically or genetically enhanced capacity to survive high doses of antibiotics. Under certain conditions, it may result in preferential growth of resistant bacteria, while growth of susceptible bacteria is inhibited by the drug. For example, antibacterial selection for strains having previously acquired antibacterial-resistance genes was demonstrated in 1943 by the Luria–Delbrück experiment. Antibiotics such as penicillin and erythromycin, which used to have a high efficacy against many bacterial species and strains, have become less effective, due to the increased resistance of many bacterial strains. | {
"tokens": [
"The",
"emergence",
"of",
"resistance",
"of",
"bacteria",
"to",
"antibiotics",
"is",
"a",
"common",
"phenomenon",
".",
"Emergence",
"of",
"resistance",
"often",
"reflects",
"evolutionary",
"processes",
"that",
"take",
"place",
"during",
"antibiotic",
"therapy",
".",
"The",
"antibiotic",
"treatment",
"may",
"select",
"for",
"bacterial",
"strains",
"with",
"physiologically",
"or",
"genetically",
"enhanced",
"capacity",
"to",
"survive",
"high",
"doses",
"of",
"antibiotics",
".",
"Under",
"certain",
"conditions",
",",
"it",
"may",
"result",
"in",
"preferential",
"growth",
"of",
"resistant",
"bacteria",
",",
"while",
"growth",
"of",
"susceptible",
"bacteria",
"is",
"inhibited",
"by",
"the",
"drug",
".",
"For",
"example",
",",
"antibacterial",
"selection",
"for",
"strains",
"having",
"previously",
"acquired",
"antibacterial",
"-",
"resistance",
"genes",
"was",
"demonstrated",
"in",
"1943",
"by",
"the",
"Luria",
"–",
"Delbrück",
"experiment",
".",
"Antibiotics",
"such",
"as",
"penicillin",
"and",
"erythromycin",
",",
"which",
"used",
"to",
"have",
"a",
"high",
"efficacy",
"against",
"many",
"bacterial",
"species",
"and",
"strains",
",",
"have",
"become",
"less",
"effective",
",",
"due",
"to",
"the",
"increased",
"resistance",
"of",
"many",
"bacterial",
"strains",
"."
],
"offsets": [
0,
4,
14,
17,
28,
31,
40,
43,
55,
58,
60,
67,
77,
79,
89,
92,
103,
109,
118,
131,
141,
146,
151,
157,
164,
175,
182,
184,
188,
199,
209,
213,
220,
224,
234,
242,
247,
263,
266,
278,
287,
296,
299,
307,
312,
318,
321,
332,
334,
340,
348,
358,
360,
363,
367,
374,
377,
390,
397,
400,
410,
418,
420,
426,
433,
436,
448,
457,
460,
470,
473,
477,
481,
483,
487,
494,
496,
510,
520,
524,
532,
539,
550,
559,
572,
573,
584,
590,
594,
607,
610,
615,
618,
622,
627,
628,
637,
647,
649,
661,
666,
669,
680,
684,
696,
698,
704,
709,
712,
717,
719,
724,
733,
741,
746,
756,
764,
768,
775,
777,
782,
789,
794,
803,
805,
809,
812,
816,
826,
837,
840,
845,
855,
862
]
} | 3a8994cdf0304cd1bf8c66fb51d8f7db | What does emergence of resistance reflect? | {
"tokens": [
"What",
"does",
"emergence",
"of",
"resistance",
"reflect",
"?"
],
"offsets": [
0,
5,
10,
20,
23,
34,
41
]
} | {
"text": [
"evolutionary processes"
],
"char_spans": [
{
"start": [
118
],
"end": [
139
]
}
],
"token_spans": [
{
"start": [
18
],
"end": [
19
]
}
]
} | [
"evolutionary processes"
] |
SQuAD | The emergence of resistance of bacteria to antibiotics is a common phenomenon. Emergence of resistance often reflects evolutionary processes that take place during antibiotic therapy. The antibiotic treatment may select for bacterial strains with physiologically or genetically enhanced capacity to survive high doses of antibiotics. Under certain conditions, it may result in preferential growth of resistant bacteria, while growth of susceptible bacteria is inhibited by the drug. For example, antibacterial selection for strains having previously acquired antibacterial-resistance genes was demonstrated in 1943 by the Luria–Delbrück experiment. Antibiotics such as penicillin and erythromycin, which used to have a high efficacy against many bacterial species and strains, have become less effective, due to the increased resistance of many bacterial strains. | {
"tokens": [
"The",
"emergence",
"of",
"resistance",
"of",
"bacteria",
"to",
"antibiotics",
"is",
"a",
"common",
"phenomenon",
".",
"Emergence",
"of",
"resistance",
"often",
"reflects",
"evolutionary",
"processes",
"that",
"take",
"place",
"during",
"antibiotic",
"therapy",
".",
"The",
"antibiotic",
"treatment",
"may",
"select",
"for",
"bacterial",
"strains",
"with",
"physiologically",
"or",
"genetically",
"enhanced",
"capacity",
"to",
"survive",
"high",
"doses",
"of",
"antibiotics",
".",
"Under",
"certain",
"conditions",
",",
"it",
"may",
"result",
"in",
"preferential",
"growth",
"of",
"resistant",
"bacteria",
",",
"while",
"growth",
"of",
"susceptible",
"bacteria",
"is",
"inhibited",
"by",
"the",
"drug",
".",
"For",
"example",
",",
"antibacterial",
"selection",
"for",
"strains",
"having",
"previously",
"acquired",
"antibacterial",
"-",
"resistance",
"genes",
"was",
"demonstrated",
"in",
"1943",
"by",
"the",
"Luria",
"–",
"Delbrück",
"experiment",
".",
"Antibiotics",
"such",
"as",
"penicillin",
"and",
"erythromycin",
",",
"which",
"used",
"to",
"have",
"a",
"high",
"efficacy",
"against",
"many",
"bacterial",
"species",
"and",
"strains",
",",
"have",
"become",
"less",
"effective",
",",
"due",
"to",
"the",
"increased",
"resistance",
"of",
"many",
"bacterial",
"strains",
"."
],
"offsets": [
0,
4,
14,
17,
28,
31,
40,
43,
55,
58,
60,
67,
77,
79,
89,
92,
103,
109,
118,
131,
141,
146,
151,
157,
164,
175,
182,
184,
188,
199,
209,
213,
220,
224,
234,
242,
247,
263,
266,
278,
287,
296,
299,
307,
312,
318,
321,
332,
334,
340,
348,
358,
360,
363,
367,
374,
377,
390,
397,
400,
410,
418,
420,
426,
433,
436,
448,
457,
460,
470,
473,
477,
481,
483,
487,
494,
496,
510,
520,
524,
532,
539,
550,
559,
572,
573,
584,
590,
594,
607,
610,
615,
618,
622,
627,
628,
637,
647,
649,
661,
666,
669,
680,
684,
696,
698,
704,
709,
712,
717,
719,
724,
733,
741,
746,
756,
764,
768,
775,
777,
782,
789,
794,
803,
805,
809,
812,
816,
826,
837,
840,
845,
855,
862
]
} | 299d7812db11465f95eec9fc52b274dd | What is the purpose of antibiotic treatment? | {
"tokens": [
"What",
"is",
"the",
"purpose",
"of",
"antibiotic",
"treatment",
"?"
],
"offsets": [
0,
5,
8,
12,
20,
23,
34,
43
]
} | {
"text": [
"survive high doses of antibiotics"
],
"char_spans": [
{
"start": [
299
],
"end": [
331
]
}
],
"token_spans": [
{
"start": [
42
],
"end": [
46
]
}
]
} | [
"survive high doses of antibiotics"
] |
SQuAD | The emergence of resistance of bacteria to antibiotics is a common phenomenon. Emergence of resistance often reflects evolutionary processes that take place during antibiotic therapy. The antibiotic treatment may select for bacterial strains with physiologically or genetically enhanced capacity to survive high doses of antibiotics. Under certain conditions, it may result in preferential growth of resistant bacteria, while growth of susceptible bacteria is inhibited by the drug. For example, antibacterial selection for strains having previously acquired antibacterial-resistance genes was demonstrated in 1943 by the Luria–Delbrück experiment. Antibiotics such as penicillin and erythromycin, which used to have a high efficacy against many bacterial species and strains, have become less effective, due to the increased resistance of many bacterial strains. | {
"tokens": [
"The",
"emergence",
"of",
"resistance",
"of",
"bacteria",
"to",
"antibiotics",
"is",
"a",
"common",
"phenomenon",
".",
"Emergence",
"of",
"resistance",
"often",
"reflects",
"evolutionary",
"processes",
"that",
"take",
"place",
"during",
"antibiotic",
"therapy",
".",
"The",
"antibiotic",
"treatment",
"may",
"select",
"for",
"bacterial",
"strains",
"with",
"physiologically",
"or",
"genetically",
"enhanced",
"capacity",
"to",
"survive",
"high",
"doses",
"of",
"antibiotics",
".",
"Under",
"certain",
"conditions",
",",
"it",
"may",
"result",
"in",
"preferential",
"growth",
"of",
"resistant",
"bacteria",
",",
"while",
"growth",
"of",
"susceptible",
"bacteria",
"is",
"inhibited",
"by",
"the",
"drug",
".",
"For",
"example",
",",
"antibacterial",
"selection",
"for",
"strains",
"having",
"previously",
"acquired",
"antibacterial",
"-",
"resistance",
"genes",
"was",
"demonstrated",
"in",
"1943",
"by",
"the",
"Luria",
"–",
"Delbrück",
"experiment",
".",
"Antibiotics",
"such",
"as",
"penicillin",
"and",
"erythromycin",
",",
"which",
"used",
"to",
"have",
"a",
"high",
"efficacy",
"against",
"many",
"bacterial",
"species",
"and",
"strains",
",",
"have",
"become",
"less",
"effective",
",",
"due",
"to",
"the",
"increased",
"resistance",
"of",
"many",
"bacterial",
"strains",
"."
],
"offsets": [
0,
4,
14,
17,
28,
31,
40,
43,
55,
58,
60,
67,
77,
79,
89,
92,
103,
109,
118,
131,
141,
146,
151,
157,
164,
175,
182,
184,
188,
199,
209,
213,
220,
224,
234,
242,
247,
263,
266,
278,
287,
296,
299,
307,
312,
318,
321,
332,
334,
340,
348,
358,
360,
363,
367,
374,
377,
390,
397,
400,
410,
418,
420,
426,
433,
436,
448,
457,
460,
470,
473,
477,
481,
483,
487,
494,
496,
510,
520,
524,
532,
539,
550,
559,
572,
573,
584,
590,
594,
607,
610,
615,
618,
622,
627,
628,
637,
647,
649,
661,
666,
669,
680,
684,
696,
698,
704,
709,
712,
717,
719,
724,
733,
741,
746,
756,
764,
768,
775,
777,
782,
789,
794,
803,
805,
809,
812,
816,
826,
837,
840,
845,
855,
862
]
} | 1cd5d74a7e29415aada5f0c456f018d4 | When was antibacterial-resistance demonstrated? | {
"tokens": [
"When",
"was",
"antibacterial",
"-",
"resistance",
"demonstrated",
"?"
],
"offsets": [
0,
5,
9,
22,
23,
34,
46
]
} | {
"text": [
"1943"
],
"char_spans": [
{
"start": [
610
],
"end": [
613
]
}
],
"token_spans": [
{
"start": [
90
],
"end": [
90
]
}
]
} | [
"1943"
] |
SQuAD | The emergence of resistance of bacteria to antibiotics is a common phenomenon. Emergence of resistance often reflects evolutionary processes that take place during antibiotic therapy. The antibiotic treatment may select for bacterial strains with physiologically or genetically enhanced capacity to survive high doses of antibiotics. Under certain conditions, it may result in preferential growth of resistant bacteria, while growth of susceptible bacteria is inhibited by the drug. For example, antibacterial selection for strains having previously acquired antibacterial-resistance genes was demonstrated in 1943 by the Luria–Delbrück experiment. Antibiotics such as penicillin and erythromycin, which used to have a high efficacy against many bacterial species and strains, have become less effective, due to the increased resistance of many bacterial strains. | {
"tokens": [
"The",
"emergence",
"of",
"resistance",
"of",
"bacteria",
"to",
"antibiotics",
"is",
"a",
"common",
"phenomenon",
".",
"Emergence",
"of",
"resistance",
"often",
"reflects",
"evolutionary",
"processes",
"that",
"take",
"place",
"during",
"antibiotic",
"therapy",
".",
"The",
"antibiotic",
"treatment",
"may",
"select",
"for",
"bacterial",
"strains",
"with",
"physiologically",
"or",
"genetically",
"enhanced",
"capacity",
"to",
"survive",
"high",
"doses",
"of",
"antibiotics",
".",
"Under",
"certain",
"conditions",
",",
"it",
"may",
"result",
"in",
"preferential",
"growth",
"of",
"resistant",
"bacteria",
",",
"while",
"growth",
"of",
"susceptible",
"bacteria",
"is",
"inhibited",
"by",
"the",
"drug",
".",
"For",
"example",
",",
"antibacterial",
"selection",
"for",
"strains",
"having",
"previously",
"acquired",
"antibacterial",
"-",
"resistance",
"genes",
"was",
"demonstrated",
"in",
"1943",
"by",
"the",
"Luria",
"–",
"Delbrück",
"experiment",
".",
"Antibiotics",
"such",
"as",
"penicillin",
"and",
"erythromycin",
",",
"which",
"used",
"to",
"have",
"a",
"high",
"efficacy",
"against",
"many",
"bacterial",
"species",
"and",
"strains",
",",
"have",
"become",
"less",
"effective",
",",
"due",
"to",
"the",
"increased",
"resistance",
"of",
"many",
"bacterial",
"strains",
"."
],
"offsets": [
0,
4,
14,
17,
28,
31,
40,
43,
55,
58,
60,
67,
77,
79,
89,
92,
103,
109,
118,
131,
141,
146,
151,
157,
164,
175,
182,
184,
188,
199,
209,
213,
220,
224,
234,
242,
247,
263,
266,
278,
287,
296,
299,
307,
312,
318,
321,
332,
334,
340,
348,
358,
360,
363,
367,
374,
377,
390,
397,
400,
410,
418,
420,
426,
433,
436,
448,
457,
460,
470,
473,
477,
481,
483,
487,
494,
496,
510,
520,
524,
532,
539,
550,
559,
572,
573,
584,
590,
594,
607,
610,
615,
618,
622,
627,
628,
637,
647,
649,
661,
666,
669,
680,
684,
696,
698,
704,
709,
712,
717,
719,
724,
733,
741,
746,
756,
764,
768,
775,
777,
782,
789,
794,
803,
805,
809,
812,
816,
826,
837,
840,
845,
855,
862
]
} | 01b108445c3743d89e9c34f366c0cf62 | Who made the demonstration in 1943? | {
"tokens": [
"Who",
"made",
"the",
"demonstration",
"in",
"1943",
"?"
],
"offsets": [
0,
4,
9,
13,
27,
30,
34
]
} | {
"text": [
"Luria–Delbrück"
],
"char_spans": [
{
"start": [
622
],
"end": [
635
]
}
],
"token_spans": [
{
"start": [
93
],
"end": [
95
]
}
]
} | [
"Luria–Delbrück"
] |
SQuAD | The effects of some types of mold on infection had been noticed many times over the course of history (see: History of penicillin). In 1928, Alexander Fleming noticed the same effect in a Petri dish, where a number of disease-causing bacteria were killed by a fungus of the genus Penicillium. Fleming postulated that the effect is mediated by an antibacterial compound he named penicillin, and that its antibacterial properties could be exploited for chemotherapy. He initially characterized some of its biological properties, and attempted to use a crude preparation to treat some infections, but he was unable to pursue its further development without the aid of trained chemists. | {
"tokens": [
"The",
"effects",
"of",
"some",
"types",
"of",
"mold",
"on",
"infection",
"had",
"been",
"noticed",
"many",
"times",
"over",
"the",
"course",
"of",
"history",
"(",
"see",
":",
"History",
"of",
"penicillin",
")",
".",
"In",
"1928",
",",
"Alexander",
"Fleming",
"noticed",
"the",
"same",
"effect",
"in",
"a",
"Petri",
"dish",
",",
"where",
"a",
"number",
"of",
"disease",
"-",
"causing",
"bacteria",
"were",
"killed",
"by",
"a",
"fungus",
"of",
"the",
"genus",
"Penicillium",
".",
"Fleming",
"postulated",
"that",
"the",
"effect",
"is",
"mediated",
"by",
"an",
"antibacterial",
"compound",
"he",
"named",
"penicillin",
",",
"and",
"that",
"its",
"antibacterial",
"properties",
"could",
"be",
"exploited",
"for",
"chemotherapy",
".",
"He",
"initially",
"characterized",
"some",
"of",
"its",
"biological",
"properties",
",",
"and",
"attempted",
"to",
"use",
"a",
"crude",
"preparation",
"to",
"treat",
"some",
"infections",
",",
"but",
"he",
"was",
"unable",
"to",
"pursue",
"its",
"further",
"development",
"without",
"the",
"aid",
"of",
"trained",
"chemists",
"."
],
"offsets": [
0,
4,
12,
15,
20,
26,
29,
34,
37,
47,
51,
56,
64,
69,
75,
80,
84,
91,
94,
102,
103,
106,
108,
116,
119,
129,
130,
132,
135,
139,
141,
151,
159,
167,
171,
176,
183,
186,
188,
194,
198,
200,
206,
208,
215,
218,
225,
226,
234,
243,
248,
255,
258,
260,
267,
270,
274,
280,
291,
293,
301,
312,
317,
321,
328,
331,
340,
343,
346,
360,
369,
372,
378,
388,
390,
394,
399,
403,
417,
428,
434,
437,
447,
451,
463,
465,
468,
478,
492,
497,
500,
504,
515,
525,
527,
531,
541,
544,
548,
550,
556,
568,
571,
577,
582,
592,
594,
598,
601,
605,
612,
615,
622,
626,
634,
646,
654,
658,
662,
665,
673,
681
]
} | 23972488f5714bcd9b82b10cd6a10d3c | What type of organism has been reported to have worked on infections? | {
"tokens": [
"What",
"type",
"of",
"organism",
"has",
"been",
"reported",
"to",
"have",
"worked",
"on",
"infections",
"?"
],
"offsets": [
0,
5,
10,
13,
22,
26,
31,
40,
43,
48,
55,
58,
68
]
} | {
"text": [
"mold"
],
"char_spans": [
{
"start": [
29
],
"end": [
32
]
}
],
"token_spans": [
{
"start": [
6
],
"end": [
6
]
}
]
} | [
"mold"
] |
SQuAD | The effects of some types of mold on infection had been noticed many times over the course of history (see: History of penicillin). In 1928, Alexander Fleming noticed the same effect in a Petri dish, where a number of disease-causing bacteria were killed by a fungus of the genus Penicillium. Fleming postulated that the effect is mediated by an antibacterial compound he named penicillin, and that its antibacterial properties could be exploited for chemotherapy. He initially characterized some of its biological properties, and attempted to use a crude preparation to treat some infections, but he was unable to pursue its further development without the aid of trained chemists. | {
"tokens": [
"The",
"effects",
"of",
"some",
"types",
"of",
"mold",
"on",
"infection",
"had",
"been",
"noticed",
"many",
"times",
"over",
"the",
"course",
"of",
"history",
"(",
"see",
":",
"History",
"of",
"penicillin",
")",
".",
"In",
"1928",
",",
"Alexander",
"Fleming",
"noticed",
"the",
"same",
"effect",
"in",
"a",
"Petri",
"dish",
",",
"where",
"a",
"number",
"of",
"disease",
"-",
"causing",
"bacteria",
"were",
"killed",
"by",
"a",
"fungus",
"of",
"the",
"genus",
"Penicillium",
".",
"Fleming",
"postulated",
"that",
"the",
"effect",
"is",
"mediated",
"by",
"an",
"antibacterial",
"compound",
"he",
"named",
"penicillin",
",",
"and",
"that",
"its",
"antibacterial",
"properties",
"could",
"be",
"exploited",
"for",
"chemotherapy",
".",
"He",
"initially",
"characterized",
"some",
"of",
"its",
"biological",
"properties",
",",
"and",
"attempted",
"to",
"use",
"a",
"crude",
"preparation",
"to",
"treat",
"some",
"infections",
",",
"but",
"he",
"was",
"unable",
"to",
"pursue",
"its",
"further",
"development",
"without",
"the",
"aid",
"of",
"trained",
"chemists",
"."
],
"offsets": [
0,
4,
12,
15,
20,
26,
29,
34,
37,
47,
51,
56,
64,
69,
75,
80,
84,
91,
94,
102,
103,
106,
108,
116,
119,
129,
130,
132,
135,
139,
141,
151,
159,
167,
171,
176,
183,
186,
188,
194,
198,
200,
206,
208,
215,
218,
225,
226,
234,
243,
248,
255,
258,
260,
267,
270,
274,
280,
291,
293,
301,
312,
317,
321,
328,
331,
340,
343,
346,
360,
369,
372,
378,
388,
390,
394,
399,
403,
417,
428,
434,
437,
447,
451,
463,
465,
468,
478,
492,
497,
500,
504,
515,
525,
527,
531,
541,
544,
548,
550,
556,
568,
571,
577,
582,
592,
594,
598,
601,
605,
612,
615,
622,
626,
634,
646,
654,
658,
662,
665,
673,
681
]
} | fcddb21b6e8b41a3aa612f3d3b0cd7d4 | Who noticed in a lab the antibacterial characteristics of mold? | {
"tokens": [
"Who",
"noticed",
"in",
"a",
"lab",
"the",
"antibacterial",
"characteristics",
"of",
"mold",
"?"
],
"offsets": [
0,
4,
12,
15,
17,
21,
25,
39,
55,
58,
62
]
} | {
"text": [
"Alexander Fleming"
],
"char_spans": [
{
"start": [
141
],
"end": [
157
]
}
],
"token_spans": [
{
"start": [
30
],
"end": [
31
]
}
]
} | [
"Alexander Fleming"
] |
SQuAD | The effects of some types of mold on infection had been noticed many times over the course of history (see: History of penicillin). In 1928, Alexander Fleming noticed the same effect in a Petri dish, where a number of disease-causing bacteria were killed by a fungus of the genus Penicillium. Fleming postulated that the effect is mediated by an antibacterial compound he named penicillin, and that its antibacterial properties could be exploited for chemotherapy. He initially characterized some of its biological properties, and attempted to use a crude preparation to treat some infections, but he was unable to pursue its further development without the aid of trained chemists. | {
"tokens": [
"The",
"effects",
"of",
"some",
"types",
"of",
"mold",
"on",
"infection",
"had",
"been",
"noticed",
"many",
"times",
"over",
"the",
"course",
"of",
"history",
"(",
"see",
":",
"History",
"of",
"penicillin",
")",
".",
"In",
"1928",
",",
"Alexander",
"Fleming",
"noticed",
"the",
"same",
"effect",
"in",
"a",
"Petri",
"dish",
",",
"where",
"a",
"number",
"of",
"disease",
"-",
"causing",
"bacteria",
"were",
"killed",
"by",
"a",
"fungus",
"of",
"the",
"genus",
"Penicillium",
".",
"Fleming",
"postulated",
"that",
"the",
"effect",
"is",
"mediated",
"by",
"an",
"antibacterial",
"compound",
"he",
"named",
"penicillin",
",",
"and",
"that",
"its",
"antibacterial",
"properties",
"could",
"be",
"exploited",
"for",
"chemotherapy",
".",
"He",
"initially",
"characterized",
"some",
"of",
"its",
"biological",
"properties",
",",
"and",
"attempted",
"to",
"use",
"a",
"crude",
"preparation",
"to",
"treat",
"some",
"infections",
",",
"but",
"he",
"was",
"unable",
"to",
"pursue",
"its",
"further",
"development",
"without",
"the",
"aid",
"of",
"trained",
"chemists",
"."
],
"offsets": [
0,
4,
12,
15,
20,
26,
29,
34,
37,
47,
51,
56,
64,
69,
75,
80,
84,
91,
94,
102,
103,
106,
108,
116,
119,
129,
130,
132,
135,
139,
141,
151,
159,
167,
171,
176,
183,
186,
188,
194,
198,
200,
206,
208,
215,
218,
225,
226,
234,
243,
248,
255,
258,
260,
267,
270,
274,
280,
291,
293,
301,
312,
317,
321,
328,
331,
340,
343,
346,
360,
369,
372,
378,
388,
390,
394,
399,
403,
417,
428,
434,
437,
447,
451,
463,
465,
468,
478,
492,
497,
500,
504,
515,
525,
527,
531,
541,
544,
548,
550,
556,
568,
571,
577,
582,
592,
594,
598,
601,
605,
612,
615,
622,
626,
634,
646,
654,
658,
662,
665,
673,
681
]
} | ef2ee552c6a342e1a4f3bf86f5e430a1 | What mold did Fleming notice had antibacterial properties? | {
"tokens": [
"What",
"mold",
"did",
"Fleming",
"notice",
"had",
"antibacterial",
"properties",
"?"
],
"offsets": [
0,
5,
10,
14,
22,
29,
33,
47,
57
]
} | {
"text": [
"penicillin"
],
"char_spans": [
{
"start": [
378
],
"end": [
387
]
}
],
"token_spans": [
{
"start": [
72
],
"end": [
72
]
}
]
} | [
"penicillin"
] |
SQuAD | The effects of some types of mold on infection had been noticed many times over the course of history (see: History of penicillin). In 1928, Alexander Fleming noticed the same effect in a Petri dish, where a number of disease-causing bacteria were killed by a fungus of the genus Penicillium. Fleming postulated that the effect is mediated by an antibacterial compound he named penicillin, and that its antibacterial properties could be exploited for chemotherapy. He initially characterized some of its biological properties, and attempted to use a crude preparation to treat some infections, but he was unable to pursue its further development without the aid of trained chemists. | {
"tokens": [
"The",
"effects",
"of",
"some",
"types",
"of",
"mold",
"on",
"infection",
"had",
"been",
"noticed",
"many",
"times",
"over",
"the",
"course",
"of",
"history",
"(",
"see",
":",
"History",
"of",
"penicillin",
")",
".",
"In",
"1928",
",",
"Alexander",
"Fleming",
"noticed",
"the",
"same",
"effect",
"in",
"a",
"Petri",
"dish",
",",
"where",
"a",
"number",
"of",
"disease",
"-",
"causing",
"bacteria",
"were",
"killed",
"by",
"a",
"fungus",
"of",
"the",
"genus",
"Penicillium",
".",
"Fleming",
"postulated",
"that",
"the",
"effect",
"is",
"mediated",
"by",
"an",
"antibacterial",
"compound",
"he",
"named",
"penicillin",
",",
"and",
"that",
"its",
"antibacterial",
"properties",
"could",
"be",
"exploited",
"for",
"chemotherapy",
".",
"He",
"initially",
"characterized",
"some",
"of",
"its",
"biological",
"properties",
",",
"and",
"attempted",
"to",
"use",
"a",
"crude",
"preparation",
"to",
"treat",
"some",
"infections",
",",
"but",
"he",
"was",
"unable",
"to",
"pursue",
"its",
"further",
"development",
"without",
"the",
"aid",
"of",
"trained",
"chemists",
"."
],
"offsets": [
0,
4,
12,
15,
20,
26,
29,
34,
37,
47,
51,
56,
64,
69,
75,
80,
84,
91,
94,
102,
103,
106,
108,
116,
119,
129,
130,
132,
135,
139,
141,
151,
159,
167,
171,
176,
183,
186,
188,
194,
198,
200,
206,
208,
215,
218,
225,
226,
234,
243,
248,
255,
258,
260,
267,
270,
274,
280,
291,
293,
301,
312,
317,
321,
328,
331,
340,
343,
346,
360,
369,
372,
378,
388,
390,
394,
399,
403,
417,
428,
434,
437,
447,
451,
463,
465,
468,
478,
492,
497,
500,
504,
515,
525,
527,
531,
541,
544,
548,
550,
556,
568,
571,
577,
582,
592,
594,
598,
601,
605,
612,
615,
622,
626,
634,
646,
654,
658,
662,
665,
673,
681
]
} | 1cc88d566372479eb28d41bcfbcec69f | What did Fleming initially think a good use would be for it? | {
"tokens": [
"What",
"did",
"Fleming",
"initially",
"think",
"a",
"good",
"use",
"would",
"be",
"for",
"it",
"?"
],
"offsets": [
0,
5,
9,
17,
27,
33,
35,
40,
44,
50,
53,
57,
59
]
} | {
"text": [
"chemotherapy"
],
"char_spans": [
{
"start": [
451
],
"end": [
462
]
}
],
"token_spans": [
{
"start": [
83
],
"end": [
83
]
}
]
} | [
"chemotherapy"
] |
SQuAD | Antibacterial-resistant strains and species, sometimes referred to as "superbugs", now contribute to the emergence of diseases that were for a while well controlled. For example, emergent bacterial strains causing tuberculosis (TB) that are resistant to previously effective antibacterial treatments pose many therapeutic challenges. Every year, nearly half a million new cases of multidrug-resistant tuberculosis (MDR-TB) are estimated to occur worldwide. For example, NDM-1 is a newly identified enzyme conveying bacterial resistance to a broad range of beta-lactam antibacterials. The United Kingdom's Health Protection Agency has stated that "most isolates with NDM-1 enzyme are resistant to all standard intravenous antibiotics for treatment of severe infections." | {
"tokens": [
"Antibacterial",
"-",
"resistant",
"strains",
"and",
"species",
",",
"sometimes",
"referred",
"to",
"as",
"\"",
"superbugs",
"\"",
",",
"now",
"contribute",
"to",
"the",
"emergence",
"of",
"diseases",
"that",
"were",
"for",
"a",
"while",
"well",
"controlled",
".",
"For",
"example",
",",
"emergent",
"bacterial",
"strains",
"causing",
"tuberculosis",
"(",
"TB",
")",
"that",
"are",
"resistant",
"to",
"previously",
"effective",
"antibacterial",
"treatments",
"pose",
"many",
"therapeutic",
"challenges",
".",
"Every",
"year",
",",
"nearly",
"half",
"a",
"million",
"new",
"cases",
"of",
"multidrug",
"-",
"resistant",
"tuberculosis",
"(",
"MDR",
"-",
"TB",
")",
"are",
"estimated",
"to",
"occur",
"worldwide",
".",
"For",
"example",
",",
"NDM-1",
"is",
"a",
"newly",
"identified",
"enzyme",
"conveying",
"bacterial",
"resistance",
"to",
"a",
"broad",
"range",
"of",
"beta",
"-",
"lactam",
"antibacterials",
".",
"The",
"United",
"Kingdom",
"'s",
"Health",
"Protection",
"Agency",
"has",
"stated",
"that",
"\"",
"most",
"isolates",
"with",
"NDM-1",
"enzyme",
"are",
"resistant",
"to",
"all",
"standard",
"intravenous",
"antibiotics",
"for",
"treatment",
"of",
"severe",
"infections",
".",
"\""
],
"offsets": [
0,
13,
14,
24,
32,
36,
43,
45,
55,
64,
67,
70,
71,
80,
81,
83,
87,
98,
101,
105,
115,
118,
127,
132,
137,
141,
143,
149,
154,
164,
166,
170,
177,
179,
188,
198,
206,
214,
227,
228,
230,
232,
237,
241,
251,
254,
265,
275,
289,
300,
305,
310,
322,
332,
334,
340,
344,
346,
353,
358,
360,
368,
372,
378,
381,
390,
391,
401,
414,
415,
418,
419,
421,
423,
427,
437,
440,
446,
455,
457,
461,
468,
470,
476,
479,
481,
487,
498,
505,
515,
525,
536,
539,
541,
547,
553,
556,
560,
561,
568,
582,
584,
588,
595,
602,
605,
612,
623,
630,
634,
641,
646,
647,
652,
661,
666,
672,
679,
683,
693,
696,
700,
709,
721,
733,
737,
747,
750,
757,
767,
768
]
} | 73ac6325a8f648aeb0ae2fcc6078f2e9 | What are strains that are resistant to antibiotics called sometimes? | {
"tokens": [
"What",
"are",
"strains",
"that",
"are",
"resistant",
"to",
"antibiotics",
"called",
"sometimes",
"?"
],
"offsets": [
0,
5,
9,
17,
22,
26,
36,
39,
51,
58,
67
]
} | {
"text": [
"superbugs"
],
"char_spans": [
{
"start": [
71
],
"end": [
79
]
}
],
"token_spans": [
{
"start": [
12
],
"end": [
12
]
}
]
} | [
"superbugs"
] |
SQuAD | Antibacterial-resistant strains and species, sometimes referred to as "superbugs", now contribute to the emergence of diseases that were for a while well controlled. For example, emergent bacterial strains causing tuberculosis (TB) that are resistant to previously effective antibacterial treatments pose many therapeutic challenges. Every year, nearly half a million new cases of multidrug-resistant tuberculosis (MDR-TB) are estimated to occur worldwide. For example, NDM-1 is a newly identified enzyme conveying bacterial resistance to a broad range of beta-lactam antibacterials. The United Kingdom's Health Protection Agency has stated that "most isolates with NDM-1 enzyme are resistant to all standard intravenous antibiotics for treatment of severe infections." | {
"tokens": [
"Antibacterial",
"-",
"resistant",
"strains",
"and",
"species",
",",
"sometimes",
"referred",
"to",
"as",
"\"",
"superbugs",
"\"",
",",
"now",
"contribute",
"to",
"the",
"emergence",
"of",
"diseases",
"that",
"were",
"for",
"a",
"while",
"well",
"controlled",
".",
"For",
"example",
",",
"emergent",
"bacterial",
"strains",
"causing",
"tuberculosis",
"(",
"TB",
")",
"that",
"are",
"resistant",
"to",
"previously",
"effective",
"antibacterial",
"treatments",
"pose",
"many",
"therapeutic",
"challenges",
".",
"Every",
"year",
",",
"nearly",
"half",
"a",
"million",
"new",
"cases",
"of",
"multidrug",
"-",
"resistant",
"tuberculosis",
"(",
"MDR",
"-",
"TB",
")",
"are",
"estimated",
"to",
"occur",
"worldwide",
".",
"For",
"example",
",",
"NDM-1",
"is",
"a",
"newly",
"identified",
"enzyme",
"conveying",
"bacterial",
"resistance",
"to",
"a",
"broad",
"range",
"of",
"beta",
"-",
"lactam",
"antibacterials",
".",
"The",
"United",
"Kingdom",
"'s",
"Health",
"Protection",
"Agency",
"has",
"stated",
"that",
"\"",
"most",
"isolates",
"with",
"NDM-1",
"enzyme",
"are",
"resistant",
"to",
"all",
"standard",
"intravenous",
"antibiotics",
"for",
"treatment",
"of",
"severe",
"infections",
".",
"\""
],
"offsets": [
0,
13,
14,
24,
32,
36,
43,
45,
55,
64,
67,
70,
71,
80,
81,
83,
87,
98,
101,
105,
115,
118,
127,
132,
137,
141,
143,
149,
154,
164,
166,
170,
177,
179,
188,
198,
206,
214,
227,
228,
230,
232,
237,
241,
251,
254,
265,
275,
289,
300,
305,
310,
322,
332,
334,
340,
344,
346,
353,
358,
360,
368,
372,
378,
381,
390,
391,
401,
414,
415,
418,
419,
421,
423,
427,
437,
440,
446,
455,
457,
461,
468,
470,
476,
479,
481,
487,
498,
505,
515,
525,
536,
539,
541,
547,
553,
556,
560,
561,
568,
582,
584,
588,
595,
602,
605,
612,
623,
630,
634,
641,
646,
647,
652,
661,
666,
672,
679,
683,
693,
696,
700,
709,
721,
733,
737,
747,
750,
757,
767,
768
]
} | 1a03453461e24157828c182dba4b82c6 | What was a once almost controlled disease that is coming back do to resistance? | {
"tokens": [
"What",
"was",
"a",
"once",
"almost",
"controlled",
"disease",
"that",
"is",
"coming",
"back",
"do",
"to",
"resistance",
"?"
],
"offsets": [
0,
5,
9,
11,
16,
23,
34,
42,
47,
50,
57,
62,
65,
68,
78
]
} | {
"text": [
"tuberculosis"
],
"char_spans": [
{
"start": [
214
],
"end": [
225
]
}
],
"token_spans": [
{
"start": [
37
],
"end": [
37
]
}
]
} | [
"tuberculosis"
] |
SQuAD | Antibacterial-resistant strains and species, sometimes referred to as "superbugs", now contribute to the emergence of diseases that were for a while well controlled. For example, emergent bacterial strains causing tuberculosis (TB) that are resistant to previously effective antibacterial treatments pose many therapeutic challenges. Every year, nearly half a million new cases of multidrug-resistant tuberculosis (MDR-TB) are estimated to occur worldwide. For example, NDM-1 is a newly identified enzyme conveying bacterial resistance to a broad range of beta-lactam antibacterials. The United Kingdom's Health Protection Agency has stated that "most isolates with NDM-1 enzyme are resistant to all standard intravenous antibiotics for treatment of severe infections." | {
"tokens": [
"Antibacterial",
"-",
"resistant",
"strains",
"and",
"species",
",",
"sometimes",
"referred",
"to",
"as",
"\"",
"superbugs",
"\"",
",",
"now",
"contribute",
"to",
"the",
"emergence",
"of",
"diseases",
"that",
"were",
"for",
"a",
"while",
"well",
"controlled",
".",
"For",
"example",
",",
"emergent",
"bacterial",
"strains",
"causing",
"tuberculosis",
"(",
"TB",
")",
"that",
"are",
"resistant",
"to",
"previously",
"effective",
"antibacterial",
"treatments",
"pose",
"many",
"therapeutic",
"challenges",
".",
"Every",
"year",
",",
"nearly",
"half",
"a",
"million",
"new",
"cases",
"of",
"multidrug",
"-",
"resistant",
"tuberculosis",
"(",
"MDR",
"-",
"TB",
")",
"are",
"estimated",
"to",
"occur",
"worldwide",
".",
"For",
"example",
",",
"NDM-1",
"is",
"a",
"newly",
"identified",
"enzyme",
"conveying",
"bacterial",
"resistance",
"to",
"a",
"broad",
"range",
"of",
"beta",
"-",
"lactam",
"antibacterials",
".",
"The",
"United",
"Kingdom",
"'s",
"Health",
"Protection",
"Agency",
"has",
"stated",
"that",
"\"",
"most",
"isolates",
"with",
"NDM-1",
"enzyme",
"are",
"resistant",
"to",
"all",
"standard",
"intravenous",
"antibiotics",
"for",
"treatment",
"of",
"severe",
"infections",
".",
"\""
],
"offsets": [
0,
13,
14,
24,
32,
36,
43,
45,
55,
64,
67,
70,
71,
80,
81,
83,
87,
98,
101,
105,
115,
118,
127,
132,
137,
141,
143,
149,
154,
164,
166,
170,
177,
179,
188,
198,
206,
214,
227,
228,
230,
232,
237,
241,
251,
254,
265,
275,
289,
300,
305,
310,
322,
332,
334,
340,
344,
346,
353,
358,
360,
368,
372,
378,
381,
390,
391,
401,
414,
415,
418,
419,
421,
423,
427,
437,
440,
446,
455,
457,
461,
468,
470,
476,
479,
481,
487,
498,
505,
515,
525,
536,
539,
541,
547,
553,
556,
560,
561,
568,
582,
584,
588,
595,
602,
605,
612,
623,
630,
634,
641,
646,
647,
652,
661,
666,
672,
679,
683,
693,
696,
700,
709,
721,
733,
737,
747,
750,
757,
767,
768
]
} | 3bf709400d474fdaa788c4200f6d03c6 | How many new infections of resistant TB are reported per year? | {
"tokens": [
"How",
"many",
"new",
"infections",
"of",
"resistant",
"TB",
"are",
"reported",
"per",
"year",
"?"
],
"offsets": [
0,
4,
9,
13,
24,
27,
37,
40,
44,
53,
57,
61
]
} | {
"text": [
"half a million"
],
"char_spans": [
{
"start": [
353
],
"end": [
366
]
}
],
"token_spans": [
{
"start": [
58
],
"end": [
60
]
}
]
} | [
"half a million"
] |
SQuAD | Antibacterial-resistant strains and species, sometimes referred to as "superbugs", now contribute to the emergence of diseases that were for a while well controlled. For example, emergent bacterial strains causing tuberculosis (TB) that are resistant to previously effective antibacterial treatments pose many therapeutic challenges. Every year, nearly half a million new cases of multidrug-resistant tuberculosis (MDR-TB) are estimated to occur worldwide. For example, NDM-1 is a newly identified enzyme conveying bacterial resistance to a broad range of beta-lactam antibacterials. The United Kingdom's Health Protection Agency has stated that "most isolates with NDM-1 enzyme are resistant to all standard intravenous antibiotics for treatment of severe infections." | {
"tokens": [
"Antibacterial",
"-",
"resistant",
"strains",
"and",
"species",
",",
"sometimes",
"referred",
"to",
"as",
"\"",
"superbugs",
"\"",
",",
"now",
"contribute",
"to",
"the",
"emergence",
"of",
"diseases",
"that",
"were",
"for",
"a",
"while",
"well",
"controlled",
".",
"For",
"example",
",",
"emergent",
"bacterial",
"strains",
"causing",
"tuberculosis",
"(",
"TB",
")",
"that",
"are",
"resistant",
"to",
"previously",
"effective",
"antibacterial",
"treatments",
"pose",
"many",
"therapeutic",
"challenges",
".",
"Every",
"year",
",",
"nearly",
"half",
"a",
"million",
"new",
"cases",
"of",
"multidrug",
"-",
"resistant",
"tuberculosis",
"(",
"MDR",
"-",
"TB",
")",
"are",
"estimated",
"to",
"occur",
"worldwide",
".",
"For",
"example",
",",
"NDM-1",
"is",
"a",
"newly",
"identified",
"enzyme",
"conveying",
"bacterial",
"resistance",
"to",
"a",
"broad",
"range",
"of",
"beta",
"-",
"lactam",
"antibacterials",
".",
"The",
"United",
"Kingdom",
"'s",
"Health",
"Protection",
"Agency",
"has",
"stated",
"that",
"\"",
"most",
"isolates",
"with",
"NDM-1",
"enzyme",
"are",
"resistant",
"to",
"all",
"standard",
"intravenous",
"antibiotics",
"for",
"treatment",
"of",
"severe",
"infections",
".",
"\""
],
"offsets": [
0,
13,
14,
24,
32,
36,
43,
45,
55,
64,
67,
70,
71,
80,
81,
83,
87,
98,
101,
105,
115,
118,
127,
132,
137,
141,
143,
149,
154,
164,
166,
170,
177,
179,
188,
198,
206,
214,
227,
228,
230,
232,
237,
241,
251,
254,
265,
275,
289,
300,
305,
310,
322,
332,
334,
340,
344,
346,
353,
358,
360,
368,
372,
378,
381,
390,
391,
401,
414,
415,
418,
419,
421,
423,
427,
437,
440,
446,
455,
457,
461,
468,
470,
476,
479,
481,
487,
498,
505,
515,
525,
536,
539,
541,
547,
553,
556,
560,
561,
568,
582,
584,
588,
595,
602,
605,
612,
623,
630,
634,
641,
646,
647,
652,
661,
666,
672,
679,
683,
693,
696,
700,
709,
721,
733,
737,
747,
750,
757,
767,
768
]
} | 1b71343ef56f42cca8f2d61e504832fe | What is the acronym used to describe resistant TB? | {
"tokens": [
"What",
"is",
"the",
"acronym",
"used",
"to",
"describe",
"resistant",
"TB",
"?"
],
"offsets": [
0,
5,
8,
12,
20,
25,
28,
37,
47,
49
]
} | {
"text": [
"MDR-TB"
],
"char_spans": [
{
"start": [
415
],
"end": [
420
]
}
],
"token_spans": [
{
"start": [
69
],
"end": [
71
]
}
]
} | [
"MDR-TB"
] |
SQuAD | Interactions between alcohol and certain antibiotics may occur and may cause side-effects and decreased effectiveness of antibiotic therapy. While moderate alcohol consumption is unlikely to interfere with many common antibiotics, there are specific types of antibiotics with which alcohol consumption may cause serious side-effects. Therefore, potential risks of side-effects and effectiveness depend on the type of antibiotic administered. Despite the lack of a categorical counterindication, the belief that alcohol and antibiotics should never be mixed is widespread. | {
"tokens": [
"Interactions",
"between",
"alcohol",
"and",
"certain",
"antibiotics",
"may",
"occur",
"and",
"may",
"cause",
"side",
"-",
"effects",
"and",
"decreased",
"effectiveness",
"of",
"antibiotic",
"therapy",
".",
"While",
"moderate",
"alcohol",
"consumption",
"is",
"unlikely",
"to",
"interfere",
"with",
"many",
"common",
"antibiotics",
",",
"there",
"are",
"specific",
"types",
"of",
"antibiotics",
"with",
"which",
"alcohol",
"consumption",
"may",
"cause",
"serious",
"side",
"-",
"effects",
".",
"Therefore",
",",
"potential",
"risks",
"of",
"side",
"-",
"effects",
"and",
"effectiveness",
"depend",
"on",
"the",
"type",
"of",
"antibiotic",
"administered",
".",
"Despite",
"the",
"lack",
"of",
"a",
"categorical",
"counterindication",
",",
"the",
"belief",
"that",
"alcohol",
"and",
"antibiotics",
"should",
"never",
"be",
"mixed",
"is",
"widespread",
"."
],
"offsets": [
0,
13,
21,
29,
33,
41,
53,
57,
63,
67,
71,
77,
81,
82,
90,
94,
104,
118,
121,
132,
139,
141,
147,
156,
164,
176,
179,
188,
191,
201,
206,
211,
218,
229,
231,
237,
241,
250,
256,
259,
271,
276,
282,
290,
302,
306,
312,
320,
324,
325,
332,
334,
343,
345,
355,
361,
364,
368,
369,
377,
381,
395,
402,
405,
409,
414,
417,
428,
440,
442,
450,
454,
459,
462,
464,
476,
493,
495,
499,
506,
511,
519,
523,
535,
542,
548,
551,
557,
560,
570
]
} | d21d5dbc82e0491d9781d85e7681ccc6 | What is one potential issue with drinking alcohol while taking antibiotics? | {
"tokens": [
"What",
"is",
"one",
"potential",
"issue",
"with",
"drinking",
"alcohol",
"while",
"taking",
"antibiotics",
"?"
],
"offsets": [
0,
5,
8,
12,
22,
28,
33,
42,
50,
56,
63,
74
]
} | {
"text": [
"decreased effectiveness"
],
"char_spans": [
{
"start": [
94
],
"end": [
116
]
}
],
"token_spans": [
{
"start": [
15
],
"end": [
16
]
}
]
} | [
"decreased effectiveness"
] |
SQuAD | Interactions between alcohol and certain antibiotics may occur and may cause side-effects and decreased effectiveness of antibiotic therapy. While moderate alcohol consumption is unlikely to interfere with many common antibiotics, there are specific types of antibiotics with which alcohol consumption may cause serious side-effects. Therefore, potential risks of side-effects and effectiveness depend on the type of antibiotic administered. Despite the lack of a categorical counterindication, the belief that alcohol and antibiotics should never be mixed is widespread. | {
"tokens": [
"Interactions",
"between",
"alcohol",
"and",
"certain",
"antibiotics",
"may",
"occur",
"and",
"may",
"cause",
"side",
"-",
"effects",
"and",
"decreased",
"effectiveness",
"of",
"antibiotic",
"therapy",
".",
"While",
"moderate",
"alcohol",
"consumption",
"is",
"unlikely",
"to",
"interfere",
"with",
"many",
"common",
"antibiotics",
",",
"there",
"are",
"specific",
"types",
"of",
"antibiotics",
"with",
"which",
"alcohol",
"consumption",
"may",
"cause",
"serious",
"side",
"-",
"effects",
".",
"Therefore",
",",
"potential",
"risks",
"of",
"side",
"-",
"effects",
"and",
"effectiveness",
"depend",
"on",
"the",
"type",
"of",
"antibiotic",
"administered",
".",
"Despite",
"the",
"lack",
"of",
"a",
"categorical",
"counterindication",
",",
"the",
"belief",
"that",
"alcohol",
"and",
"antibiotics",
"should",
"never",
"be",
"mixed",
"is",
"widespread",
"."
],
"offsets": [
0,
13,
21,
29,
33,
41,
53,
57,
63,
67,
71,
77,
81,
82,
90,
94,
104,
118,
121,
132,
139,
141,
147,
156,
164,
176,
179,
188,
191,
201,
206,
211,
218,
229,
231,
237,
241,
250,
256,
259,
271,
276,
282,
290,
302,
306,
312,
320,
324,
325,
332,
334,
343,
345,
355,
361,
364,
368,
369,
377,
381,
395,
402,
405,
409,
414,
417,
428,
440,
442,
450,
454,
459,
462,
464,
476,
493,
495,
499,
506,
511,
519,
523,
535,
542,
548,
551,
557,
560,
570
]
} | f70af04127e440958de7536156769cc4 | Do all antibiotics interact dangerously with alcohol? | {
"tokens": [
"Do",
"all",
"antibiotics",
"interact",
"dangerously",
"with",
"alcohol",
"?"
],
"offsets": [
0,
3,
7,
19,
28,
40,
45,
52
]
} | {
"text": [
"moderate alcohol consumption is unlikely to interfere with many common antibiotics"
],
"char_spans": [
{
"start": [
147
],
"end": [
228
]
}
],
"token_spans": [
{
"start": [
22
],
"end": [
32
]
}
]
} | [
"moderate alcohol consumption is unlikely to interfere with many common antibiotics"
] |
SQuAD | Interactions between alcohol and certain antibiotics may occur and may cause side-effects and decreased effectiveness of antibiotic therapy. While moderate alcohol consumption is unlikely to interfere with many common antibiotics, there are specific types of antibiotics with which alcohol consumption may cause serious side-effects. Therefore, potential risks of side-effects and effectiveness depend on the type of antibiotic administered. Despite the lack of a categorical counterindication, the belief that alcohol and antibiotics should never be mixed is widespread. | {
"tokens": [
"Interactions",
"between",
"alcohol",
"and",
"certain",
"antibiotics",
"may",
"occur",
"and",
"may",
"cause",
"side",
"-",
"effects",
"and",
"decreased",
"effectiveness",
"of",
"antibiotic",
"therapy",
".",
"While",
"moderate",
"alcohol",
"consumption",
"is",
"unlikely",
"to",
"interfere",
"with",
"many",
"common",
"antibiotics",
",",
"there",
"are",
"specific",
"types",
"of",
"antibiotics",
"with",
"which",
"alcohol",
"consumption",
"may",
"cause",
"serious",
"side",
"-",
"effects",
".",
"Therefore",
",",
"potential",
"risks",
"of",
"side",
"-",
"effects",
"and",
"effectiveness",
"depend",
"on",
"the",
"type",
"of",
"antibiotic",
"administered",
".",
"Despite",
"the",
"lack",
"of",
"a",
"categorical",
"counterindication",
",",
"the",
"belief",
"that",
"alcohol",
"and",
"antibiotics",
"should",
"never",
"be",
"mixed",
"is",
"widespread",
"."
],
"offsets": [
0,
13,
21,
29,
33,
41,
53,
57,
63,
67,
71,
77,
81,
82,
90,
94,
104,
118,
121,
132,
139,
141,
147,
156,
164,
176,
179,
188,
191,
201,
206,
211,
218,
229,
231,
237,
241,
250,
256,
259,
271,
276,
282,
290,
302,
306,
312,
320,
324,
325,
332,
334,
343,
345,
355,
361,
364,
368,
369,
377,
381,
395,
402,
405,
409,
414,
417,
428,
440,
442,
450,
454,
459,
462,
464,
476,
493,
495,
499,
506,
511,
519,
523,
535,
542,
548,
551,
557,
560,
570
]
} | fdb3aeb3989e4000ad51ff9580999796 | Is it OK to drink alcohol while taking any antibiotic? | {
"tokens": [
"Is",
"it",
"OK",
"to",
"drink",
"alcohol",
"while",
"taking",
"any",
"antibiotic",
"?"
],
"offsets": [
0,
3,
6,
9,
12,
18,
26,
32,
39,
43,
53
]
} | {
"text": [
"there are specific types of antibiotics with which alcohol consumption may cause serious side-effects"
],
"char_spans": [
{
"start": [
231
],
"end": [
331
]
}
],
"token_spans": [
{
"start": [
34
],
"end": [
49
]
}
]
} | [
"there are specific types of antibiotics with which alcohol consumption may cause serious side-effects"
] |
SQuAD | Interactions between alcohol and certain antibiotics may occur and may cause side-effects and decreased effectiveness of antibiotic therapy. While moderate alcohol consumption is unlikely to interfere with many common antibiotics, there are specific types of antibiotics with which alcohol consumption may cause serious side-effects. Therefore, potential risks of side-effects and effectiveness depend on the type of antibiotic administered. Despite the lack of a categorical counterindication, the belief that alcohol and antibiotics should never be mixed is widespread. | {
"tokens": [
"Interactions",
"between",
"alcohol",
"and",
"certain",
"antibiotics",
"may",
"occur",
"and",
"may",
"cause",
"side",
"-",
"effects",
"and",
"decreased",
"effectiveness",
"of",
"antibiotic",
"therapy",
".",
"While",
"moderate",
"alcohol",
"consumption",
"is",
"unlikely",
"to",
"interfere",
"with",
"many",
"common",
"antibiotics",
",",
"there",
"are",
"specific",
"types",
"of",
"antibiotics",
"with",
"which",
"alcohol",
"consumption",
"may",
"cause",
"serious",
"side",
"-",
"effects",
".",
"Therefore",
",",
"potential",
"risks",
"of",
"side",
"-",
"effects",
"and",
"effectiveness",
"depend",
"on",
"the",
"type",
"of",
"antibiotic",
"administered",
".",
"Despite",
"the",
"lack",
"of",
"a",
"categorical",
"counterindication",
",",
"the",
"belief",
"that",
"alcohol",
"and",
"antibiotics",
"should",
"never",
"be",
"mixed",
"is",
"widespread",
"."
],
"offsets": [
0,
13,
21,
29,
33,
41,
53,
57,
63,
67,
71,
77,
81,
82,
90,
94,
104,
118,
121,
132,
139,
141,
147,
156,
164,
176,
179,
188,
191,
201,
206,
211,
218,
229,
231,
237,
241,
250,
256,
259,
271,
276,
282,
290,
302,
306,
312,
320,
324,
325,
332,
334,
343,
345,
355,
361,
364,
368,
369,
377,
381,
395,
402,
405,
409,
414,
417,
428,
440,
442,
450,
454,
459,
462,
464,
476,
493,
495,
499,
506,
511,
519,
523,
535,
542,
548,
551,
557,
560,
570
]
} | c8c5955b18424a2880d20da9452c3110 | How common is the belief that alcohol and antibiotics should never be mixed? | {
"tokens": [
"How",
"common",
"is",
"the",
"belief",
"that",
"alcohol",
"and",
"antibiotics",
"should",
"never",
"be",
"mixed",
"?"
],
"offsets": [
0,
4,
11,
14,
18,
25,
30,
38,
42,
54,
61,
67,
70,
75
]
} | {
"text": [
"widespread"
],
"char_spans": [
{
"start": [
560
],
"end": [
569
]
}
],
"token_spans": [
{
"start": [
88
],
"end": [
88
]
}
]
} | [
"widespread"
] |
SQuAD | Interactions between alcohol and certain antibiotics may occur and may cause side-effects and decreased effectiveness of antibiotic therapy. While moderate alcohol consumption is unlikely to interfere with many common antibiotics, there are specific types of antibiotics with which alcohol consumption may cause serious side-effects. Therefore, potential risks of side-effects and effectiveness depend on the type of antibiotic administered. Despite the lack of a categorical counterindication, the belief that alcohol and antibiotics should never be mixed is widespread. | {
"tokens": [
"Interactions",
"between",
"alcohol",
"and",
"certain",
"antibiotics",
"may",
"occur",
"and",
"may",
"cause",
"side",
"-",
"effects",
"and",
"decreased",
"effectiveness",
"of",
"antibiotic",
"therapy",
".",
"While",
"moderate",
"alcohol",
"consumption",
"is",
"unlikely",
"to",
"interfere",
"with",
"many",
"common",
"antibiotics",
",",
"there",
"are",
"specific",
"types",
"of",
"antibiotics",
"with",
"which",
"alcohol",
"consumption",
"may",
"cause",
"serious",
"side",
"-",
"effects",
".",
"Therefore",
",",
"potential",
"risks",
"of",
"side",
"-",
"effects",
"and",
"effectiveness",
"depend",
"on",
"the",
"type",
"of",
"antibiotic",
"administered",
".",
"Despite",
"the",
"lack",
"of",
"a",
"categorical",
"counterindication",
",",
"the",
"belief",
"that",
"alcohol",
"and",
"antibiotics",
"should",
"never",
"be",
"mixed",
"is",
"widespread",
"."
],
"offsets": [
0,
13,
21,
29,
33,
41,
53,
57,
63,
67,
71,
77,
81,
82,
90,
94,
104,
118,
121,
132,
139,
141,
147,
156,
164,
176,
179,
188,
191,
201,
206,
211,
218,
229,
231,
237,
241,
250,
256,
259,
271,
276,
282,
290,
302,
306,
312,
320,
324,
325,
332,
334,
343,
345,
355,
361,
364,
368,
369,
377,
381,
395,
402,
405,
409,
414,
417,
428,
440,
442,
450,
454,
459,
462,
464,
476,
493,
495,
499,
506,
511,
519,
523,
535,
542,
548,
551,
557,
560,
570
]
} | 32ad67a17f6244deb9737a2aa2253de8 | What can alcohol and certain antibiotics cause? | {
"tokens": [
"What",
"can",
"alcohol",
"and",
"certain",
"antibiotics",
"cause",
"?"
],
"offsets": [
0,
5,
9,
17,
21,
29,
41,
46
]
} | {
"text": [
"decreased effectiveness of antibiotic therapy"
],
"char_spans": [
{
"start": [
94
],
"end": [
138
]
}
],
"token_spans": [
{
"start": [
15
],
"end": [
19
]
}
]
} | [
"decreased effectiveness of antibiotic therapy"
] |
SQuAD | Interactions between alcohol and certain antibiotics may occur and may cause side-effects and decreased effectiveness of antibiotic therapy. While moderate alcohol consumption is unlikely to interfere with many common antibiotics, there are specific types of antibiotics with which alcohol consumption may cause serious side-effects. Therefore, potential risks of side-effects and effectiveness depend on the type of antibiotic administered. Despite the lack of a categorical counterindication, the belief that alcohol and antibiotics should never be mixed is widespread. | {
"tokens": [
"Interactions",
"between",
"alcohol",
"and",
"certain",
"antibiotics",
"may",
"occur",
"and",
"may",
"cause",
"side",
"-",
"effects",
"and",
"decreased",
"effectiveness",
"of",
"antibiotic",
"therapy",
".",
"While",
"moderate",
"alcohol",
"consumption",
"is",
"unlikely",
"to",
"interfere",
"with",
"many",
"common",
"antibiotics",
",",
"there",
"are",
"specific",
"types",
"of",
"antibiotics",
"with",
"which",
"alcohol",
"consumption",
"may",
"cause",
"serious",
"side",
"-",
"effects",
".",
"Therefore",
",",
"potential",
"risks",
"of",
"side",
"-",
"effects",
"and",
"effectiveness",
"depend",
"on",
"the",
"type",
"of",
"antibiotic",
"administered",
".",
"Despite",
"the",
"lack",
"of",
"a",
"categorical",
"counterindication",
",",
"the",
"belief",
"that",
"alcohol",
"and",
"antibiotics",
"should",
"never",
"be",
"mixed",
"is",
"widespread",
"."
],
"offsets": [
0,
13,
21,
29,
33,
41,
53,
57,
63,
67,
71,
77,
81,
82,
90,
94,
104,
118,
121,
132,
139,
141,
147,
156,
164,
176,
179,
188,
191,
201,
206,
211,
218,
229,
231,
237,
241,
250,
256,
259,
271,
276,
282,
290,
302,
306,
312,
320,
324,
325,
332,
334,
343,
345,
355,
361,
364,
368,
369,
377,
381,
395,
402,
405,
409,
414,
417,
428,
440,
442,
450,
454,
459,
462,
464,
476,
493,
495,
499,
506,
511,
519,
523,
535,
542,
548,
551,
557,
560,
570
]
} | 5e3dab5559fe45d2b453d3b726b4ceb3 | What is unlikely to interfere with with many common antibiotics? | {
"tokens": [
"What",
"is",
"unlikely",
"to",
"interfere",
"with",
" ",
"with",
"many",
"common",
"antibiotics",
"?"
],
"offsets": [
0,
5,
8,
17,
20,
30,
35,
36,
41,
46,
53,
64
]
} | {
"text": [
"alcohol consumption"
],
"char_spans": [
{
"start": [
156
],
"end": [
174
]
}
],
"token_spans": [
{
"start": [
23
],
"end": [
24
]
}
]
} | [
"alcohol consumption"
] |
SQuAD | Interactions between alcohol and certain antibiotics may occur and may cause side-effects and decreased effectiveness of antibiotic therapy. While moderate alcohol consumption is unlikely to interfere with many common antibiotics, there are specific types of antibiotics with which alcohol consumption may cause serious side-effects. Therefore, potential risks of side-effects and effectiveness depend on the type of antibiotic administered. Despite the lack of a categorical counterindication, the belief that alcohol and antibiotics should never be mixed is widespread. | {
"tokens": [
"Interactions",
"between",
"alcohol",
"and",
"certain",
"antibiotics",
"may",
"occur",
"and",
"may",
"cause",
"side",
"-",
"effects",
"and",
"decreased",
"effectiveness",
"of",
"antibiotic",
"therapy",
".",
"While",
"moderate",
"alcohol",
"consumption",
"is",
"unlikely",
"to",
"interfere",
"with",
"many",
"common",
"antibiotics",
",",
"there",
"are",
"specific",
"types",
"of",
"antibiotics",
"with",
"which",
"alcohol",
"consumption",
"may",
"cause",
"serious",
"side",
"-",
"effects",
".",
"Therefore",
",",
"potential",
"risks",
"of",
"side",
"-",
"effects",
"and",
"effectiveness",
"depend",
"on",
"the",
"type",
"of",
"antibiotic",
"administered",
".",
"Despite",
"the",
"lack",
"of",
"a",
"categorical",
"counterindication",
",",
"the",
"belief",
"that",
"alcohol",
"and",
"antibiotics",
"should",
"never",
"be",
"mixed",
"is",
"widespread",
"."
],
"offsets": [
0,
13,
21,
29,
33,
41,
53,
57,
63,
67,
71,
77,
81,
82,
90,
94,
104,
118,
121,
132,
139,
141,
147,
156,
164,
176,
179,
188,
191,
201,
206,
211,
218,
229,
231,
237,
241,
250,
256,
259,
271,
276,
282,
290,
302,
306,
312,
320,
324,
325,
332,
334,
343,
345,
355,
361,
364,
368,
369,
377,
381,
395,
402,
405,
409,
414,
417,
428,
440,
442,
450,
454,
459,
462,
464,
476,
493,
495,
499,
506,
511,
519,
523,
535,
542,
548,
551,
557,
560,
570
]
} | ea0fe659212041f58b98f0dd3f823d20 | What belief should bever be mixed widespread? | {
"tokens": [
"What",
"belief",
"should",
"bever",
"be",
"mixed",
"widespread",
"?"
],
"offsets": [
0,
5,
12,
19,
25,
28,
34,
44
]
} | {
"text": [
"alcohol and antibiotics"
],
"char_spans": [
{
"start": [
511
],
"end": [
533
]
}
],
"token_spans": [
{
"start": [
80
],
"end": [
82
]
}
]
} | [
"alcohol and antibiotics"
] |
SQuAD | Interactions between alcohol and certain antibiotics may occur and may cause side-effects and decreased effectiveness of antibiotic therapy. While moderate alcohol consumption is unlikely to interfere with many common antibiotics, there are specific types of antibiotics with which alcohol consumption may cause serious side-effects. Therefore, potential risks of side-effects and effectiveness depend on the type of antibiotic administered. Despite the lack of a categorical counterindication, the belief that alcohol and antibiotics should never be mixed is widespread. | {
"tokens": [
"Interactions",
"between",
"alcohol",
"and",
"certain",
"antibiotics",
"may",
"occur",
"and",
"may",
"cause",
"side",
"-",
"effects",
"and",
"decreased",
"effectiveness",
"of",
"antibiotic",
"therapy",
".",
"While",
"moderate",
"alcohol",
"consumption",
"is",
"unlikely",
"to",
"interfere",
"with",
"many",
"common",
"antibiotics",
",",
"there",
"are",
"specific",
"types",
"of",
"antibiotics",
"with",
"which",
"alcohol",
"consumption",
"may",
"cause",
"serious",
"side",
"-",
"effects",
".",
"Therefore",
",",
"potential",
"risks",
"of",
"side",
"-",
"effects",
"and",
"effectiveness",
"depend",
"on",
"the",
"type",
"of",
"antibiotic",
"administered",
".",
"Despite",
"the",
"lack",
"of",
"a",
"categorical",
"counterindication",
",",
"the",
"belief",
"that",
"alcohol",
"and",
"antibiotics",
"should",
"never",
"be",
"mixed",
"is",
"widespread",
"."
],
"offsets": [
0,
13,
21,
29,
33,
41,
53,
57,
63,
67,
71,
77,
81,
82,
90,
94,
104,
118,
121,
132,
139,
141,
147,
156,
164,
176,
179,
188,
191,
201,
206,
211,
218,
229,
231,
237,
241,
250,
256,
259,
271,
276,
282,
290,
302,
306,
312,
320,
324,
325,
332,
334,
343,
345,
355,
361,
364,
368,
369,
377,
381,
395,
402,
405,
409,
414,
417,
428,
440,
442,
450,
454,
459,
462,
464,
476,
493,
495,
499,
506,
511,
519,
523,
535,
542,
548,
551,
557,
560,
570
]
} | 9453a7a803bb45e6b0b105233cbb2835 | What common drug can reduce antibiotic effectiveness? | {
"tokens": [
"What",
"common",
"drug",
"can",
"reduce",
"antibiotic",
"effectiveness",
"?"
],
"offsets": [
0,
5,
12,
17,
21,
28,
39,
52
]
} | {
"text": [
"alcohol"
],
"char_spans": [
{
"start": [
21
],
"end": [
27
]
}
],
"token_spans": [
{
"start": [
2
],
"end": [
2
]
}
]
} | [
"alcohol"
] |
SQuAD | Interactions between alcohol and certain antibiotics may occur and may cause side-effects and decreased effectiveness of antibiotic therapy. While moderate alcohol consumption is unlikely to interfere with many common antibiotics, there are specific types of antibiotics with which alcohol consumption may cause serious side-effects. Therefore, potential risks of side-effects and effectiveness depend on the type of antibiotic administered. Despite the lack of a categorical counterindication, the belief that alcohol and antibiotics should never be mixed is widespread. | {
"tokens": [
"Interactions",
"between",
"alcohol",
"and",
"certain",
"antibiotics",
"may",
"occur",
"and",
"may",
"cause",
"side",
"-",
"effects",
"and",
"decreased",
"effectiveness",
"of",
"antibiotic",
"therapy",
".",
"While",
"moderate",
"alcohol",
"consumption",
"is",
"unlikely",
"to",
"interfere",
"with",
"many",
"common",
"antibiotics",
",",
"there",
"are",
"specific",
"types",
"of",
"antibiotics",
"with",
"which",
"alcohol",
"consumption",
"may",
"cause",
"serious",
"side",
"-",
"effects",
".",
"Therefore",
",",
"potential",
"risks",
"of",
"side",
"-",
"effects",
"and",
"effectiveness",
"depend",
"on",
"the",
"type",
"of",
"antibiotic",
"administered",
".",
"Despite",
"the",
"lack",
"of",
"a",
"categorical",
"counterindication",
",",
"the",
"belief",
"that",
"alcohol",
"and",
"antibiotics",
"should",
"never",
"be",
"mixed",
"is",
"widespread",
"."
],
"offsets": [
0,
13,
21,
29,
33,
41,
53,
57,
63,
67,
71,
77,
81,
82,
90,
94,
104,
118,
121,
132,
139,
141,
147,
156,
164,
176,
179,
188,
191,
201,
206,
211,
218,
229,
231,
237,
241,
250,
256,
259,
271,
276,
282,
290,
302,
306,
312,
320,
324,
325,
332,
334,
343,
345,
355,
361,
364,
368,
369,
377,
381,
395,
402,
405,
409,
414,
417,
428,
440,
442,
450,
454,
459,
462,
464,
476,
493,
495,
499,
506,
511,
519,
523,
535,
542,
548,
551,
557,
560,
570
]
} | db4752ba50bc4b549df1aff62d6158a1 | What type of antibiotic is most likely to be a problem with alcohol? | {
"tokens": [
"What",
"type",
"of",
"antibiotic",
"is",
"most",
"likely",
"to",
"be",
"a",
"problem",
"with",
"alcohol",
"?"
],
"offsets": [
0,
5,
10,
13,
24,
27,
32,
39,
42,
45,
47,
55,
60,
67
]
} | {
"text": [
"specific types of antibiotics with which alcohol consumption may cause serious side-effects"
],
"char_spans": [
{
"start": [
241
],
"end": [
331
]
}
],
"token_spans": [
{
"start": [
36
],
"end": [
49
]
}
]
} | [
"specific types of antibiotics with which alcohol consumption may cause serious side-effects"
] |
SQuAD | Interactions between alcohol and certain antibiotics may occur and may cause side-effects and decreased effectiveness of antibiotic therapy. While moderate alcohol consumption is unlikely to interfere with many common antibiotics, there are specific types of antibiotics with which alcohol consumption may cause serious side-effects. Therefore, potential risks of side-effects and effectiveness depend on the type of antibiotic administered. Despite the lack of a categorical counterindication, the belief that alcohol and antibiotics should never be mixed is widespread. | {
"tokens": [
"Interactions",
"between",
"alcohol",
"and",
"certain",
"antibiotics",
"may",
"occur",
"and",
"may",
"cause",
"side",
"-",
"effects",
"and",
"decreased",
"effectiveness",
"of",
"antibiotic",
"therapy",
".",
"While",
"moderate",
"alcohol",
"consumption",
"is",
"unlikely",
"to",
"interfere",
"with",
"many",
"common",
"antibiotics",
",",
"there",
"are",
"specific",
"types",
"of",
"antibiotics",
"with",
"which",
"alcohol",
"consumption",
"may",
"cause",
"serious",
"side",
"-",
"effects",
".",
"Therefore",
",",
"potential",
"risks",
"of",
"side",
"-",
"effects",
"and",
"effectiveness",
"depend",
"on",
"the",
"type",
"of",
"antibiotic",
"administered",
".",
"Despite",
"the",
"lack",
"of",
"a",
"categorical",
"counterindication",
",",
"the",
"belief",
"that",
"alcohol",
"and",
"antibiotics",
"should",
"never",
"be",
"mixed",
"is",
"widespread",
"."
],
"offsets": [
0,
13,
21,
29,
33,
41,
53,
57,
63,
67,
71,
77,
81,
82,
90,
94,
104,
118,
121,
132,
139,
141,
147,
156,
164,
176,
179,
188,
191,
201,
206,
211,
218,
229,
231,
237,
241,
250,
256,
259,
271,
276,
282,
290,
302,
306,
312,
320,
324,
325,
332,
334,
343,
345,
355,
361,
364,
368,
369,
377,
381,
395,
402,
405,
409,
414,
417,
428,
440,
442,
450,
454,
459,
462,
464,
476,
493,
495,
499,
506,
511,
519,
523,
535,
542,
548,
551,
557,
560,
570
]
} | 46658ac9f3ea4afdb22e50175b58d7a3 | Should alcohol be used while on antibiotics? | {
"tokens": [
"Should",
"alcohol",
"be",
"used",
"while",
"on",
"antibiotics",
"?"
],
"offsets": [
0,
7,
15,
18,
23,
29,
32,
43
]
} | {
"text": [
"alcohol and antibiotics should never be mixed"
],
"char_spans": [
{
"start": [
511
],
"end": [
555
]
}
],
"token_spans": [
{
"start": [
80
],
"end": [
86
]
}
]
} | [
"alcohol and antibiotics should never be mixed"
] |
SQuAD | The first sulfonamide and first commercially available antibacterial, Prontosil, was developed by a research team led by Gerhard Domagk in 1932 at the Bayer Laboratories of the IG Farben conglomerate in Germany. Domagk received the 1939 Nobel Prize for Medicine for his efforts. Prontosil had a relatively broad effect against Gram-positive cocci, but not against enterobacteria. Research was stimulated apace by its success. The discovery and development of this sulfonamide drug opened the era of antibacterials. | {
"tokens": [
"The",
"first",
"sulfonamide",
"and",
"first",
"commercially",
"available",
"antibacterial",
",",
"Prontosil",
",",
"was",
"developed",
"by",
"a",
"research",
"team",
"led",
"by",
"Gerhard",
"Domagk",
"in",
"1932",
"at",
"the",
"Bayer",
"Laboratories",
"of",
"the",
"IG",
"Farben",
"conglomerate",
"in",
"Germany",
".",
"Domagk",
"received",
"the",
"1939",
"Nobel",
"Prize",
"for",
"Medicine",
"for",
"his",
"efforts",
".",
"Prontosil",
"had",
"a",
"relatively",
"broad",
"effect",
"against",
"Gram",
"-",
"positive",
"cocci",
",",
"but",
"not",
"against",
"enterobacteria",
".",
"Research",
"was",
"stimulated",
"apace",
"by",
"its",
"success",
".",
"The",
"discovery",
"and",
"development",
"of",
"this",
"sulfonamide",
"drug",
"opened",
"the",
"era",
"of",
"antibacterials",
"."
],
"offsets": [
0,
4,
10,
22,
26,
32,
45,
55,
68,
70,
79,
81,
85,
95,
98,
100,
109,
114,
118,
121,
129,
136,
139,
144,
147,
151,
157,
170,
173,
177,
180,
187,
200,
203,
210,
212,
219,
228,
232,
237,
243,
249,
253,
262,
266,
270,
277,
279,
289,
293,
295,
306,
312,
319,
327,
331,
332,
341,
346,
348,
352,
356,
364,
378,
380,
389,
393,
404,
410,
413,
417,
424,
426,
430,
440,
444,
456,
459,
464,
476,
481,
488,
492,
496,
499,
513
]
} | 0c33f2f420ce40ed8b127515fb52b25b | What was the first available antibiotic? | {
"tokens": [
"What",
"was",
"the",
"first",
"available",
"antibiotic",
"?"
],
"offsets": [
0,
5,
9,
13,
19,
29,
39
]
} | {
"text": [
"Prontosil"
],
"char_spans": [
{
"start": [
70
],
"end": [
78
]
}
],
"token_spans": [
{
"start": [
9
],
"end": [
9
]
}
]
} | [
"Prontosil"
] |
SQuAD | The first sulfonamide and first commercially available antibacterial, Prontosil, was developed by a research team led by Gerhard Domagk in 1932 at the Bayer Laboratories of the IG Farben conglomerate in Germany. Domagk received the 1939 Nobel Prize for Medicine for his efforts. Prontosil had a relatively broad effect against Gram-positive cocci, but not against enterobacteria. Research was stimulated apace by its success. The discovery and development of this sulfonamide drug opened the era of antibacterials. | {
"tokens": [
"The",
"first",
"sulfonamide",
"and",
"first",
"commercially",
"available",
"antibacterial",
",",
"Prontosil",
",",
"was",
"developed",
"by",
"a",
"research",
"team",
"led",
"by",
"Gerhard",
"Domagk",
"in",
"1932",
"at",
"the",
"Bayer",
"Laboratories",
"of",
"the",
"IG",
"Farben",
"conglomerate",
"in",
"Germany",
".",
"Domagk",
"received",
"the",
"1939",
"Nobel",
"Prize",
"for",
"Medicine",
"for",
"his",
"efforts",
".",
"Prontosil",
"had",
"a",
"relatively",
"broad",
"effect",
"against",
"Gram",
"-",
"positive",
"cocci",
",",
"but",
"not",
"against",
"enterobacteria",
".",
"Research",
"was",
"stimulated",
"apace",
"by",
"its",
"success",
".",
"The",
"discovery",
"and",
"development",
"of",
"this",
"sulfonamide",
"drug",
"opened",
"the",
"era",
"of",
"antibacterials",
"."
],
"offsets": [
0,
4,
10,
22,
26,
32,
45,
55,
68,
70,
79,
81,
85,
95,
98,
100,
109,
114,
118,
121,
129,
136,
139,
144,
147,
151,
157,
170,
173,
177,
180,
187,
200,
203,
210,
212,
219,
228,
232,
237,
243,
249,
253,
262,
266,
270,
277,
279,
289,
293,
295,
306,
312,
319,
327,
331,
332,
341,
346,
348,
352,
356,
364,
378,
380,
389,
393,
404,
410,
413,
417,
424,
426,
430,
440,
444,
456,
459,
464,
476,
481,
488,
492,
496,
499,
513
]
} | cae7afdccade491889a2087336a03517 | What company developed Prontosil? | {
"tokens": [
"What",
"company",
"developed",
"Prontosil",
"?"
],
"offsets": [
0,
5,
13,
23,
32
]
} | {
"text": [
"IG Farben"
],
"char_spans": [
{
"start": [
177
],
"end": [
185
]
}
],
"token_spans": [
{
"start": [
29
],
"end": [
30
]
}
]
} | [
"IG Farben"
] |
SQuAD | The first sulfonamide and first commercially available antibacterial, Prontosil, was developed by a research team led by Gerhard Domagk in 1932 at the Bayer Laboratories of the IG Farben conglomerate in Germany. Domagk received the 1939 Nobel Prize for Medicine for his efforts. Prontosil had a relatively broad effect against Gram-positive cocci, but not against enterobacteria. Research was stimulated apace by its success. The discovery and development of this sulfonamide drug opened the era of antibacterials. | {
"tokens": [
"The",
"first",
"sulfonamide",
"and",
"first",
"commercially",
"available",
"antibacterial",
",",
"Prontosil",
",",
"was",
"developed",
"by",
"a",
"research",
"team",
"led",
"by",
"Gerhard",
"Domagk",
"in",
"1932",
"at",
"the",
"Bayer",
"Laboratories",
"of",
"the",
"IG",
"Farben",
"conglomerate",
"in",
"Germany",
".",
"Domagk",
"received",
"the",
"1939",
"Nobel",
"Prize",
"for",
"Medicine",
"for",
"his",
"efforts",
".",
"Prontosil",
"had",
"a",
"relatively",
"broad",
"effect",
"against",
"Gram",
"-",
"positive",
"cocci",
",",
"but",
"not",
"against",
"enterobacteria",
".",
"Research",
"was",
"stimulated",
"apace",
"by",
"its",
"success",
".",
"The",
"discovery",
"and",
"development",
"of",
"this",
"sulfonamide",
"drug",
"opened",
"the",
"era",
"of",
"antibacterials",
"."
],
"offsets": [
0,
4,
10,
22,
26,
32,
45,
55,
68,
70,
79,
81,
85,
95,
98,
100,
109,
114,
118,
121,
129,
136,
139,
144,
147,
151,
157,
170,
173,
177,
180,
187,
200,
203,
210,
212,
219,
228,
232,
237,
243,
249,
253,
262,
266,
270,
277,
279,
289,
293,
295,
306,
312,
319,
327,
331,
332,
341,
346,
348,
352,
356,
364,
378,
380,
389,
393,
404,
410,
413,
417,
424,
426,
430,
440,
444,
456,
459,
464,
476,
481,
488,
492,
496,
499,
513
]
} | c25607a835cc4d09a54b8e1a5bef4ed7 | Who led the team that came up with Prontosil? | {
"tokens": [
"Who",
"led",
"the",
"team",
"that",
"came",
"up",
"with",
"Prontosil",
"?"
],
"offsets": [
0,
4,
8,
12,
17,
22,
27,
30,
35,
44
]
} | {
"text": [
"Gerhard Domagk"
],
"char_spans": [
{
"start": [
121
],
"end": [
134
]
}
],
"token_spans": [
{
"start": [
19
],
"end": [
20
]
}
]
} | [
"Gerhard Domagk"
] |
SQuAD | The first sulfonamide and first commercially available antibacterial, Prontosil, was developed by a research team led by Gerhard Domagk in 1932 at the Bayer Laboratories of the IG Farben conglomerate in Germany. Domagk received the 1939 Nobel Prize for Medicine for his efforts. Prontosil had a relatively broad effect against Gram-positive cocci, but not against enterobacteria. Research was stimulated apace by its success. The discovery and development of this sulfonamide drug opened the era of antibacterials. | {
"tokens": [
"The",
"first",
"sulfonamide",
"and",
"first",
"commercially",
"available",
"antibacterial",
",",
"Prontosil",
",",
"was",
"developed",
"by",
"a",
"research",
"team",
"led",
"by",
"Gerhard",
"Domagk",
"in",
"1932",
"at",
"the",
"Bayer",
"Laboratories",
"of",
"the",
"IG",
"Farben",
"conglomerate",
"in",
"Germany",
".",
"Domagk",
"received",
"the",
"1939",
"Nobel",
"Prize",
"for",
"Medicine",
"for",
"his",
"efforts",
".",
"Prontosil",
"had",
"a",
"relatively",
"broad",
"effect",
"against",
"Gram",
"-",
"positive",
"cocci",
",",
"but",
"not",
"against",
"enterobacteria",
".",
"Research",
"was",
"stimulated",
"apace",
"by",
"its",
"success",
".",
"The",
"discovery",
"and",
"development",
"of",
"this",
"sulfonamide",
"drug",
"opened",
"the",
"era",
"of",
"antibacterials",
"."
],
"offsets": [
0,
4,
10,
22,
26,
32,
45,
55,
68,
70,
79,
81,
85,
95,
98,
100,
109,
114,
118,
121,
129,
136,
139,
144,
147,
151,
157,
170,
173,
177,
180,
187,
200,
203,
210,
212,
219,
228,
232,
237,
243,
249,
253,
262,
266,
270,
277,
279,
289,
293,
295,
306,
312,
319,
327,
331,
332,
341,
346,
348,
352,
356,
364,
378,
380,
389,
393,
404,
410,
413,
417,
424,
426,
430,
440,
444,
456,
459,
464,
476,
481,
488,
492,
496,
499,
513
]
} | 91237ba6118f44d68f98638cd2fd3455 | What prize did Domagk get for his work? | {
"tokens": [
"What",
"prize",
"did",
"Domagk",
"get",
"for",
"his",
"work",
"?"
],
"offsets": [
0,
5,
11,
15,
22,
26,
30,
34,
38
]
} | {
"text": [
"1939 Nobel Prize for Medicine"
],
"char_spans": [
{
"start": [
232
],
"end": [
260
]
}
],
"token_spans": [
{
"start": [
38
],
"end": [
42
]
}
]
} | [
"1939 Nobel Prize for Medicine"
] |
SQuAD | Common forms of antibiotic misuse include excessive use of prophylactic antibiotics in travelers and failure of medical professionals to prescribe the correct dosage of antibiotics on the basis of the patient's weight and history of prior use. Other forms of misuse include failure to take the entire prescribed course of the antibiotic, incorrect dosage and administration, or failure to rest for sufficient recovery. Inappropriate antibiotic treatment, for example, is their prescription to treat viral infections such as the common cold. One study on respiratory tract infections found "physicians were more likely to prescribe antibiotics to patients who appeared to expect them". Multifactorial interventions aimed at both physicians and patients can reduce inappropriate prescription of antibiotics. | {
"tokens": [
"Common",
"forms",
"of",
"antibiotic",
"misuse",
"include",
"excessive",
"use",
"of",
"prophylactic",
"antibiotics",
"in",
"travelers",
"and",
"failure",
"of",
"medical",
"professionals",
"to",
"prescribe",
"the",
"correct",
"dosage",
"of",
"antibiotics",
"on",
"the",
"basis",
"of",
"the",
"patient",
"'s",
"weight",
"and",
"history",
"of",
"prior",
"use",
".",
"Other",
"forms",
"of",
"misuse",
"include",
"failure",
"to",
"take",
"the",
"entire",
"prescribed",
"course",
"of",
"the",
"antibiotic",
",",
"incorrect",
"dosage",
"and",
"administration",
",",
"or",
"failure",
"to",
"rest",
"for",
"sufficient",
"recovery",
".",
"Inappropriate",
"antibiotic",
"treatment",
",",
"for",
"example",
",",
"is",
"their",
"prescription",
"to",
"treat",
"viral",
"infections",
"such",
"as",
"the",
"common",
"cold",
".",
"One",
"study",
"on",
"respiratory",
"tract",
"infections",
"found",
"\"",
"physicians",
"were",
"more",
"likely",
"to",
"prescribe",
"antibiotics",
"to",
"patients",
"who",
"appeared",
"to",
"expect",
"them",
"\"",
".",
"Multifactorial",
"interventions",
"aimed",
"at",
"both",
"physicians",
"and",
"patients",
"can",
"reduce",
"inappropriate",
"prescription",
"of",
"antibiotics",
"."
],
"offsets": [
0,
7,
13,
16,
27,
34,
42,
52,
56,
59,
72,
84,
87,
97,
101,
109,
112,
120,
134,
137,
147,
151,
159,
166,
169,
181,
184,
188,
194,
197,
201,
208,
211,
218,
222,
230,
233,
239,
242,
244,
250,
256,
259,
266,
274,
282,
285,
290,
294,
301,
312,
319,
322,
326,
336,
338,
348,
355,
359,
373,
375,
378,
386,
389,
394,
398,
409,
417,
419,
433,
444,
453,
455,
459,
466,
468,
471,
477,
490,
493,
499,
505,
516,
521,
524,
528,
535,
539,
541,
545,
551,
554,
566,
572,
583,
589,
590,
601,
606,
611,
618,
621,
631,
643,
646,
655,
659,
668,
671,
678,
682,
683,
685,
700,
714,
720,
723,
728,
739,
743,
752,
756,
763,
777,
790,
793,
804
]
} | 4023a820def14c428f354a0bbef576a6 | What is a way of improperly using antibiotics for those traveling? | {
"tokens": [
"What",
"is",
"a",
"way",
"of",
"improperly",
"using",
"antibiotics",
"for",
"those",
"traveling",
"?"
],
"offsets": [
0,
5,
8,
10,
14,
17,
28,
34,
46,
50,
56,
65
]
} | {
"text": [
"prophylactic antibiotics"
],
"char_spans": [
{
"start": [
59
],
"end": [
82
]
}
],
"token_spans": [
{
"start": [
9
],
"end": [
10
]
}
]
} | [
"prophylactic antibiotics"
] |
SQuAD | Common forms of antibiotic misuse include excessive use of prophylactic antibiotics in travelers and failure of medical professionals to prescribe the correct dosage of antibiotics on the basis of the patient's weight and history of prior use. Other forms of misuse include failure to take the entire prescribed course of the antibiotic, incorrect dosage and administration, or failure to rest for sufficient recovery. Inappropriate antibiotic treatment, for example, is their prescription to treat viral infections such as the common cold. One study on respiratory tract infections found "physicians were more likely to prescribe antibiotics to patients who appeared to expect them". Multifactorial interventions aimed at both physicians and patients can reduce inappropriate prescription of antibiotics. | {
"tokens": [
"Common",
"forms",
"of",
"antibiotic",
"misuse",
"include",
"excessive",
"use",
"of",
"prophylactic",
"antibiotics",
"in",
"travelers",
"and",
"failure",
"of",
"medical",
"professionals",
"to",
"prescribe",
"the",
"correct",
"dosage",
"of",
"antibiotics",
"on",
"the",
"basis",
"of",
"the",
"patient",
"'s",
"weight",
"and",
"history",
"of",
"prior",
"use",
".",
"Other",
"forms",
"of",
"misuse",
"include",
"failure",
"to",
"take",
"the",
"entire",
"prescribed",
"course",
"of",
"the",
"antibiotic",
",",
"incorrect",
"dosage",
"and",
"administration",
",",
"or",
"failure",
"to",
"rest",
"for",
"sufficient",
"recovery",
".",
"Inappropriate",
"antibiotic",
"treatment",
",",
"for",
"example",
",",
"is",
"their",
"prescription",
"to",
"treat",
"viral",
"infections",
"such",
"as",
"the",
"common",
"cold",
".",
"One",
"study",
"on",
"respiratory",
"tract",
"infections",
"found",
"\"",
"physicians",
"were",
"more",
"likely",
"to",
"prescribe",
"antibiotics",
"to",
"patients",
"who",
"appeared",
"to",
"expect",
"them",
"\"",
".",
"Multifactorial",
"interventions",
"aimed",
"at",
"both",
"physicians",
"and",
"patients",
"can",
"reduce",
"inappropriate",
"prescription",
"of",
"antibiotics",
"."
],
"offsets": [
0,
7,
13,
16,
27,
34,
42,
52,
56,
59,
72,
84,
87,
97,
101,
109,
112,
120,
134,
137,
147,
151,
159,
166,
169,
181,
184,
188,
194,
197,
201,
208,
211,
218,
222,
230,
233,
239,
242,
244,
250,
256,
259,
266,
274,
282,
285,
290,
294,
301,
312,
319,
322,
326,
336,
338,
348,
355,
359,
373,
375,
378,
386,
389,
394,
398,
409,
417,
419,
433,
444,
453,
455,
459,
466,
468,
471,
477,
490,
493,
499,
505,
516,
521,
524,
528,
535,
539,
541,
545,
551,
554,
566,
572,
583,
589,
590,
601,
606,
611,
618,
621,
631,
643,
646,
655,
659,
668,
671,
678,
682,
683,
685,
700,
714,
720,
723,
728,
739,
743,
752,
756,
763,
777,
790,
793,
804
]
} | 19cf4926c14f475b876ab433ce88a25c | What can happen if a doctor doesn't prescribe to a person's weight and prior use? | {
"tokens": [
"What",
"can",
"happen",
"if",
"a",
"doctor",
"does",
"n't",
"prescribe",
"to",
"a",
"person",
"'s",
"weight",
"and",
"prior",
"use",
"?"
],
"offsets": [
0,
5,
9,
16,
19,
21,
28,
32,
36,
46,
49,
51,
57,
60,
67,
71,
77,
80
]
} | {
"text": [
"failure of medical professionals to prescribe the correct dosage"
],
"char_spans": [
{
"start": [
101
],
"end": [
164
]
}
],
"token_spans": [
{
"start": [
14
],
"end": [
22
]
}
]
} | [
"failure of medical professionals to prescribe the correct dosage"
] |
SQuAD | Common forms of antibiotic misuse include excessive use of prophylactic antibiotics in travelers and failure of medical professionals to prescribe the correct dosage of antibiotics on the basis of the patient's weight and history of prior use. Other forms of misuse include failure to take the entire prescribed course of the antibiotic, incorrect dosage and administration, or failure to rest for sufficient recovery. Inappropriate antibiotic treatment, for example, is their prescription to treat viral infections such as the common cold. One study on respiratory tract infections found "physicians were more likely to prescribe antibiotics to patients who appeared to expect them". Multifactorial interventions aimed at both physicians and patients can reduce inappropriate prescription of antibiotics. | {
"tokens": [
"Common",
"forms",
"of",
"antibiotic",
"misuse",
"include",
"excessive",
"use",
"of",
"prophylactic",
"antibiotics",
"in",
"travelers",
"and",
"failure",
"of",
"medical",
"professionals",
"to",
"prescribe",
"the",
"correct",
"dosage",
"of",
"antibiotics",
"on",
"the",
"basis",
"of",
"the",
"patient",
"'s",
"weight",
"and",
"history",
"of",
"prior",
"use",
".",
"Other",
"forms",
"of",
"misuse",
"include",
"failure",
"to",
"take",
"the",
"entire",
"prescribed",
"course",
"of",
"the",
"antibiotic",
",",
"incorrect",
"dosage",
"and",
"administration",
",",
"or",
"failure",
"to",
"rest",
"for",
"sufficient",
"recovery",
".",
"Inappropriate",
"antibiotic",
"treatment",
",",
"for",
"example",
",",
"is",
"their",
"prescription",
"to",
"treat",
"viral",
"infections",
"such",
"as",
"the",
"common",
"cold",
".",
"One",
"study",
"on",
"respiratory",
"tract",
"infections",
"found",
"\"",
"physicians",
"were",
"more",
"likely",
"to",
"prescribe",
"antibiotics",
"to",
"patients",
"who",
"appeared",
"to",
"expect",
"them",
"\"",
".",
"Multifactorial",
"interventions",
"aimed",
"at",
"both",
"physicians",
"and",
"patients",
"can",
"reduce",
"inappropriate",
"prescription",
"of",
"antibiotics",
"."
],
"offsets": [
0,
7,
13,
16,
27,
34,
42,
52,
56,
59,
72,
84,
87,
97,
101,
109,
112,
120,
134,
137,
147,
151,
159,
166,
169,
181,
184,
188,
194,
197,
201,
208,
211,
218,
222,
230,
233,
239,
242,
244,
250,
256,
259,
266,
274,
282,
285,
290,
294,
301,
312,
319,
322,
326,
336,
338,
348,
355,
359,
373,
375,
378,
386,
389,
394,
398,
409,
417,
419,
433,
444,
453,
455,
459,
466,
468,
471,
477,
490,
493,
499,
505,
516,
521,
524,
528,
535,
539,
541,
545,
551,
554,
566,
572,
583,
589,
590,
601,
606,
611,
618,
621,
631,
643,
646,
655,
659,
668,
671,
678,
682,
683,
685,
700,
714,
720,
723,
728,
739,
743,
752,
756,
763,
777,
790,
793,
804
]
} | 8e78e24aa7914bc3a58122895fd3299e | What are 3 other common forms of bad antibiotic practices? | {
"tokens": [
"What",
"are",
"3",
"other",
"common",
"forms",
"of",
"bad",
"antibiotic",
"practices",
"?"
],
"offsets": [
0,
5,
9,
11,
17,
24,
30,
33,
37,
48,
57
]
} | {
"text": [
"failure to take the entire prescribed course of the antibiotic, incorrect dosage and administration, or failure to rest for sufficient recovery"
],
"char_spans": [
{
"start": [
274
],
"end": [
416
]
}
],
"token_spans": [
{
"start": [
44
],
"end": [
66
]
}
]
} | [
"failure to take the entire prescribed course of the antibiotic, incorrect dosage and administration, or failure to rest for sufficient recovery"
] |
SQuAD | Common forms of antibiotic misuse include excessive use of prophylactic antibiotics in travelers and failure of medical professionals to prescribe the correct dosage of antibiotics on the basis of the patient's weight and history of prior use. Other forms of misuse include failure to take the entire prescribed course of the antibiotic, incorrect dosage and administration, or failure to rest for sufficient recovery. Inappropriate antibiotic treatment, for example, is their prescription to treat viral infections such as the common cold. One study on respiratory tract infections found "physicians were more likely to prescribe antibiotics to patients who appeared to expect them". Multifactorial interventions aimed at both physicians and patients can reduce inappropriate prescription of antibiotics. | {
"tokens": [
"Common",
"forms",
"of",
"antibiotic",
"misuse",
"include",
"excessive",
"use",
"of",
"prophylactic",
"antibiotics",
"in",
"travelers",
"and",
"failure",
"of",
"medical",
"professionals",
"to",
"prescribe",
"the",
"correct",
"dosage",
"of",
"antibiotics",
"on",
"the",
"basis",
"of",
"the",
"patient",
"'s",
"weight",
"and",
"history",
"of",
"prior",
"use",
".",
"Other",
"forms",
"of",
"misuse",
"include",
"failure",
"to",
"take",
"the",
"entire",
"prescribed",
"course",
"of",
"the",
"antibiotic",
",",
"incorrect",
"dosage",
"and",
"administration",
",",
"or",
"failure",
"to",
"rest",
"for",
"sufficient",
"recovery",
".",
"Inappropriate",
"antibiotic",
"treatment",
",",
"for",
"example",
",",
"is",
"their",
"prescription",
"to",
"treat",
"viral",
"infections",
"such",
"as",
"the",
"common",
"cold",
".",
"One",
"study",
"on",
"respiratory",
"tract",
"infections",
"found",
"\"",
"physicians",
"were",
"more",
"likely",
"to",
"prescribe",
"antibiotics",
"to",
"patients",
"who",
"appeared",
"to",
"expect",
"them",
"\"",
".",
"Multifactorial",
"interventions",
"aimed",
"at",
"both",
"physicians",
"and",
"patients",
"can",
"reduce",
"inappropriate",
"prescription",
"of",
"antibiotics",
"."
],
"offsets": [
0,
7,
13,
16,
27,
34,
42,
52,
56,
59,
72,
84,
87,
97,
101,
109,
112,
120,
134,
137,
147,
151,
159,
166,
169,
181,
184,
188,
194,
197,
201,
208,
211,
218,
222,
230,
233,
239,
242,
244,
250,
256,
259,
266,
274,
282,
285,
290,
294,
301,
312,
319,
322,
326,
336,
338,
348,
355,
359,
373,
375,
378,
386,
389,
394,
398,
409,
417,
419,
433,
444,
453,
455,
459,
466,
468,
471,
477,
490,
493,
499,
505,
516,
521,
524,
528,
535,
539,
541,
545,
551,
554,
566,
572,
583,
589,
590,
601,
606,
611,
618,
621,
631,
643,
646,
655,
659,
668,
671,
678,
682,
683,
685,
700,
714,
720,
723,
728,
739,
743,
752,
756,
763,
777,
790,
793,
804
]
} | 9a16c9f008494f68ad66bea1c1d52c1c | What happens when a cold is treated with antibiotics? | {
"tokens": [
"What",
"happens",
"when",
"a",
"cold",
"is",
"treated",
"with",
"antibiotics",
"?"
],
"offsets": [
0,
5,
13,
18,
20,
25,
28,
36,
41,
52
]
} | {
"text": [
"Inappropriate antibiotic treatment"
],
"char_spans": [
{
"start": [
419
],
"end": [
452
]
}
],
"token_spans": [
{
"start": [
68
],
"end": [
70
]
}
]
} | [
"Inappropriate antibiotic treatment"
] |
SQuAD | Common forms of antibiotic misuse include excessive use of prophylactic antibiotics in travelers and failure of medical professionals to prescribe the correct dosage of antibiotics on the basis of the patient's weight and history of prior use. Other forms of misuse include failure to take the entire prescribed course of the antibiotic, incorrect dosage and administration, or failure to rest for sufficient recovery. Inappropriate antibiotic treatment, for example, is their prescription to treat viral infections such as the common cold. One study on respiratory tract infections found "physicians were more likely to prescribe antibiotics to patients who appeared to expect them". Multifactorial interventions aimed at both physicians and patients can reduce inappropriate prescription of antibiotics. | {
"tokens": [
"Common",
"forms",
"of",
"antibiotic",
"misuse",
"include",
"excessive",
"use",
"of",
"prophylactic",
"antibiotics",
"in",
"travelers",
"and",
"failure",
"of",
"medical",
"professionals",
"to",
"prescribe",
"the",
"correct",
"dosage",
"of",
"antibiotics",
"on",
"the",
"basis",
"of",
"the",
"patient",
"'s",
"weight",
"and",
"history",
"of",
"prior",
"use",
".",
"Other",
"forms",
"of",
"misuse",
"include",
"failure",
"to",
"take",
"the",
"entire",
"prescribed",
"course",
"of",
"the",
"antibiotic",
",",
"incorrect",
"dosage",
"and",
"administration",
",",
"or",
"failure",
"to",
"rest",
"for",
"sufficient",
"recovery",
".",
"Inappropriate",
"antibiotic",
"treatment",
",",
"for",
"example",
",",
"is",
"their",
"prescription",
"to",
"treat",
"viral",
"infections",
"such",
"as",
"the",
"common",
"cold",
".",
"One",
"study",
"on",
"respiratory",
"tract",
"infections",
"found",
"\"",
"physicians",
"were",
"more",
"likely",
"to",
"prescribe",
"antibiotics",
"to",
"patients",
"who",
"appeared",
"to",
"expect",
"them",
"\"",
".",
"Multifactorial",
"interventions",
"aimed",
"at",
"both",
"physicians",
"and",
"patients",
"can",
"reduce",
"inappropriate",
"prescription",
"of",
"antibiotics",
"."
],
"offsets": [
0,
7,
13,
16,
27,
34,
42,
52,
56,
59,
72,
84,
87,
97,
101,
109,
112,
120,
134,
137,
147,
151,
159,
166,
169,
181,
184,
188,
194,
197,
201,
208,
211,
218,
222,
230,
233,
239,
242,
244,
250,
256,
259,
266,
274,
282,
285,
290,
294,
301,
312,
319,
322,
326,
336,
338,
348,
355,
359,
373,
375,
378,
386,
389,
394,
398,
409,
417,
419,
433,
444,
453,
455,
459,
466,
468,
471,
477,
490,
493,
499,
505,
516,
521,
524,
528,
535,
539,
541,
545,
551,
554,
566,
572,
583,
589,
590,
601,
606,
611,
618,
621,
631,
643,
646,
655,
659,
668,
671,
678,
682,
683,
685,
700,
714,
720,
723,
728,
739,
743,
752,
756,
763,
777,
790,
793,
804
]
} | 095bdc6325864f9ba4a106e976417823 | What do doctors usually do when a patient seems to want antibiotics even though they may not be right? | {
"tokens": [
"What",
"do",
"doctors",
"usually",
"do",
"when",
"a",
"patient",
"seems",
"to",
"want",
"antibiotics",
"even",
"though",
"they",
"may",
"not",
"be",
"right",
"?"
],
"offsets": [
0,
5,
8,
16,
24,
27,
32,
34,
42,
48,
51,
56,
68,
73,
80,
85,
89,
93,
96,
101
]
} | {
"text": [
"prescribe antibiotics"
],
"char_spans": [
{
"start": [
621
],
"end": [
641
]
}
],
"token_spans": [
{
"start": [
101
],
"end": [
102
]
}
]
} | [
"prescribe antibiotics"
] |
SQuAD | About 30 people have been indicted for participating in genocide or complicity in genocide during the early 1990s in Bosnia. To date, after several plea bargains and some convictions that were successfully challenged on appeal two men, Vujadin Popović and Ljubiša Beara, have been found guilty of committing genocide, Zdravko Tolimir has been found guilty of committing genocide and conspiracy to commit genocide, and two others, Radislav Krstić and Drago Nikolić, have been found guilty of aiding and abetting genocide. Three others have been found guilty of participating in genocides in Bosnia by German courts, one of whom Nikola Jorgić lost an appeal against his conviction in the European Court of Human Rights. A further eight men, former members of the Bosnian Serb security forces were found guilty of genocide by the State Court of Bosnia and Herzegovina (See List of Bosnian genocide prosecutions). | {
"tokens": [
"About",
"30",
"people",
"have",
"been",
"indicted",
"for",
"participating",
"in",
"genocide",
"or",
"complicity",
"in",
"genocide",
"during",
"the",
"early",
"1990s",
"in",
"Bosnia",
".",
"To",
"date",
",",
"after",
"several",
"plea",
"bargains",
"and",
"some",
"convictions",
"that",
"were",
"successfully",
"challenged",
"on",
"appeal",
"two",
"men",
",",
"Vujadin",
"Popović",
"and",
"Ljubiša",
"Beara",
",",
"have",
"been",
"found",
"guilty",
"of",
"committing",
"genocide",
",",
"Zdravko",
"Tolimir",
"has",
"been",
"found",
"guilty",
"of",
"committing",
"genocide",
"and",
"conspiracy",
"to",
"commit",
"genocide",
",",
"and",
"two",
"others",
",",
"Radislav",
"Krstić",
"and",
"Drago",
"Nikolić",
",",
"have",
"been",
"found",
"guilty",
"of",
"aiding",
"and",
"abetting",
"genocide",
".",
"Three",
"others",
"have",
"been",
"found",
"guilty",
"of",
"participating",
"in",
"genocides",
"in",
"Bosnia",
"by",
"German",
"courts",
",",
"one",
"of",
"whom",
"Nikola",
"Jorgić",
"lost",
"an",
"appeal",
"against",
"his",
"conviction",
"in",
"the",
"European",
"Court",
"of",
"Human",
"Rights",
".",
"A",
"further",
"eight",
"men",
",",
"former",
"members",
"of",
"the",
"Bosnian",
"Serb",
"security",
"forces",
"were",
"found",
"guilty",
"of",
"genocide",
"by",
"the",
"State",
"Court",
"of",
"Bosnia",
"and",
"Herzegovina",
"(",
"See",
"List",
"of",
"Bosnian",
"genocide",
"prosecutions",
")",
"."
],
"offsets": [
0,
6,
9,
16,
21,
26,
35,
39,
53,
56,
65,
68,
79,
82,
91,
98,
102,
108,
114,
117,
123,
125,
128,
132,
134,
140,
148,
153,
162,
166,
171,
183,
188,
193,
206,
217,
220,
227,
231,
234,
236,
244,
252,
256,
264,
269,
271,
276,
281,
287,
294,
297,
308,
316,
318,
326,
334,
338,
343,
349,
356,
359,
370,
379,
383,
394,
397,
404,
412,
414,
418,
422,
428,
430,
439,
446,
450,
456,
463,
465,
470,
475,
481,
488,
491,
498,
502,
511,
519,
521,
527,
534,
539,
544,
550,
557,
560,
574,
577,
587,
590,
597,
600,
607,
613,
615,
619,
622,
627,
634,
641,
646,
649,
656,
664,
668,
679,
682,
686,
695,
701,
704,
710,
716,
718,
720,
728,
734,
737,
739,
746,
754,
757,
761,
769,
774,
783,
790,
795,
801,
808,
811,
820,
823,
827,
833,
839,
842,
849,
853,
865,
866,
870,
875,
878,
886,
895,
907,
908
]
} | 1f812d2d0ba14078a5285487b07baf99 | In the 1990s, how many people were indicted for war crimes that were officially defined as genocide? | {
"tokens": [
"In",
"the",
"1990s",
",",
"how",
"many",
"people",
"were",
"indicted",
"for",
"war",
"crimes",
"that",
"were",
"officially",
"defined",
"as",
"genocide",
"?"
],
"offsets": [
0,
3,
7,
12,
14,
18,
23,
30,
35,
44,
48,
52,
59,
64,
69,
80,
88,
91,
99
]
} | {
"text": [
"About 30"
],
"char_spans": [
{
"start": [
0
],
"end": [
7
]
}
],
"token_spans": [
{
"start": [
0
],
"end": [
1
]
}
]
} | [
"About 30"
] |
SQuAD | About 30 people have been indicted for participating in genocide or complicity in genocide during the early 1990s in Bosnia. To date, after several plea bargains and some convictions that were successfully challenged on appeal two men, Vujadin Popović and Ljubiša Beara, have been found guilty of committing genocide, Zdravko Tolimir has been found guilty of committing genocide and conspiracy to commit genocide, and two others, Radislav Krstić and Drago Nikolić, have been found guilty of aiding and abetting genocide. Three others have been found guilty of participating in genocides in Bosnia by German courts, one of whom Nikola Jorgić lost an appeal against his conviction in the European Court of Human Rights. A further eight men, former members of the Bosnian Serb security forces were found guilty of genocide by the State Court of Bosnia and Herzegovina (See List of Bosnian genocide prosecutions). | {
"tokens": [
"About",
"30",
"people",
"have",
"been",
"indicted",
"for",
"participating",
"in",
"genocide",
"or",
"complicity",
"in",
"genocide",
"during",
"the",
"early",
"1990s",
"in",
"Bosnia",
".",
"To",
"date",
",",
"after",
"several",
"plea",
"bargains",
"and",
"some",
"convictions",
"that",
"were",
"successfully",
"challenged",
"on",
"appeal",
"two",
"men",
",",
"Vujadin",
"Popović",
"and",
"Ljubiša",
"Beara",
",",
"have",
"been",
"found",
"guilty",
"of",
"committing",
"genocide",
",",
"Zdravko",
"Tolimir",
"has",
"been",
"found",
"guilty",
"of",
"committing",
"genocide",
"and",
"conspiracy",
"to",
"commit",
"genocide",
",",
"and",
"two",
"others",
",",
"Radislav",
"Krstić",
"and",
"Drago",
"Nikolić",
",",
"have",
"been",
"found",
"guilty",
"of",
"aiding",
"and",
"abetting",
"genocide",
".",
"Three",
"others",
"have",
"been",
"found",
"guilty",
"of",
"participating",
"in",
"genocides",
"in",
"Bosnia",
"by",
"German",
"courts",
",",
"one",
"of",
"whom",
"Nikola",
"Jorgić",
"lost",
"an",
"appeal",
"against",
"his",
"conviction",
"in",
"the",
"European",
"Court",
"of",
"Human",
"Rights",
".",
"A",
"further",
"eight",
"men",
",",
"former",
"members",
"of",
"the",
"Bosnian",
"Serb",
"security",
"forces",
"were",
"found",
"guilty",
"of",
"genocide",
"by",
"the",
"State",
"Court",
"of",
"Bosnia",
"and",
"Herzegovina",
"(",
"See",
"List",
"of",
"Bosnian",
"genocide",
"prosecutions",
")",
"."
],
"offsets": [
0,
6,
9,
16,
21,
26,
35,
39,
53,
56,
65,
68,
79,
82,
91,
98,
102,
108,
114,
117,
123,
125,
128,
132,
134,
140,
148,
153,
162,
166,
171,
183,
188,
193,
206,
217,
220,
227,
231,
234,
236,
244,
252,
256,
264,
269,
271,
276,
281,
287,
294,
297,
308,
316,
318,
326,
334,
338,
343,
349,
356,
359,
370,
379,
383,
394,
397,
404,
412,
414,
418,
422,
428,
430,
439,
446,
450,
456,
463,
465,
470,
475,
481,
488,
491,
498,
502,
511,
519,
521,
527,
534,
539,
544,
550,
557,
560,
574,
577,
587,
590,
597,
600,
607,
613,
615,
619,
622,
627,
634,
641,
646,
649,
656,
664,
668,
679,
682,
686,
695,
701,
704,
710,
716,
718,
720,
728,
734,
737,
739,
746,
754,
757,
761,
769,
774,
783,
790,
795,
801,
808,
811,
820,
823,
827,
833,
839,
842,
849,
853,
865,
866,
870,
875,
878,
886,
895,
907,
908
]
} | 987f20a0e5b04fc8af51be2196ec9006 | Convicted perpetrators Popovic and Beara were found guilty of genocide despite what evasive action? | {
"tokens": [
"Convicted",
"perpetrators",
"Popovic",
"and",
"Beara",
"were",
"found",
"guilty",
"of",
"genocide",
"despite",
"what",
"evasive",
"action",
"?"
],
"offsets": [
0,
10,
23,
31,
35,
41,
46,
52,
59,
62,
71,
79,
84,
92,
98
]
} | {
"text": [
"several plea bargains"
],
"char_spans": [
{
"start": [
140
],
"end": [
160
]
}
],
"token_spans": [
{
"start": [
25
],
"end": [
27
]
}
]
} | [
"several plea bargains"
] |
SQuAD | About 30 people have been indicted for participating in genocide or complicity in genocide during the early 1990s in Bosnia. To date, after several plea bargains and some convictions that were successfully challenged on appeal two men, Vujadin Popović and Ljubiša Beara, have been found guilty of committing genocide, Zdravko Tolimir has been found guilty of committing genocide and conspiracy to commit genocide, and two others, Radislav Krstić and Drago Nikolić, have been found guilty of aiding and abetting genocide. Three others have been found guilty of participating in genocides in Bosnia by German courts, one of whom Nikola Jorgić lost an appeal against his conviction in the European Court of Human Rights. A further eight men, former members of the Bosnian Serb security forces were found guilty of genocide by the State Court of Bosnia and Herzegovina (See List of Bosnian genocide prosecutions). | {
"tokens": [
"About",
"30",
"people",
"have",
"been",
"indicted",
"for",
"participating",
"in",
"genocide",
"or",
"complicity",
"in",
"genocide",
"during",
"the",
"early",
"1990s",
"in",
"Bosnia",
".",
"To",
"date",
",",
"after",
"several",
"plea",
"bargains",
"and",
"some",
"convictions",
"that",
"were",
"successfully",
"challenged",
"on",
"appeal",
"two",
"men",
",",
"Vujadin",
"Popović",
"and",
"Ljubiša",
"Beara",
",",
"have",
"been",
"found",
"guilty",
"of",
"committing",
"genocide",
",",
"Zdravko",
"Tolimir",
"has",
"been",
"found",
"guilty",
"of",
"committing",
"genocide",
"and",
"conspiracy",
"to",
"commit",
"genocide",
",",
"and",
"two",
"others",
",",
"Radislav",
"Krstić",
"and",
"Drago",
"Nikolić",
",",
"have",
"been",
"found",
"guilty",
"of",
"aiding",
"and",
"abetting",
"genocide",
".",
"Three",
"others",
"have",
"been",
"found",
"guilty",
"of",
"participating",
"in",
"genocides",
"in",
"Bosnia",
"by",
"German",
"courts",
",",
"one",
"of",
"whom",
"Nikola",
"Jorgić",
"lost",
"an",
"appeal",
"against",
"his",
"conviction",
"in",
"the",
"European",
"Court",
"of",
"Human",
"Rights",
".",
"A",
"further",
"eight",
"men",
",",
"former",
"members",
"of",
"the",
"Bosnian",
"Serb",
"security",
"forces",
"were",
"found",
"guilty",
"of",
"genocide",
"by",
"the",
"State",
"Court",
"of",
"Bosnia",
"and",
"Herzegovina",
"(",
"See",
"List",
"of",
"Bosnian",
"genocide",
"prosecutions",
")",
"."
],
"offsets": [
0,
6,
9,
16,
21,
26,
35,
39,
53,
56,
65,
68,
79,
82,
91,
98,
102,
108,
114,
117,
123,
125,
128,
132,
134,
140,
148,
153,
162,
166,
171,
183,
188,
193,
206,
217,
220,
227,
231,
234,
236,
244,
252,
256,
264,
269,
271,
276,
281,
287,
294,
297,
308,
316,
318,
326,
334,
338,
343,
349,
356,
359,
370,
379,
383,
394,
397,
404,
412,
414,
418,
422,
428,
430,
439,
446,
450,
456,
463,
465,
470,
475,
481,
488,
491,
498,
502,
511,
519,
521,
527,
534,
539,
544,
550,
557,
560,
574,
577,
587,
590,
597,
600,
607,
613,
615,
619,
622,
627,
634,
641,
646,
649,
656,
664,
668,
679,
682,
686,
695,
701,
704,
710,
716,
718,
720,
728,
734,
737,
739,
746,
754,
757,
761,
769,
774,
783,
790,
795,
801,
808,
811,
820,
823,
827,
833,
839,
842,
849,
853,
865,
866,
870,
875,
878,
886,
895,
907,
908
]
} | c442c65f07d5461abe562aafcebc56f0 | Tolimir was found guilty of both genocide and what other charge? | {
"tokens": [
"Tolimir",
"was",
"found",
"guilty",
"of",
"both",
"genocide",
"and",
"what",
"other",
"charge",
"?"
],
"offsets": [
0,
8,
12,
18,
25,
28,
33,
42,
46,
51,
57,
63
]
} | {
"text": [
"conspiracy to commit genocide"
],
"char_spans": [
{
"start": [
383
],
"end": [
411
]
}
],
"token_spans": [
{
"start": [
64
],
"end": [
67
]
}
]
} | [
"conspiracy to commit genocide"
] |
SQuAD | About 30 people have been indicted for participating in genocide or complicity in genocide during the early 1990s in Bosnia. To date, after several plea bargains and some convictions that were successfully challenged on appeal two men, Vujadin Popović and Ljubiša Beara, have been found guilty of committing genocide, Zdravko Tolimir has been found guilty of committing genocide and conspiracy to commit genocide, and two others, Radislav Krstić and Drago Nikolić, have been found guilty of aiding and abetting genocide. Three others have been found guilty of participating in genocides in Bosnia by German courts, one of whom Nikola Jorgić lost an appeal against his conviction in the European Court of Human Rights. A further eight men, former members of the Bosnian Serb security forces were found guilty of genocide by the State Court of Bosnia and Herzegovina (See List of Bosnian genocide prosecutions). | {
"tokens": [
"About",
"30",
"people",
"have",
"been",
"indicted",
"for",
"participating",
"in",
"genocide",
"or",
"complicity",
"in",
"genocide",
"during",
"the",
"early",
"1990s",
"in",
"Bosnia",
".",
"To",
"date",
",",
"after",
"several",
"plea",
"bargains",
"and",
"some",
"convictions",
"that",
"were",
"successfully",
"challenged",
"on",
"appeal",
"two",
"men",
",",
"Vujadin",
"Popović",
"and",
"Ljubiša",
"Beara",
",",
"have",
"been",
"found",
"guilty",
"of",
"committing",
"genocide",
",",
"Zdravko",
"Tolimir",
"has",
"been",
"found",
"guilty",
"of",
"committing",
"genocide",
"and",
"conspiracy",
"to",
"commit",
"genocide",
",",
"and",
"two",
"others",
",",
"Radislav",
"Krstić",
"and",
"Drago",
"Nikolić",
",",
"have",
"been",
"found",
"guilty",
"of",
"aiding",
"and",
"abetting",
"genocide",
".",
"Three",
"others",
"have",
"been",
"found",
"guilty",
"of",
"participating",
"in",
"genocides",
"in",
"Bosnia",
"by",
"German",
"courts",
",",
"one",
"of",
"whom",
"Nikola",
"Jorgić",
"lost",
"an",
"appeal",
"against",
"his",
"conviction",
"in",
"the",
"European",
"Court",
"of",
"Human",
"Rights",
".",
"A",
"further",
"eight",
"men",
",",
"former",
"members",
"of",
"the",
"Bosnian",
"Serb",
"security",
"forces",
"were",
"found",
"guilty",
"of",
"genocide",
"by",
"the",
"State",
"Court",
"of",
"Bosnia",
"and",
"Herzegovina",
"(",
"See",
"List",
"of",
"Bosnian",
"genocide",
"prosecutions",
")",
"."
],
"offsets": [
0,
6,
9,
16,
21,
26,
35,
39,
53,
56,
65,
68,
79,
82,
91,
98,
102,
108,
114,
117,
123,
125,
128,
132,
134,
140,
148,
153,
162,
166,
171,
183,
188,
193,
206,
217,
220,
227,
231,
234,
236,
244,
252,
256,
264,
269,
271,
276,
281,
287,
294,
297,
308,
316,
318,
326,
334,
338,
343,
349,
356,
359,
370,
379,
383,
394,
397,
404,
412,
414,
418,
422,
428,
430,
439,
446,
450,
456,
463,
465,
470,
475,
481,
488,
491,
498,
502,
511,
519,
521,
527,
534,
539,
544,
550,
557,
560,
574,
577,
587,
590,
597,
600,
607,
613,
615,
619,
622,
627,
634,
641,
646,
649,
656,
664,
668,
679,
682,
686,
695,
701,
704,
710,
716,
718,
720,
728,
734,
737,
739,
746,
754,
757,
761,
769,
774,
783,
790,
795,
801,
808,
811,
820,
823,
827,
833,
839,
842,
849,
853,
865,
866,
870,
875,
878,
886,
895,
907,
908
]
} | 80644e2e50dd40a49b1bbdc715f42744 | Another charge beyond the act of genocide and for which Krstic and Nikolic were found guilty was what? | {
"tokens": [
"Another",
"charge",
"beyond",
"the",
"act",
"of",
"genocide",
"and",
"for",
"which",
"Krstic",
"and",
"Nikolic",
"were",
"found",
"guilty",
"was",
"what",
"?"
],
"offsets": [
0,
8,
15,
22,
26,
30,
33,
42,
46,
50,
56,
63,
67,
75,
80,
86,
93,
97,
101
]
} | {
"text": [
"aiding and abetting genocide"
],
"char_spans": [
{
"start": [
491
],
"end": [
518
]
}
],
"token_spans": [
{
"start": [
84
],
"end": [
87
]
}
]
} | [
"aiding and abetting genocide"
] |
SQuAD | About 30 people have been indicted for participating in genocide or complicity in genocide during the early 1990s in Bosnia. To date, after several plea bargains and some convictions that were successfully challenged on appeal two men, Vujadin Popović and Ljubiša Beara, have been found guilty of committing genocide, Zdravko Tolimir has been found guilty of committing genocide and conspiracy to commit genocide, and two others, Radislav Krstić and Drago Nikolić, have been found guilty of aiding and abetting genocide. Three others have been found guilty of participating in genocides in Bosnia by German courts, one of whom Nikola Jorgić lost an appeal against his conviction in the European Court of Human Rights. A further eight men, former members of the Bosnian Serb security forces were found guilty of genocide by the State Court of Bosnia and Herzegovina (See List of Bosnian genocide prosecutions). | {
"tokens": [
"About",
"30",
"people",
"have",
"been",
"indicted",
"for",
"participating",
"in",
"genocide",
"or",
"complicity",
"in",
"genocide",
"during",
"the",
"early",
"1990s",
"in",
"Bosnia",
".",
"To",
"date",
",",
"after",
"several",
"plea",
"bargains",
"and",
"some",
"convictions",
"that",
"were",
"successfully",
"challenged",
"on",
"appeal",
"two",
"men",
",",
"Vujadin",
"Popović",
"and",
"Ljubiša",
"Beara",
",",
"have",
"been",
"found",
"guilty",
"of",
"committing",
"genocide",
",",
"Zdravko",
"Tolimir",
"has",
"been",
"found",
"guilty",
"of",
"committing",
"genocide",
"and",
"conspiracy",
"to",
"commit",
"genocide",
",",
"and",
"two",
"others",
",",
"Radislav",
"Krstić",
"and",
"Drago",
"Nikolić",
",",
"have",
"been",
"found",
"guilty",
"of",
"aiding",
"and",
"abetting",
"genocide",
".",
"Three",
"others",
"have",
"been",
"found",
"guilty",
"of",
"participating",
"in",
"genocides",
"in",
"Bosnia",
"by",
"German",
"courts",
",",
"one",
"of",
"whom",
"Nikola",
"Jorgić",
"lost",
"an",
"appeal",
"against",
"his",
"conviction",
"in",
"the",
"European",
"Court",
"of",
"Human",
"Rights",
".",
"A",
"further",
"eight",
"men",
",",
"former",
"members",
"of",
"the",
"Bosnian",
"Serb",
"security",
"forces",
"were",
"found",
"guilty",
"of",
"genocide",
"by",
"the",
"State",
"Court",
"of",
"Bosnia",
"and",
"Herzegovina",
"(",
"See",
"List",
"of",
"Bosnian",
"genocide",
"prosecutions",
")",
"."
],
"offsets": [
0,
6,
9,
16,
21,
26,
35,
39,
53,
56,
65,
68,
79,
82,
91,
98,
102,
108,
114,
117,
123,
125,
128,
132,
134,
140,
148,
153,
162,
166,
171,
183,
188,
193,
206,
217,
220,
227,
231,
234,
236,
244,
252,
256,
264,
269,
271,
276,
281,
287,
294,
297,
308,
316,
318,
326,
334,
338,
343,
349,
356,
359,
370,
379,
383,
394,
397,
404,
412,
414,
418,
422,
428,
430,
439,
446,
450,
456,
463,
465,
470,
475,
481,
488,
491,
498,
502,
511,
519,
521,
527,
534,
539,
544,
550,
557,
560,
574,
577,
587,
590,
597,
600,
607,
613,
615,
619,
622,
627,
634,
641,
646,
649,
656,
664,
668,
679,
682,
686,
695,
701,
704,
710,
716,
718,
720,
728,
734,
737,
739,
746,
754,
757,
761,
769,
774,
783,
790,
795,
801,
808,
811,
820,
823,
827,
833,
839,
842,
849,
853,
865,
866,
870,
875,
878,
886,
895,
907,
908
]
} | 8f3c861371484624b60df70b0e43e703 | Three others were charged with participating in genocides in Bosnia by which country's courts? | {
"tokens": [
"Three",
"others",
"were",
"charged",
"with",
"participating",
"in",
"genocides",
"in",
"Bosnia",
"by",
"which",
"country",
"'s",
"courts",
"?"
],
"offsets": [
0,
6,
13,
18,
26,
31,
45,
48,
58,
61,
68,
71,
77,
84,
87,
93
]
} | {
"text": [
"German courts"
],
"char_spans": [
{
"start": [
600
],
"end": [
612
]
}
],
"token_spans": [
{
"start": [
102
],
"end": [
103
]
}
]
} | [
"German courts"
] |
SQuAD | Several organizations concerned with antimicrobial resistance are lobbying to eliminate the unnecessary use of antibiotics. The issues of misuse and overuse of antibiotics have been addressed by the formation of the US Interagency Task Force on Antimicrobial Resistance. This task force aims to actively address antimicrobial resistance, and is coordinated by the US Centers for Disease Control and Prevention, the Food and Drug Administration (FDA), and the National Institutes of Health (NIH), as well as other US agencies. An NGO campaign group is Keep Antibiotics Working. In France, an "Antibiotics are not automatic" government campaign started in 2002 and led to a marked reduction of unnecessary antibiotic prescriptions, especially in children. | {
"tokens": [
"Several",
"organizations",
"concerned",
"with",
"antimicrobial",
"resistance",
"are",
"lobbying",
"to",
"eliminate",
"the",
"unnecessary",
"use",
"of",
"antibiotics",
".",
"The",
"issues",
"of",
"misuse",
"and",
"overuse",
"of",
"antibiotics",
"have",
"been",
"addressed",
"by",
"the",
"formation",
"of",
"the",
"US",
"Interagency",
"Task",
"Force",
"on",
"Antimicrobial",
"Resistance",
".",
"This",
"task",
"force",
"aims",
"to",
"actively",
"address",
"antimicrobial",
"resistance",
",",
"and",
"is",
"coordinated",
"by",
"the",
"US",
"Centers",
"for",
"Disease",
"Control",
"and",
"Prevention",
",",
"the",
"Food",
"and",
"Drug",
"Administration",
"(",
"FDA",
")",
",",
"and",
"the",
"National",
"Institutes",
"of",
"Health",
"(",
"NIH",
")",
",",
"as",
"well",
"as",
"other",
"US",
"agencies",
".",
"An",
"NGO",
"campaign",
"group",
"is",
"Keep",
"Antibiotics",
"Working",
".",
"In",
"France",
",",
"an",
"\"",
"Antibiotics",
"are",
"not",
"automatic",
"\"",
"government",
"campaign",
"started",
"in",
"2002",
"and",
"led",
"to",
"a",
"marked",
"reduction",
"of",
"unnecessary",
"antibiotic",
"prescriptions",
",",
"especially",
"in",
"children",
"."
],
"offsets": [
0,
8,
22,
32,
37,
51,
62,
66,
75,
78,
88,
92,
104,
108,
111,
122,
124,
128,
135,
138,
145,
149,
157,
160,
172,
177,
182,
192,
195,
199,
209,
212,
216,
219,
231,
236,
242,
245,
259,
269,
271,
276,
281,
287,
292,
295,
304,
312,
326,
336,
338,
342,
345,
357,
360,
364,
367,
375,
379,
387,
395,
399,
409,
411,
415,
420,
424,
429,
444,
445,
448,
449,
451,
455,
459,
468,
479,
482,
489,
490,
493,
494,
496,
499,
504,
507,
513,
516,
524,
526,
529,
533,
542,
548,
551,
556,
568,
575,
577,
580,
586,
588,
591,
592,
604,
608,
612,
621,
623,
634,
643,
651,
654,
659,
663,
667,
670,
672,
679,
689,
692,
704,
715,
728,
730,
741,
744,
752
]
} | 1505637ee2474e19a7ad5b3d19e032a4 | What is the name of a US government agency tasked with trying to stop improper use of antibiotics? | {
"tokens": [
"What",
"is",
"the",
"name",
"of",
"a",
"US",
"government",
"agency",
"tasked",
"with",
"trying",
"to",
"stop",
"improper",
"use",
"of",
"antibiotics",
"?"
],
"offsets": [
0,
5,
8,
12,
17,
20,
22,
25,
36,
43,
50,
55,
62,
65,
70,
79,
83,
86,
97
]
} | {
"text": [
"US Interagency Task Force on Antimicrobial Resistance"
],
"char_spans": [
{
"start": [
216
],
"end": [
268
]
}
],
"token_spans": [
{
"start": [
32
],
"end": [
38
]
}
]
} | [
"US Interagency Task Force on Antimicrobial Resistance"
] |
SQuAD | Several organizations concerned with antimicrobial resistance are lobbying to eliminate the unnecessary use of antibiotics. The issues of misuse and overuse of antibiotics have been addressed by the formation of the US Interagency Task Force on Antimicrobial Resistance. This task force aims to actively address antimicrobial resistance, and is coordinated by the US Centers for Disease Control and Prevention, the Food and Drug Administration (FDA), and the National Institutes of Health (NIH), as well as other US agencies. An NGO campaign group is Keep Antibiotics Working. In France, an "Antibiotics are not automatic" government campaign started in 2002 and led to a marked reduction of unnecessary antibiotic prescriptions, especially in children. | {
"tokens": [
"Several",
"organizations",
"concerned",
"with",
"antimicrobial",
"resistance",
"are",
"lobbying",
"to",
"eliminate",
"the",
"unnecessary",
"use",
"of",
"antibiotics",
".",
"The",
"issues",
"of",
"misuse",
"and",
"overuse",
"of",
"antibiotics",
"have",
"been",
"addressed",
"by",
"the",
"formation",
"of",
"the",
"US",
"Interagency",
"Task",
"Force",
"on",
"Antimicrobial",
"Resistance",
".",
"This",
"task",
"force",
"aims",
"to",
"actively",
"address",
"antimicrobial",
"resistance",
",",
"and",
"is",
"coordinated",
"by",
"the",
"US",
"Centers",
"for",
"Disease",
"Control",
"and",
"Prevention",
",",
"the",
"Food",
"and",
"Drug",
"Administration",
"(",
"FDA",
")",
",",
"and",
"the",
"National",
"Institutes",
"of",
"Health",
"(",
"NIH",
")",
",",
"as",
"well",
"as",
"other",
"US",
"agencies",
".",
"An",
"NGO",
"campaign",
"group",
"is",
"Keep",
"Antibiotics",
"Working",
".",
"In",
"France",
",",
"an",
"\"",
"Antibiotics",
"are",
"not",
"automatic",
"\"",
"government",
"campaign",
"started",
"in",
"2002",
"and",
"led",
"to",
"a",
"marked",
"reduction",
"of",
"unnecessary",
"antibiotic",
"prescriptions",
",",
"especially",
"in",
"children",
"."
],
"offsets": [
0,
8,
22,
32,
37,
51,
62,
66,
75,
78,
88,
92,
104,
108,
111,
122,
124,
128,
135,
138,
145,
149,
157,
160,
172,
177,
182,
192,
195,
199,
209,
212,
216,
219,
231,
236,
242,
245,
259,
269,
271,
276,
281,
287,
292,
295,
304,
312,
326,
336,
338,
342,
345,
357,
360,
364,
367,
375,
379,
387,
395,
399,
409,
411,
415,
420,
424,
429,
444,
445,
448,
449,
451,
455,
459,
468,
479,
482,
489,
490,
493,
494,
496,
499,
504,
507,
513,
516,
524,
526,
529,
533,
542,
548,
551,
556,
568,
575,
577,
580,
586,
588,
591,
592,
604,
608,
612,
621,
623,
634,
643,
651,
654,
659,
663,
667,
670,
672,
679,
689,
692,
704,
715,
728,
730,
741,
744,
752
]
} | 54a395b904994573bd78d7b65c1797e4 | Which agencies control this task force? | {
"tokens": [
"Which",
"agencies",
"control",
"this",
"task",
"force",
"?"
],
"offsets": [
0,
6,
15,
23,
28,
33,
38
]
} | {
"text": [
"US Centers for Disease Control and Prevention, the Food and Drug Administration (FDA), and the National Institutes of Health (NIH)"
],
"char_spans": [
{
"start": [
364
],
"end": [
493
]
}
],
"token_spans": [
{
"start": [
55
],
"end": [
80
]
}
]
} | [
"US Centers for Disease Control and Prevention, the Food and Drug Administration (FDA), and the National Institutes of Health (NIH)"
] |
SQuAD | Several organizations concerned with antimicrobial resistance are lobbying to eliminate the unnecessary use of antibiotics. The issues of misuse and overuse of antibiotics have been addressed by the formation of the US Interagency Task Force on Antimicrobial Resistance. This task force aims to actively address antimicrobial resistance, and is coordinated by the US Centers for Disease Control and Prevention, the Food and Drug Administration (FDA), and the National Institutes of Health (NIH), as well as other US agencies. An NGO campaign group is Keep Antibiotics Working. In France, an "Antibiotics are not automatic" government campaign started in 2002 and led to a marked reduction of unnecessary antibiotic prescriptions, especially in children. | {
"tokens": [
"Several",
"organizations",
"concerned",
"with",
"antimicrobial",
"resistance",
"are",
"lobbying",
"to",
"eliminate",
"the",
"unnecessary",
"use",
"of",
"antibiotics",
".",
"The",
"issues",
"of",
"misuse",
"and",
"overuse",
"of",
"antibiotics",
"have",
"been",
"addressed",
"by",
"the",
"formation",
"of",
"the",
"US",
"Interagency",
"Task",
"Force",
"on",
"Antimicrobial",
"Resistance",
".",
"This",
"task",
"force",
"aims",
"to",
"actively",
"address",
"antimicrobial",
"resistance",
",",
"and",
"is",
"coordinated",
"by",
"the",
"US",
"Centers",
"for",
"Disease",
"Control",
"and",
"Prevention",
",",
"the",
"Food",
"and",
"Drug",
"Administration",
"(",
"FDA",
")",
",",
"and",
"the",
"National",
"Institutes",
"of",
"Health",
"(",
"NIH",
")",
",",
"as",
"well",
"as",
"other",
"US",
"agencies",
".",
"An",
"NGO",
"campaign",
"group",
"is",
"Keep",
"Antibiotics",
"Working",
".",
"In",
"France",
",",
"an",
"\"",
"Antibiotics",
"are",
"not",
"automatic",
"\"",
"government",
"campaign",
"started",
"in",
"2002",
"and",
"led",
"to",
"a",
"marked",
"reduction",
"of",
"unnecessary",
"antibiotic",
"prescriptions",
",",
"especially",
"in",
"children",
"."
],
"offsets": [
0,
8,
22,
32,
37,
51,
62,
66,
75,
78,
88,
92,
104,
108,
111,
122,
124,
128,
135,
138,
145,
149,
157,
160,
172,
177,
182,
192,
195,
199,
209,
212,
216,
219,
231,
236,
242,
245,
259,
269,
271,
276,
281,
287,
292,
295,
304,
312,
326,
336,
338,
342,
345,
357,
360,
364,
367,
375,
379,
387,
395,
399,
409,
411,
415,
420,
424,
429,
444,
445,
448,
449,
451,
455,
459,
468,
479,
482,
489,
490,
493,
494,
496,
499,
504,
507,
513,
516,
524,
526,
529,
533,
542,
548,
551,
556,
568,
575,
577,
580,
586,
588,
591,
592,
604,
608,
612,
621,
623,
634,
643,
651,
654,
659,
663,
667,
670,
672,
679,
689,
692,
704,
715,
728,
730,
741,
744,
752
]
} | 673802bb9824408493c3aa3f32a87aa3 | When did the French start going after overuse of antibiotics? | {
"tokens": [
"When",
"did",
"the",
"French",
"start",
"going",
"after",
"overuse",
"of",
"antibiotics",
"?"
],
"offsets": [
0,
5,
9,
13,
20,
26,
32,
38,
46,
49,
60
]
} | {
"text": [
"2002"
],
"char_spans": [
{
"start": [
654
],
"end": [
657
]
}
],
"token_spans": [
{
"start": [
112
],
"end": [
112
]
}
]
} | [
"2002"
] |
SQuAD | Antibacterial antibiotics are commonly classified based on their mechanism of action, chemical structure, or spectrum of activity. Most target bacterial functions or growth processes. Those that target the bacterial cell wall (penicillins and cephalosporins) or the cell membrane (polymyxins), or interfere with essential bacterial enzymes (rifamycins, lipiarmycins, quinolones, and sulfonamides) have bactericidal activities. Those that target protein synthesis (macrolides, lincosamides and tetracyclines) are usually bacteriostatic (with the exception of bactericidal aminoglycosides). Further categorization is based on their target specificity. "Narrow-spectrum" antibacterial antibiotics target specific types of bacteria, such as Gram-negative or Gram-positive bacteria, whereas broad-spectrum antibiotics affect a wide range of bacteria. Following a 40-year hiatus in discovering new classes of antibacterial compounds, four new classes of antibacterial antibiotics have been brought into clinical use in the late 2000s and early 2010s: cyclic lipopeptides (such as daptomycin), glycylcyclines (such as tigecycline), oxazolidinones (such as linezolid), and lipiarmycins (such as fidaxomicin). | {
"tokens": [
"Antibacterial",
"antibiotics",
"are",
"commonly",
"classified",
"based",
"on",
"their",
"mechanism",
"of",
"action",
",",
"chemical",
"structure",
",",
"or",
"spectrum",
"of",
"activity",
".",
"Most",
"target",
"bacterial",
"functions",
"or",
"growth",
"processes",
".",
"Those",
"that",
"target",
"the",
"bacterial",
"cell",
"wall",
"(",
"penicillins",
"and",
"cephalosporins",
")",
"or",
"the",
"cell",
"membrane",
"(",
"polymyxins",
")",
",",
"or",
"interfere",
"with",
"essential",
"bacterial",
"enzymes",
"(",
"rifamycins",
",",
"lipiarmycins",
",",
"quinolones",
",",
"and",
"sulfonamides",
")",
"have",
"bactericidal",
"activities",
".",
"Those",
"that",
"target",
"protein",
"synthesis",
"(",
"macrolides",
",",
"lincosamides",
"and",
"tetracyclines",
")",
"are",
"usually",
"bacteriostatic",
"(",
"with",
"the",
"exception",
"of",
"bactericidal",
"aminoglycosides",
")",
".",
"Further",
"categorization",
"is",
"based",
"on",
"their",
"target",
"specificity",
".",
"\"",
"Narrow",
"-",
"spectrum",
"\"",
"antibacterial",
"antibiotics",
"target",
"specific",
"types",
"of",
"bacteria",
",",
"such",
"as",
"Gram",
"-",
"negative",
"or",
"Gram",
"-",
"positive",
"bacteria",
",",
"whereas",
"broad",
"-",
"spectrum",
"antibiotics",
"affect",
"a",
"wide",
"range",
"of",
"bacteria",
".",
"Following",
"a",
"40-year",
"hiatus",
"in",
"discovering",
"new",
"classes",
"of",
"antibacterial",
"compounds",
",",
"four",
"new",
"classes",
"of",
"antibacterial",
"antibiotics",
"have",
"been",
"brought",
"into",
"clinical",
"use",
"in",
"the",
"late",
"2000s",
"and",
"early",
"2010s",
":",
"cyclic",
"lipopeptides",
"(",
"such",
"as",
"daptomycin",
")",
",",
"glycylcyclines",
"(",
"such",
"as",
"tigecycline",
")",
",",
"oxazolidinones",
"(",
"such",
"as",
"linezolid",
")",
",",
"and",
"lipiarmycins",
"(",
"such",
"as",
"fidaxomicin",
")",
"."
],
"offsets": [
0,
14,
26,
30,
39,
50,
56,
59,
65,
75,
78,
84,
86,
95,
104,
106,
109,
118,
121,
129,
131,
136,
143,
153,
163,
166,
173,
182,
184,
190,
195,
202,
206,
216,
221,
226,
227,
239,
243,
257,
259,
262,
266,
271,
280,
281,
291,
292,
294,
297,
307,
312,
322,
332,
340,
341,
351,
353,
365,
367,
377,
379,
383,
395,
397,
402,
415,
425,
427,
433,
438,
445,
453,
463,
464,
474,
476,
489,
493,
506,
508,
512,
520,
535,
536,
541,
545,
555,
558,
571,
586,
587,
589,
597,
612,
615,
621,
624,
630,
637,
648,
650,
651,
657,
658,
666,
668,
682,
694,
701,
710,
716,
719,
727,
729,
734,
737,
741,
742,
751,
754,
758,
759,
768,
776,
778,
786,
791,
792,
801,
813,
820,
822,
827,
833,
836,
844,
846,
856,
858,
866,
873,
876,
888,
892,
900,
903,
917,
926,
928,
933,
937,
945,
948,
962,
974,
979,
984,
992,
997,
1006,
1010,
1013,
1017,
1022,
1028,
1032,
1038,
1043,
1045,
1052,
1065,
1066,
1071,
1074,
1084,
1085,
1087,
1102,
1103,
1108,
1111,
1122,
1123,
1125,
1140,
1141,
1146,
1149,
1158,
1159,
1161,
1165,
1178,
1179,
1184,
1187,
1198,
1199
]
} | a8818b1c96264153b6f50ab8685ce56a | What do anitibiotics mostly target? | {
"tokens": [
"What",
"do",
"anitibiotics",
"mostly",
"target",
"?"
],
"offsets": [
0,
5,
8,
21,
28,
34
]
} | {
"text": [
"bacterial functions or growth processes"
],
"char_spans": [
{
"start": [
143
],
"end": [
181
]
}
],
"token_spans": [
{
"start": [
22
],
"end": [
26
]
}
]
} | [
"bacterial functions or growth processes"
] |
SQuAD | Antibacterial antibiotics are commonly classified based on their mechanism of action, chemical structure, or spectrum of activity. Most target bacterial functions or growth processes. Those that target the bacterial cell wall (penicillins and cephalosporins) or the cell membrane (polymyxins), or interfere with essential bacterial enzymes (rifamycins, lipiarmycins, quinolones, and sulfonamides) have bactericidal activities. Those that target protein synthesis (macrolides, lincosamides and tetracyclines) are usually bacteriostatic (with the exception of bactericidal aminoglycosides). Further categorization is based on their target specificity. "Narrow-spectrum" antibacterial antibiotics target specific types of bacteria, such as Gram-negative or Gram-positive bacteria, whereas broad-spectrum antibiotics affect a wide range of bacteria. Following a 40-year hiatus in discovering new classes of antibacterial compounds, four new classes of antibacterial antibiotics have been brought into clinical use in the late 2000s and early 2010s: cyclic lipopeptides (such as daptomycin), glycylcyclines (such as tigecycline), oxazolidinones (such as linezolid), and lipiarmycins (such as fidaxomicin). | {
"tokens": [
"Antibacterial",
"antibiotics",
"are",
"commonly",
"classified",
"based",
"on",
"their",
"mechanism",
"of",
"action",
",",
"chemical",
"structure",
",",
"or",
"spectrum",
"of",
"activity",
".",
"Most",
"target",
"bacterial",
"functions",
"or",
"growth",
"processes",
".",
"Those",
"that",
"target",
"the",
"bacterial",
"cell",
"wall",
"(",
"penicillins",
"and",
"cephalosporins",
")",
"or",
"the",
"cell",
"membrane",
"(",
"polymyxins",
")",
",",
"or",
"interfere",
"with",
"essential",
"bacterial",
"enzymes",
"(",
"rifamycins",
",",
"lipiarmycins",
",",
"quinolones",
",",
"and",
"sulfonamides",
")",
"have",
"bactericidal",
"activities",
".",
"Those",
"that",
"target",
"protein",
"synthesis",
"(",
"macrolides",
",",
"lincosamides",
"and",
"tetracyclines",
")",
"are",
"usually",
"bacteriostatic",
"(",
"with",
"the",
"exception",
"of",
"bactericidal",
"aminoglycosides",
")",
".",
"Further",
"categorization",
"is",
"based",
"on",
"their",
"target",
"specificity",
".",
"\"",
"Narrow",
"-",
"spectrum",
"\"",
"antibacterial",
"antibiotics",
"target",
"specific",
"types",
"of",
"bacteria",
",",
"such",
"as",
"Gram",
"-",
"negative",
"or",
"Gram",
"-",
"positive",
"bacteria",
",",
"whereas",
"broad",
"-",
"spectrum",
"antibiotics",
"affect",
"a",
"wide",
"range",
"of",
"bacteria",
".",
"Following",
"a",
"40-year",
"hiatus",
"in",
"discovering",
"new",
"classes",
"of",
"antibacterial",
"compounds",
",",
"four",
"new",
"classes",
"of",
"antibacterial",
"antibiotics",
"have",
"been",
"brought",
"into",
"clinical",
"use",
"in",
"the",
"late",
"2000s",
"and",
"early",
"2010s",
":",
"cyclic",
"lipopeptides",
"(",
"such",
"as",
"daptomycin",
")",
",",
"glycylcyclines",
"(",
"such",
"as",
"tigecycline",
")",
",",
"oxazolidinones",
"(",
"such",
"as",
"linezolid",
")",
",",
"and",
"lipiarmycins",
"(",
"such",
"as",
"fidaxomicin",
")",
"."
],
"offsets": [
0,
14,
26,
30,
39,
50,
56,
59,
65,
75,
78,
84,
86,
95,
104,
106,
109,
118,
121,
129,
131,
136,
143,
153,
163,
166,
173,
182,
184,
190,
195,
202,
206,
216,
221,
226,
227,
239,
243,
257,
259,
262,
266,
271,
280,
281,
291,
292,
294,
297,
307,
312,
322,
332,
340,
341,
351,
353,
365,
367,
377,
379,
383,
395,
397,
402,
415,
425,
427,
433,
438,
445,
453,
463,
464,
474,
476,
489,
493,
506,
508,
512,
520,
535,
536,
541,
545,
555,
558,
571,
586,
587,
589,
597,
612,
615,
621,
624,
630,
637,
648,
650,
651,
657,
658,
666,
668,
682,
694,
701,
710,
716,
719,
727,
729,
734,
737,
741,
742,
751,
754,
758,
759,
768,
776,
778,
786,
791,
792,
801,
813,
820,
822,
827,
833,
836,
844,
846,
856,
858,
866,
873,
876,
888,
892,
900,
903,
917,
926,
928,
933,
937,
945,
948,
962,
974,
979,
984,
992,
997,
1006,
1010,
1013,
1017,
1022,
1028,
1032,
1038,
1043,
1045,
1052,
1065,
1066,
1071,
1074,
1084,
1085,
1087,
1102,
1103,
1108,
1111,
1122,
1123,
1125,
1140,
1141,
1146,
1149,
1158,
1159,
1161,
1165,
1178,
1179,
1184,
1187,
1198,
1199
]
} | 88c79121d03446f18646faaae7606281 | Which two types of antibiotics target the cell wall? | {
"tokens": [
"Which",
"two",
"types",
"of",
"antibiotics",
"target",
"the",
"cell",
"wall",
"?"
],
"offsets": [
0,
6,
10,
16,
19,
31,
38,
42,
47,
51
]
} | {
"text": [
"penicillins and cephalosporins"
],
"char_spans": [
{
"start": [
227
],
"end": [
256
]
}
],
"token_spans": [
{
"start": [
36
],
"end": [
38
]
}
]
} | [
"penicillins and cephalosporins"
] |
SQuAD | Antibacterial antibiotics are commonly classified based on their mechanism of action, chemical structure, or spectrum of activity. Most target bacterial functions or growth processes. Those that target the bacterial cell wall (penicillins and cephalosporins) or the cell membrane (polymyxins), or interfere with essential bacterial enzymes (rifamycins, lipiarmycins, quinolones, and sulfonamides) have bactericidal activities. Those that target protein synthesis (macrolides, lincosamides and tetracyclines) are usually bacteriostatic (with the exception of bactericidal aminoglycosides). Further categorization is based on their target specificity. "Narrow-spectrum" antibacterial antibiotics target specific types of bacteria, such as Gram-negative or Gram-positive bacteria, whereas broad-spectrum antibiotics affect a wide range of bacteria. Following a 40-year hiatus in discovering new classes of antibacterial compounds, four new classes of antibacterial antibiotics have been brought into clinical use in the late 2000s and early 2010s: cyclic lipopeptides (such as daptomycin), glycylcyclines (such as tigecycline), oxazolidinones (such as linezolid), and lipiarmycins (such as fidaxomicin). | {
"tokens": [
"Antibacterial",
"antibiotics",
"are",
"commonly",
"classified",
"based",
"on",
"their",
"mechanism",
"of",
"action",
",",
"chemical",
"structure",
",",
"or",
"spectrum",
"of",
"activity",
".",
"Most",
"target",
"bacterial",
"functions",
"or",
"growth",
"processes",
".",
"Those",
"that",
"target",
"the",
"bacterial",
"cell",
"wall",
"(",
"penicillins",
"and",
"cephalosporins",
")",
"or",
"the",
"cell",
"membrane",
"(",
"polymyxins",
")",
",",
"or",
"interfere",
"with",
"essential",
"bacterial",
"enzymes",
"(",
"rifamycins",
",",
"lipiarmycins",
",",
"quinolones",
",",
"and",
"sulfonamides",
")",
"have",
"bactericidal",
"activities",
".",
"Those",
"that",
"target",
"protein",
"synthesis",
"(",
"macrolides",
",",
"lincosamides",
"and",
"tetracyclines",
")",
"are",
"usually",
"bacteriostatic",
"(",
"with",
"the",
"exception",
"of",
"bactericidal",
"aminoglycosides",
")",
".",
"Further",
"categorization",
"is",
"based",
"on",
"their",
"target",
"specificity",
".",
"\"",
"Narrow",
"-",
"spectrum",
"\"",
"antibacterial",
"antibiotics",
"target",
"specific",
"types",
"of",
"bacteria",
",",
"such",
"as",
"Gram",
"-",
"negative",
"or",
"Gram",
"-",
"positive",
"bacteria",
",",
"whereas",
"broad",
"-",
"spectrum",
"antibiotics",
"affect",
"a",
"wide",
"range",
"of",
"bacteria",
".",
"Following",
"a",
"40-year",
"hiatus",
"in",
"discovering",
"new",
"classes",
"of",
"antibacterial",
"compounds",
",",
"four",
"new",
"classes",
"of",
"antibacterial",
"antibiotics",
"have",
"been",
"brought",
"into",
"clinical",
"use",
"in",
"the",
"late",
"2000s",
"and",
"early",
"2010s",
":",
"cyclic",
"lipopeptides",
"(",
"such",
"as",
"daptomycin",
")",
",",
"glycylcyclines",
"(",
"such",
"as",
"tigecycline",
")",
",",
"oxazolidinones",
"(",
"such",
"as",
"linezolid",
")",
",",
"and",
"lipiarmycins",
"(",
"such",
"as",
"fidaxomicin",
")",
"."
],
"offsets": [
0,
14,
26,
30,
39,
50,
56,
59,
65,
75,
78,
84,
86,
95,
104,
106,
109,
118,
121,
129,
131,
136,
143,
153,
163,
166,
173,
182,
184,
190,
195,
202,
206,
216,
221,
226,
227,
239,
243,
257,
259,
262,
266,
271,
280,
281,
291,
292,
294,
297,
307,
312,
322,
332,
340,
341,
351,
353,
365,
367,
377,
379,
383,
395,
397,
402,
415,
425,
427,
433,
438,
445,
453,
463,
464,
474,
476,
489,
493,
506,
508,
512,
520,
535,
536,
541,
545,
555,
558,
571,
586,
587,
589,
597,
612,
615,
621,
624,
630,
637,
648,
650,
651,
657,
658,
666,
668,
682,
694,
701,
710,
716,
719,
727,
729,
734,
737,
741,
742,
751,
754,
758,
759,
768,
776,
778,
786,
791,
792,
801,
813,
820,
822,
827,
833,
836,
844,
846,
856,
858,
866,
873,
876,
888,
892,
900,
903,
917,
926,
928,
933,
937,
945,
948,
962,
974,
979,
984,
992,
997,
1006,
1010,
1013,
1017,
1022,
1028,
1032,
1038,
1043,
1045,
1052,
1065,
1066,
1071,
1074,
1084,
1085,
1087,
1102,
1103,
1108,
1111,
1122,
1123,
1125,
1140,
1141,
1146,
1149,
1158,
1159,
1161,
1165,
1178,
1179,
1184,
1187,
1198,
1199
]
} | e5f085fa35c244619f35b77380c181f5 | Which type of antibiotic goes after the cell membrane? | {
"tokens": [
"Which",
"type",
"of",
"antibiotic",
"goes",
"after",
"the",
"cell",
"membrane",
"?"
],
"offsets": [
0,
6,
11,
14,
25,
30,
36,
40,
45,
53
]
} | {
"text": [
"polymyxins"
],
"char_spans": [
{
"start": [
281
],
"end": [
290
]
}
],
"token_spans": [
{
"start": [
45
],
"end": [
45
]
}
]
} | [
"polymyxins"
] |
SQuAD | Antibacterial antibiotics are commonly classified based on their mechanism of action, chemical structure, or spectrum of activity. Most target bacterial functions or growth processes. Those that target the bacterial cell wall (penicillins and cephalosporins) or the cell membrane (polymyxins), or interfere with essential bacterial enzymes (rifamycins, lipiarmycins, quinolones, and sulfonamides) have bactericidal activities. Those that target protein synthesis (macrolides, lincosamides and tetracyclines) are usually bacteriostatic (with the exception of bactericidal aminoglycosides). Further categorization is based on their target specificity. "Narrow-spectrum" antibacterial antibiotics target specific types of bacteria, such as Gram-negative or Gram-positive bacteria, whereas broad-spectrum antibiotics affect a wide range of bacteria. Following a 40-year hiatus in discovering new classes of antibacterial compounds, four new classes of antibacterial antibiotics have been brought into clinical use in the late 2000s and early 2010s: cyclic lipopeptides (such as daptomycin), glycylcyclines (such as tigecycline), oxazolidinones (such as linezolid), and lipiarmycins (such as fidaxomicin). | {
"tokens": [
"Antibacterial",
"antibiotics",
"are",
"commonly",
"classified",
"based",
"on",
"their",
"mechanism",
"of",
"action",
",",
"chemical",
"structure",
",",
"or",
"spectrum",
"of",
"activity",
".",
"Most",
"target",
"bacterial",
"functions",
"or",
"growth",
"processes",
".",
"Those",
"that",
"target",
"the",
"bacterial",
"cell",
"wall",
"(",
"penicillins",
"and",
"cephalosporins",
")",
"or",
"the",
"cell",
"membrane",
"(",
"polymyxins",
")",
",",
"or",
"interfere",
"with",
"essential",
"bacterial",
"enzymes",
"(",
"rifamycins",
",",
"lipiarmycins",
",",
"quinolones",
",",
"and",
"sulfonamides",
")",
"have",
"bactericidal",
"activities",
".",
"Those",
"that",
"target",
"protein",
"synthesis",
"(",
"macrolides",
",",
"lincosamides",
"and",
"tetracyclines",
")",
"are",
"usually",
"bacteriostatic",
"(",
"with",
"the",
"exception",
"of",
"bactericidal",
"aminoglycosides",
")",
".",
"Further",
"categorization",
"is",
"based",
"on",
"their",
"target",
"specificity",
".",
"\"",
"Narrow",
"-",
"spectrum",
"\"",
"antibacterial",
"antibiotics",
"target",
"specific",
"types",
"of",
"bacteria",
",",
"such",
"as",
"Gram",
"-",
"negative",
"or",
"Gram",
"-",
"positive",
"bacteria",
",",
"whereas",
"broad",
"-",
"spectrum",
"antibiotics",
"affect",
"a",
"wide",
"range",
"of",
"bacteria",
".",
"Following",
"a",
"40-year",
"hiatus",
"in",
"discovering",
"new",
"classes",
"of",
"antibacterial",
"compounds",
",",
"four",
"new",
"classes",
"of",
"antibacterial",
"antibiotics",
"have",
"been",
"brought",
"into",
"clinical",
"use",
"in",
"the",
"late",
"2000s",
"and",
"early",
"2010s",
":",
"cyclic",
"lipopeptides",
"(",
"such",
"as",
"daptomycin",
")",
",",
"glycylcyclines",
"(",
"such",
"as",
"tigecycline",
")",
",",
"oxazolidinones",
"(",
"such",
"as",
"linezolid",
")",
",",
"and",
"lipiarmycins",
"(",
"such",
"as",
"fidaxomicin",
")",
"."
],
"offsets": [
0,
14,
26,
30,
39,
50,
56,
59,
65,
75,
78,
84,
86,
95,
104,
106,
109,
118,
121,
129,
131,
136,
143,
153,
163,
166,
173,
182,
184,
190,
195,
202,
206,
216,
221,
226,
227,
239,
243,
257,
259,
262,
266,
271,
280,
281,
291,
292,
294,
297,
307,
312,
322,
332,
340,
341,
351,
353,
365,
367,
377,
379,
383,
395,
397,
402,
415,
425,
427,
433,
438,
445,
453,
463,
464,
474,
476,
489,
493,
506,
508,
512,
520,
535,
536,
541,
545,
555,
558,
571,
586,
587,
589,
597,
612,
615,
621,
624,
630,
637,
648,
650,
651,
657,
658,
666,
668,
682,
694,
701,
710,
716,
719,
727,
729,
734,
737,
741,
742,
751,
754,
758,
759,
768,
776,
778,
786,
791,
792,
801,
813,
820,
822,
827,
833,
836,
844,
846,
856,
858,
866,
873,
876,
888,
892,
900,
903,
917,
926,
928,
933,
937,
945,
948,
962,
974,
979,
984,
992,
997,
1006,
1010,
1013,
1017,
1022,
1028,
1032,
1038,
1043,
1045,
1052,
1065,
1066,
1071,
1074,
1084,
1085,
1087,
1102,
1103,
1108,
1111,
1122,
1123,
1125,
1140,
1141,
1146,
1149,
1158,
1159,
1161,
1165,
1178,
1179,
1184,
1187,
1198,
1199
]
} | 550404bf77364fafa4666ef3dcf2abd5 | What 3 types go after protein synthesis? | {
"tokens": [
"What",
"3",
"types",
"go",
"after",
"protein",
"synthesis",
"?"
],
"offsets": [
0,
5,
7,
13,
16,
22,
30,
39
]
} | {
"text": [
"(macrolides, lincosamides and tetracyclines"
],
"char_spans": [
{
"start": [
463
],
"end": [
505
]
}
],
"token_spans": [
{
"start": [
73
],
"end": [
78
]
}
]
} | [
"(macrolides, lincosamides and tetracyclines"
] |
SQuAD | Antibacterial antibiotics are commonly classified based on their mechanism of action, chemical structure, or spectrum of activity. Most target bacterial functions or growth processes. Those that target the bacterial cell wall (penicillins and cephalosporins) or the cell membrane (polymyxins), or interfere with essential bacterial enzymes (rifamycins, lipiarmycins, quinolones, and sulfonamides) have bactericidal activities. Those that target protein synthesis (macrolides, lincosamides and tetracyclines) are usually bacteriostatic (with the exception of bactericidal aminoglycosides). Further categorization is based on their target specificity. "Narrow-spectrum" antibacterial antibiotics target specific types of bacteria, such as Gram-negative or Gram-positive bacteria, whereas broad-spectrum antibiotics affect a wide range of bacteria. Following a 40-year hiatus in discovering new classes of antibacterial compounds, four new classes of antibacterial antibiotics have been brought into clinical use in the late 2000s and early 2010s: cyclic lipopeptides (such as daptomycin), glycylcyclines (such as tigecycline), oxazolidinones (such as linezolid), and lipiarmycins (such as fidaxomicin). | {
"tokens": [
"Antibacterial",
"antibiotics",
"are",
"commonly",
"classified",
"based",
"on",
"their",
"mechanism",
"of",
"action",
",",
"chemical",
"structure",
",",
"or",
"spectrum",
"of",
"activity",
".",
"Most",
"target",
"bacterial",
"functions",
"or",
"growth",
"processes",
".",
"Those",
"that",
"target",
"the",
"bacterial",
"cell",
"wall",
"(",
"penicillins",
"and",
"cephalosporins",
")",
"or",
"the",
"cell",
"membrane",
"(",
"polymyxins",
")",
",",
"or",
"interfere",
"with",
"essential",
"bacterial",
"enzymes",
"(",
"rifamycins",
",",
"lipiarmycins",
",",
"quinolones",
",",
"and",
"sulfonamides",
")",
"have",
"bactericidal",
"activities",
".",
"Those",
"that",
"target",
"protein",
"synthesis",
"(",
"macrolides",
",",
"lincosamides",
"and",
"tetracyclines",
")",
"are",
"usually",
"bacteriostatic",
"(",
"with",
"the",
"exception",
"of",
"bactericidal",
"aminoglycosides",
")",
".",
"Further",
"categorization",
"is",
"based",
"on",
"their",
"target",
"specificity",
".",
"\"",
"Narrow",
"-",
"spectrum",
"\"",
"antibacterial",
"antibiotics",
"target",
"specific",
"types",
"of",
"bacteria",
",",
"such",
"as",
"Gram",
"-",
"negative",
"or",
"Gram",
"-",
"positive",
"bacteria",
",",
"whereas",
"broad",
"-",
"spectrum",
"antibiotics",
"affect",
"a",
"wide",
"range",
"of",
"bacteria",
".",
"Following",
"a",
"40-year",
"hiatus",
"in",
"discovering",
"new",
"classes",
"of",
"antibacterial",
"compounds",
",",
"four",
"new",
"classes",
"of",
"antibacterial",
"antibiotics",
"have",
"been",
"brought",
"into",
"clinical",
"use",
"in",
"the",
"late",
"2000s",
"and",
"early",
"2010s",
":",
"cyclic",
"lipopeptides",
"(",
"such",
"as",
"daptomycin",
")",
",",
"glycylcyclines",
"(",
"such",
"as",
"tigecycline",
")",
",",
"oxazolidinones",
"(",
"such",
"as",
"linezolid",
")",
",",
"and",
"lipiarmycins",
"(",
"such",
"as",
"fidaxomicin",
")",
"."
],
"offsets": [
0,
14,
26,
30,
39,
50,
56,
59,
65,
75,
78,
84,
86,
95,
104,
106,
109,
118,
121,
129,
131,
136,
143,
153,
163,
166,
173,
182,
184,
190,
195,
202,
206,
216,
221,
226,
227,
239,
243,
257,
259,
262,
266,
271,
280,
281,
291,
292,
294,
297,
307,
312,
322,
332,
340,
341,
351,
353,
365,
367,
377,
379,
383,
395,
397,
402,
415,
425,
427,
433,
438,
445,
453,
463,
464,
474,
476,
489,
493,
506,
508,
512,
520,
535,
536,
541,
545,
555,
558,
571,
586,
587,
589,
597,
612,
615,
621,
624,
630,
637,
648,
650,
651,
657,
658,
666,
668,
682,
694,
701,
710,
716,
719,
727,
729,
734,
737,
741,
742,
751,
754,
758,
759,
768,
776,
778,
786,
791,
792,
801,
813,
820,
822,
827,
833,
836,
844,
846,
856,
858,
866,
873,
876,
888,
892,
900,
903,
917,
926,
928,
933,
937,
945,
948,
962,
974,
979,
984,
992,
997,
1006,
1010,
1013,
1017,
1022,
1028,
1032,
1038,
1043,
1045,
1052,
1065,
1066,
1071,
1074,
1084,
1085,
1087,
1102,
1103,
1108,
1111,
1122,
1123,
1125,
1140,
1141,
1146,
1149,
1158,
1159,
1161,
1165,
1178,
1179,
1184,
1187,
1198,
1199
]
} | dc0c7dcc5f00401284740e43222b306e | Besides sprectrum of activity and chemical structure, how can antibacterial antibiotics classified? | {
"tokens": [
"Besides",
"sprectrum",
"of",
"activity",
"and",
"chemical",
"structure",
",",
"how",
"can",
"antibacterial",
"antibiotics",
"classified",
"?"
],
"offsets": [
0,
8,
18,
21,
30,
34,
43,
52,
54,
58,
62,
76,
88,
98
]
} | {
"text": [
"mechanism of action"
],
"char_spans": [
{
"start": [
65
],
"end": [
83
]
}
],
"token_spans": [
{
"start": [
8
],
"end": [
10
]
}
]
} | [
"mechanism of action"
] |
SQuAD | Antibacterial antibiotics are commonly classified based on their mechanism of action, chemical structure, or spectrum of activity. Most target bacterial functions or growth processes. Those that target the bacterial cell wall (penicillins and cephalosporins) or the cell membrane (polymyxins), or interfere with essential bacterial enzymes (rifamycins, lipiarmycins, quinolones, and sulfonamides) have bactericidal activities. Those that target protein synthesis (macrolides, lincosamides and tetracyclines) are usually bacteriostatic (with the exception of bactericidal aminoglycosides). Further categorization is based on their target specificity. "Narrow-spectrum" antibacterial antibiotics target specific types of bacteria, such as Gram-negative or Gram-positive bacteria, whereas broad-spectrum antibiotics affect a wide range of bacteria. Following a 40-year hiatus in discovering new classes of antibacterial compounds, four new classes of antibacterial antibiotics have been brought into clinical use in the late 2000s and early 2010s: cyclic lipopeptides (such as daptomycin), glycylcyclines (such as tigecycline), oxazolidinones (such as linezolid), and lipiarmycins (such as fidaxomicin). | {
"tokens": [
"Antibacterial",
"antibiotics",
"are",
"commonly",
"classified",
"based",
"on",
"their",
"mechanism",
"of",
"action",
",",
"chemical",
"structure",
",",
"or",
"spectrum",
"of",
"activity",
".",
"Most",
"target",
"bacterial",
"functions",
"or",
"growth",
"processes",
".",
"Those",
"that",
"target",
"the",
"bacterial",
"cell",
"wall",
"(",
"penicillins",
"and",
"cephalosporins",
")",
"or",
"the",
"cell",
"membrane",
"(",
"polymyxins",
")",
",",
"or",
"interfere",
"with",
"essential",
"bacterial",
"enzymes",
"(",
"rifamycins",
",",
"lipiarmycins",
",",
"quinolones",
",",
"and",
"sulfonamides",
")",
"have",
"bactericidal",
"activities",
".",
"Those",
"that",
"target",
"protein",
"synthesis",
"(",
"macrolides",
",",
"lincosamides",
"and",
"tetracyclines",
")",
"are",
"usually",
"bacteriostatic",
"(",
"with",
"the",
"exception",
"of",
"bactericidal",
"aminoglycosides",
")",
".",
"Further",
"categorization",
"is",
"based",
"on",
"their",
"target",
"specificity",
".",
"\"",
"Narrow",
"-",
"spectrum",
"\"",
"antibacterial",
"antibiotics",
"target",
"specific",
"types",
"of",
"bacteria",
",",
"such",
"as",
"Gram",
"-",
"negative",
"or",
"Gram",
"-",
"positive",
"bacteria",
",",
"whereas",
"broad",
"-",
"spectrum",
"antibiotics",
"affect",
"a",
"wide",
"range",
"of",
"bacteria",
".",
"Following",
"a",
"40-year",
"hiatus",
"in",
"discovering",
"new",
"classes",
"of",
"antibacterial",
"compounds",
",",
"four",
"new",
"classes",
"of",
"antibacterial",
"antibiotics",
"have",
"been",
"brought",
"into",
"clinical",
"use",
"in",
"the",
"late",
"2000s",
"and",
"early",
"2010s",
":",
"cyclic",
"lipopeptides",
"(",
"such",
"as",
"daptomycin",
")",
",",
"glycylcyclines",
"(",
"such",
"as",
"tigecycline",
")",
",",
"oxazolidinones",
"(",
"such",
"as",
"linezolid",
")",
",",
"and",
"lipiarmycins",
"(",
"such",
"as",
"fidaxomicin",
")",
"."
],
"offsets": [
0,
14,
26,
30,
39,
50,
56,
59,
65,
75,
78,
84,
86,
95,
104,
106,
109,
118,
121,
129,
131,
136,
143,
153,
163,
166,
173,
182,
184,
190,
195,
202,
206,
216,
221,
226,
227,
239,
243,
257,
259,
262,
266,
271,
280,
281,
291,
292,
294,
297,
307,
312,
322,
332,
340,
341,
351,
353,
365,
367,
377,
379,
383,
395,
397,
402,
415,
425,
427,
433,
438,
445,
453,
463,
464,
474,
476,
489,
493,
506,
508,
512,
520,
535,
536,
541,
545,
555,
558,
571,
586,
587,
589,
597,
612,
615,
621,
624,
630,
637,
648,
650,
651,
657,
658,
666,
668,
682,
694,
701,
710,
716,
719,
727,
729,
734,
737,
741,
742,
751,
754,
758,
759,
768,
776,
778,
786,
791,
792,
801,
813,
820,
822,
827,
833,
836,
844,
846,
856,
858,
866,
873,
876,
888,
892,
900,
903,
917,
926,
928,
933,
937,
945,
948,
962,
974,
979,
984,
992,
997,
1006,
1010,
1013,
1017,
1022,
1028,
1032,
1038,
1043,
1045,
1052,
1065,
1066,
1071,
1074,
1084,
1085,
1087,
1102,
1103,
1108,
1111,
1122,
1123,
1125,
1140,
1141,
1146,
1149,
1158,
1159,
1161,
1165,
1178,
1179,
1184,
1187,
1198,
1199
]
} | 748e92d37945436eb364ae46c70cf8e3 | What is another name used for bacterial cell wall? | {
"tokens": [
"What",
"is",
"another",
"name",
"used",
"for",
"bacterial",
"cell",
"wall",
"?"
],
"offsets": [
0,
5,
8,
16,
21,
26,
30,
40,
45,
49
]
} | {
"text": [
"penicillins and cephalosporins"
],
"char_spans": [
{
"start": [
227
],
"end": [
256
]
}
],
"token_spans": [
{
"start": [
36
],
"end": [
38
]
}
]
} | [
"penicillins and cephalosporins"
] |
SQuAD | Antibacterial antibiotics are commonly classified based on their mechanism of action, chemical structure, or spectrum of activity. Most target bacterial functions or growth processes. Those that target the bacterial cell wall (penicillins and cephalosporins) or the cell membrane (polymyxins), or interfere with essential bacterial enzymes (rifamycins, lipiarmycins, quinolones, and sulfonamides) have bactericidal activities. Those that target protein synthesis (macrolides, lincosamides and tetracyclines) are usually bacteriostatic (with the exception of bactericidal aminoglycosides). Further categorization is based on their target specificity. "Narrow-spectrum" antibacterial antibiotics target specific types of bacteria, such as Gram-negative or Gram-positive bacteria, whereas broad-spectrum antibiotics affect a wide range of bacteria. Following a 40-year hiatus in discovering new classes of antibacterial compounds, four new classes of antibacterial antibiotics have been brought into clinical use in the late 2000s and early 2010s: cyclic lipopeptides (such as daptomycin), glycylcyclines (such as tigecycline), oxazolidinones (such as linezolid), and lipiarmycins (such as fidaxomicin). | {
"tokens": [
"Antibacterial",
"antibiotics",
"are",
"commonly",
"classified",
"based",
"on",
"their",
"mechanism",
"of",
"action",
",",
"chemical",
"structure",
",",
"or",
"spectrum",
"of",
"activity",
".",
"Most",
"target",
"bacterial",
"functions",
"or",
"growth",
"processes",
".",
"Those",
"that",
"target",
"the",
"bacterial",
"cell",
"wall",
"(",
"penicillins",
"and",
"cephalosporins",
")",
"or",
"the",
"cell",
"membrane",
"(",
"polymyxins",
")",
",",
"or",
"interfere",
"with",
"essential",
"bacterial",
"enzymes",
"(",
"rifamycins",
",",
"lipiarmycins",
",",
"quinolones",
",",
"and",
"sulfonamides",
")",
"have",
"bactericidal",
"activities",
".",
"Those",
"that",
"target",
"protein",
"synthesis",
"(",
"macrolides",
",",
"lincosamides",
"and",
"tetracyclines",
")",
"are",
"usually",
"bacteriostatic",
"(",
"with",
"the",
"exception",
"of",
"bactericidal",
"aminoglycosides",
")",
".",
"Further",
"categorization",
"is",
"based",
"on",
"their",
"target",
"specificity",
".",
"\"",
"Narrow",
"-",
"spectrum",
"\"",
"antibacterial",
"antibiotics",
"target",
"specific",
"types",
"of",
"bacteria",
",",
"such",
"as",
"Gram",
"-",
"negative",
"or",
"Gram",
"-",
"positive",
"bacteria",
",",
"whereas",
"broad",
"-",
"spectrum",
"antibiotics",
"affect",
"a",
"wide",
"range",
"of",
"bacteria",
".",
"Following",
"a",
"40-year",
"hiatus",
"in",
"discovering",
"new",
"classes",
"of",
"antibacterial",
"compounds",
",",
"four",
"new",
"classes",
"of",
"antibacterial",
"antibiotics",
"have",
"been",
"brought",
"into",
"clinical",
"use",
"in",
"the",
"late",
"2000s",
"and",
"early",
"2010s",
":",
"cyclic",
"lipopeptides",
"(",
"such",
"as",
"daptomycin",
")",
",",
"glycylcyclines",
"(",
"such",
"as",
"tigecycline",
")",
",",
"oxazolidinones",
"(",
"such",
"as",
"linezolid",
")",
",",
"and",
"lipiarmycins",
"(",
"such",
"as",
"fidaxomicin",
")",
"."
],
"offsets": [
0,
14,
26,
30,
39,
50,
56,
59,
65,
75,
78,
84,
86,
95,
104,
106,
109,
118,
121,
129,
131,
136,
143,
153,
163,
166,
173,
182,
184,
190,
195,
202,
206,
216,
221,
226,
227,
239,
243,
257,
259,
262,
266,
271,
280,
281,
291,
292,
294,
297,
307,
312,
322,
332,
340,
341,
351,
353,
365,
367,
377,
379,
383,
395,
397,
402,
415,
425,
427,
433,
438,
445,
453,
463,
464,
474,
476,
489,
493,
506,
508,
512,
520,
535,
536,
541,
545,
555,
558,
571,
586,
587,
589,
597,
612,
615,
621,
624,
630,
637,
648,
650,
651,
657,
658,
666,
668,
682,
694,
701,
710,
716,
719,
727,
729,
734,
737,
741,
742,
751,
754,
758,
759,
768,
776,
778,
786,
791,
792,
801,
813,
820,
822,
827,
833,
836,
844,
846,
856,
858,
866,
873,
876,
888,
892,
900,
903,
917,
926,
928,
933,
937,
945,
948,
962,
974,
979,
984,
992,
997,
1006,
1010,
1013,
1017,
1022,
1028,
1032,
1038,
1043,
1045,
1052,
1065,
1066,
1071,
1074,
1084,
1085,
1087,
1102,
1103,
1108,
1111,
1122,
1123,
1125,
1140,
1141,
1146,
1149,
1158,
1159,
1161,
1165,
1178,
1179,
1184,
1187,
1198,
1199
]
} | dc194b126f3f482b9ec99f0e3f60634e | whats another word for cell membrane? | {
"tokens": [
"what",
"s",
"another",
"word",
"for",
"cell",
"membrane",
"?"
],
"offsets": [
0,
4,
6,
14,
19,
23,
28,
36
]
} | {
"text": [
"polymyxins"
],
"char_spans": [
{
"start": [
281
],
"end": [
290
]
}
],
"token_spans": [
{
"start": [
45
],
"end": [
45
]
}
]
} | [
"polymyxins"
] |
SQuAD | Antibacterial antibiotics are commonly classified based on their mechanism of action, chemical structure, or spectrum of activity. Most target bacterial functions or growth processes. Those that target the bacterial cell wall (penicillins and cephalosporins) or the cell membrane (polymyxins), or interfere with essential bacterial enzymes (rifamycins, lipiarmycins, quinolones, and sulfonamides) have bactericidal activities. Those that target protein synthesis (macrolides, lincosamides and tetracyclines) are usually bacteriostatic (with the exception of bactericidal aminoglycosides). Further categorization is based on their target specificity. "Narrow-spectrum" antibacterial antibiotics target specific types of bacteria, such as Gram-negative or Gram-positive bacteria, whereas broad-spectrum antibiotics affect a wide range of bacteria. Following a 40-year hiatus in discovering new classes of antibacterial compounds, four new classes of antibacterial antibiotics have been brought into clinical use in the late 2000s and early 2010s: cyclic lipopeptides (such as daptomycin), glycylcyclines (such as tigecycline), oxazolidinones (such as linezolid), and lipiarmycins (such as fidaxomicin). | {
"tokens": [
"Antibacterial",
"antibiotics",
"are",
"commonly",
"classified",
"based",
"on",
"their",
"mechanism",
"of",
"action",
",",
"chemical",
"structure",
",",
"or",
"spectrum",
"of",
"activity",
".",
"Most",
"target",
"bacterial",
"functions",
"or",
"growth",
"processes",
".",
"Those",
"that",
"target",
"the",
"bacterial",
"cell",
"wall",
"(",
"penicillins",
"and",
"cephalosporins",
")",
"or",
"the",
"cell",
"membrane",
"(",
"polymyxins",
")",
",",
"or",
"interfere",
"with",
"essential",
"bacterial",
"enzymes",
"(",
"rifamycins",
",",
"lipiarmycins",
",",
"quinolones",
",",
"and",
"sulfonamides",
")",
"have",
"bactericidal",
"activities",
".",
"Those",
"that",
"target",
"protein",
"synthesis",
"(",
"macrolides",
",",
"lincosamides",
"and",
"tetracyclines",
")",
"are",
"usually",
"bacteriostatic",
"(",
"with",
"the",
"exception",
"of",
"bactericidal",
"aminoglycosides",
")",
".",
"Further",
"categorization",
"is",
"based",
"on",
"their",
"target",
"specificity",
".",
"\"",
"Narrow",
"-",
"spectrum",
"\"",
"antibacterial",
"antibiotics",
"target",
"specific",
"types",
"of",
"bacteria",
",",
"such",
"as",
"Gram",
"-",
"negative",
"or",
"Gram",
"-",
"positive",
"bacteria",
",",
"whereas",
"broad",
"-",
"spectrum",
"antibiotics",
"affect",
"a",
"wide",
"range",
"of",
"bacteria",
".",
"Following",
"a",
"40-year",
"hiatus",
"in",
"discovering",
"new",
"classes",
"of",
"antibacterial",
"compounds",
",",
"four",
"new",
"classes",
"of",
"antibacterial",
"antibiotics",
"have",
"been",
"brought",
"into",
"clinical",
"use",
"in",
"the",
"late",
"2000s",
"and",
"early",
"2010s",
":",
"cyclic",
"lipopeptides",
"(",
"such",
"as",
"daptomycin",
")",
",",
"glycylcyclines",
"(",
"such",
"as",
"tigecycline",
")",
",",
"oxazolidinones",
"(",
"such",
"as",
"linezolid",
")",
",",
"and",
"lipiarmycins",
"(",
"such",
"as",
"fidaxomicin",
")",
"."
],
"offsets": [
0,
14,
26,
30,
39,
50,
56,
59,
65,
75,
78,
84,
86,
95,
104,
106,
109,
118,
121,
129,
131,
136,
143,
153,
163,
166,
173,
182,
184,
190,
195,
202,
206,
216,
221,
226,
227,
239,
243,
257,
259,
262,
266,
271,
280,
281,
291,
292,
294,
297,
307,
312,
322,
332,
340,
341,
351,
353,
365,
367,
377,
379,
383,
395,
397,
402,
415,
425,
427,
433,
438,
445,
453,
463,
464,
474,
476,
489,
493,
506,
508,
512,
520,
535,
536,
541,
545,
555,
558,
571,
586,
587,
589,
597,
612,
615,
621,
624,
630,
637,
648,
650,
651,
657,
658,
666,
668,
682,
694,
701,
710,
716,
719,
727,
729,
734,
737,
741,
742,
751,
754,
758,
759,
768,
776,
778,
786,
791,
792,
801,
813,
820,
822,
827,
833,
836,
844,
846,
856,
858,
866,
873,
876,
888,
892,
900,
903,
917,
926,
928,
933,
937,
945,
948,
962,
974,
979,
984,
992,
997,
1006,
1010,
1013,
1017,
1022,
1028,
1032,
1038,
1043,
1045,
1052,
1065,
1066,
1071,
1074,
1084,
1085,
1087,
1102,
1103,
1108,
1111,
1122,
1123,
1125,
1140,
1141,
1146,
1149,
1158,
1159,
1161,
1165,
1178,
1179,
1184,
1187,
1198,
1199
]
} | 26f3c5105ee44aaeb150ae1221347356 | How many new classes of antibacterial antibiotics was introduced in the late 2000's/ | {
"tokens": [
"How",
"many",
"new",
"classes",
"of",
"antibacterial",
"antibiotics",
"was",
"introduced",
"in",
"the",
"late",
"2000's/"
],
"offsets": [
0,
4,
9,
13,
21,
24,
38,
50,
54,
65,
68,
72,
77
]
} | {
"text": [
"four"
],
"char_spans": [
{
"start": [
928
],
"end": [
931
]
}
],
"token_spans": [
{
"start": [
149
],
"end": [
149
]
}
]
} | [
"four"
] |
SQuAD | Antibacterial antibiotics are commonly classified based on their mechanism of action, chemical structure, or spectrum of activity. Most target bacterial functions or growth processes. Those that target the bacterial cell wall (penicillins and cephalosporins) or the cell membrane (polymyxins), or interfere with essential bacterial enzymes (rifamycins, lipiarmycins, quinolones, and sulfonamides) have bactericidal activities. Those that target protein synthesis (macrolides, lincosamides and tetracyclines) are usually bacteriostatic (with the exception of bactericidal aminoglycosides). Further categorization is based on their target specificity. "Narrow-spectrum" antibacterial antibiotics target specific types of bacteria, such as Gram-negative or Gram-positive bacteria, whereas broad-spectrum antibiotics affect a wide range of bacteria. Following a 40-year hiatus in discovering new classes of antibacterial compounds, four new classes of antibacterial antibiotics have been brought into clinical use in the late 2000s and early 2010s: cyclic lipopeptides (such as daptomycin), glycylcyclines (such as tigecycline), oxazolidinones (such as linezolid), and lipiarmycins (such as fidaxomicin). | {
"tokens": [
"Antibacterial",
"antibiotics",
"are",
"commonly",
"classified",
"based",
"on",
"their",
"mechanism",
"of",
"action",
",",
"chemical",
"structure",
",",
"or",
"spectrum",
"of",
"activity",
".",
"Most",
"target",
"bacterial",
"functions",
"or",
"growth",
"processes",
".",
"Those",
"that",
"target",
"the",
"bacterial",
"cell",
"wall",
"(",
"penicillins",
"and",
"cephalosporins",
")",
"or",
"the",
"cell",
"membrane",
"(",
"polymyxins",
")",
",",
"or",
"interfere",
"with",
"essential",
"bacterial",
"enzymes",
"(",
"rifamycins",
",",
"lipiarmycins",
",",
"quinolones",
",",
"and",
"sulfonamides",
")",
"have",
"bactericidal",
"activities",
".",
"Those",
"that",
"target",
"protein",
"synthesis",
"(",
"macrolides",
",",
"lincosamides",
"and",
"tetracyclines",
")",
"are",
"usually",
"bacteriostatic",
"(",
"with",
"the",
"exception",
"of",
"bactericidal",
"aminoglycosides",
")",
".",
"Further",
"categorization",
"is",
"based",
"on",
"their",
"target",
"specificity",
".",
"\"",
"Narrow",
"-",
"spectrum",
"\"",
"antibacterial",
"antibiotics",
"target",
"specific",
"types",
"of",
"bacteria",
",",
"such",
"as",
"Gram",
"-",
"negative",
"or",
"Gram",
"-",
"positive",
"bacteria",
",",
"whereas",
"broad",
"-",
"spectrum",
"antibiotics",
"affect",
"a",
"wide",
"range",
"of",
"bacteria",
".",
"Following",
"a",
"40-year",
"hiatus",
"in",
"discovering",
"new",
"classes",
"of",
"antibacterial",
"compounds",
",",
"four",
"new",
"classes",
"of",
"antibacterial",
"antibiotics",
"have",
"been",
"brought",
"into",
"clinical",
"use",
"in",
"the",
"late",
"2000s",
"and",
"early",
"2010s",
":",
"cyclic",
"lipopeptides",
"(",
"such",
"as",
"daptomycin",
")",
",",
"glycylcyclines",
"(",
"such",
"as",
"tigecycline",
")",
",",
"oxazolidinones",
"(",
"such",
"as",
"linezolid",
")",
",",
"and",
"lipiarmycins",
"(",
"such",
"as",
"fidaxomicin",
")",
"."
],
"offsets": [
0,
14,
26,
30,
39,
50,
56,
59,
65,
75,
78,
84,
86,
95,
104,
106,
109,
118,
121,
129,
131,
136,
143,
153,
163,
166,
173,
182,
184,
190,
195,
202,
206,
216,
221,
226,
227,
239,
243,
257,
259,
262,
266,
271,
280,
281,
291,
292,
294,
297,
307,
312,
322,
332,
340,
341,
351,
353,
365,
367,
377,
379,
383,
395,
397,
402,
415,
425,
427,
433,
438,
445,
453,
463,
464,
474,
476,
489,
493,
506,
508,
512,
520,
535,
536,
541,
545,
555,
558,
571,
586,
587,
589,
597,
612,
615,
621,
624,
630,
637,
648,
650,
651,
657,
658,
666,
668,
682,
694,
701,
710,
716,
719,
727,
729,
734,
737,
741,
742,
751,
754,
758,
759,
768,
776,
778,
786,
791,
792,
801,
813,
820,
822,
827,
833,
836,
844,
846,
856,
858,
866,
873,
876,
888,
892,
900,
903,
917,
926,
928,
933,
937,
945,
948,
962,
974,
979,
984,
992,
997,
1006,
1010,
1013,
1017,
1022,
1028,
1032,
1038,
1043,
1045,
1052,
1065,
1066,
1071,
1074,
1084,
1085,
1087,
1102,
1103,
1108,
1111,
1122,
1123,
1125,
1140,
1141,
1146,
1149,
1158,
1159,
1161,
1165,
1178,
1179,
1184,
1187,
1198,
1199
]
} | ec800b659f0846adac47f7e7fefdc921 | What three ways are antibiotics classified? | {
"tokens": [
"What",
"three",
"ways",
"are",
"antibiotics",
"classified",
"?"
],
"offsets": [
0,
5,
11,
16,
20,
32,
42
]
} | {
"text": [
"mechanism of action, chemical structure, or spectrum of activity"
],
"char_spans": [
{
"start": [
65
],
"end": [
128
]
}
],
"token_spans": [
{
"start": [
8
],
"end": [
18
]
}
]
} | [
"mechanism of action, chemical structure, or spectrum of activity"
] |
SQuAD | The emergence of antibiotic resistance has prompted restrictions on their use in the UK in 1970 (Swann report 1969), and the EU has banned the use of antibiotics as growth-promotional agents since 2003. Moreover, several organizations (e.g., The American Society for Microbiology (ASM), American Public Health Association (APHA) and the American Medical Association (AMA)) have called for restrictions on antibiotic use in food animal production and an end to all nontherapeutic uses.[citation needed] However, commonly there are delays in regulatory and legislative actions to limit the use of antibiotics, attributable partly to resistance against such regulation by industries using or selling antibiotics, and to the time required for research to test causal links between their use and resistance to them. Two federal bills (S.742 and H.R. 2562) aimed at phasing out nontherapeutic use of antibiotics in US food animals were proposed, but have not passed. These bills were endorsed by public health and medical organizations, including the American Holistic Nurses' Association, the American Medical Association, and the American Public Health Association (APHA). | {
"tokens": [
"The",
"emergence",
"of",
"antibiotic",
"resistance",
"has",
"prompted",
"restrictions",
"on",
"their",
"use",
"in",
"the",
"UK",
"in",
"1970",
"(",
"Swann",
"report",
"1969",
")",
",",
"and",
"the",
"EU",
"has",
"banned",
"the",
"use",
"of",
"antibiotics",
"as",
"growth",
"-",
"promotional",
"agents",
"since",
"2003",
".",
"Moreover",
",",
"several",
"organizations",
"(",
"e.g.",
",",
"The",
"American",
"Society",
"for",
"Microbiology",
"(",
"ASM",
")",
",",
"American",
"Public",
"Health",
"Association",
"(",
"APHA",
")",
"and",
"the",
"American",
"Medical",
"Association",
"(",
"AMA",
")",
")",
"have",
"called",
"for",
"restrictions",
"on",
"antibiotic",
"use",
"in",
"food",
"animal",
"production",
"and",
"an",
"end",
"to",
"all",
"nontherapeutic",
"uses.[citation",
"needed",
"]",
"However",
",",
"commonly",
"there",
"are",
"delays",
"in",
"regulatory",
"and",
"legislative",
"actions",
"to",
"limit",
"the",
"use",
"of",
"antibiotics",
",",
"attributable",
"partly",
"to",
"resistance",
"against",
"such",
"regulation",
"by",
"industries",
"using",
"or",
"selling",
"antibiotics",
",",
"and",
"to",
"the",
"time",
"required",
"for",
"research",
"to",
"test",
"causal",
"links",
"between",
"their",
"use",
"and",
"resistance",
"to",
"them",
".",
"Two",
"federal",
"bills",
"(",
"S.742",
"and",
"H.R.",
"2562",
")",
"aimed",
"at",
"phasing",
"out",
"nontherapeutic",
"use",
"of",
"antibiotics",
"in",
"US",
"food",
"animals",
"were",
"proposed",
",",
"but",
"have",
"not",
"passed",
".",
"These",
"bills",
"were",
"endorsed",
"by",
"public",
"health",
"and",
"medical",
"organizations",
",",
"including",
"the",
"American",
"Holistic",
"Nurses",
"'",
"Association",
",",
"the",
"American",
"Medical",
"Association",
",",
"and",
"the",
"American",
"Public",
"Health",
"Association",
"(",
"APHA",
")",
"."
],
"offsets": [
0,
4,
14,
17,
28,
39,
43,
52,
65,
68,
74,
78,
81,
85,
88,
91,
96,
97,
103,
110,
114,
115,
117,
121,
125,
128,
132,
139,
143,
147,
150,
162,
165,
171,
172,
184,
191,
197,
201,
203,
211,
213,
221,
235,
236,
240,
242,
246,
255,
263,
267,
280,
281,
284,
285,
287,
296,
303,
310,
322,
323,
327,
329,
333,
337,
346,
354,
366,
367,
370,
371,
373,
378,
385,
389,
402,
405,
416,
420,
423,
428,
435,
446,
450,
453,
457,
460,
464,
479,
494,
500,
502,
509,
511,
520,
526,
530,
537,
540,
551,
555,
567,
575,
578,
584,
588,
592,
595,
606,
608,
621,
628,
631,
642,
650,
655,
666,
669,
680,
686,
689,
697,
708,
710,
714,
717,
721,
726,
735,
739,
748,
751,
756,
763,
769,
777,
783,
787,
791,
802,
805,
809,
811,
815,
823,
829,
830,
836,
840,
845,
849,
851,
857,
860,
868,
872,
887,
891,
894,
906,
909,
912,
917,
925,
930,
938,
940,
944,
949,
953,
959,
961,
967,
973,
978,
987,
990,
997,
1004,
1008,
1016,
1029,
1031,
1041,
1045,
1054,
1063,
1069,
1071,
1082,
1084,
1088,
1097,
1105,
1116,
1118,
1122,
1126,
1135,
1142,
1149,
1161,
1162,
1166,
1167
]
} | 604e8d470e6d41408d7881c5d7b36425 | When did the EU ban antibiotics for speeding up growth? | {
"tokens": [
"When",
"did",
"the",
"EU",
"ban",
"antibiotics",
"for",
"speeding",
"up",
"growth",
"?"
],
"offsets": [
0,
5,
9,
13,
16,
20,
32,
36,
45,
48,
54
]
} | {
"text": [
"2003"
],
"char_spans": [
{
"start": [
197
],
"end": [
200
]
}
],
"token_spans": [
{
"start": [
37
],
"end": [
37
]
}
]
} | [
"2003"
] |
SQuAD | The emergence of antibiotic resistance has prompted restrictions on their use in the UK in 1970 (Swann report 1969), and the EU has banned the use of antibiotics as growth-promotional agents since 2003. Moreover, several organizations (e.g., The American Society for Microbiology (ASM), American Public Health Association (APHA) and the American Medical Association (AMA)) have called for restrictions on antibiotic use in food animal production and an end to all nontherapeutic uses.[citation needed] However, commonly there are delays in regulatory and legislative actions to limit the use of antibiotics, attributable partly to resistance against such regulation by industries using or selling antibiotics, and to the time required for research to test causal links between their use and resistance to them. Two federal bills (S.742 and H.R. 2562) aimed at phasing out nontherapeutic use of antibiotics in US food animals were proposed, but have not passed. These bills were endorsed by public health and medical organizations, including the American Holistic Nurses' Association, the American Medical Association, and the American Public Health Association (APHA). | {
"tokens": [
"The",
"emergence",
"of",
"antibiotic",
"resistance",
"has",
"prompted",
"restrictions",
"on",
"their",
"use",
"in",
"the",
"UK",
"in",
"1970",
"(",
"Swann",
"report",
"1969",
")",
",",
"and",
"the",
"EU",
"has",
"banned",
"the",
"use",
"of",
"antibiotics",
"as",
"growth",
"-",
"promotional",
"agents",
"since",
"2003",
".",
"Moreover",
",",
"several",
"organizations",
"(",
"e.g.",
",",
"The",
"American",
"Society",
"for",
"Microbiology",
"(",
"ASM",
")",
",",
"American",
"Public",
"Health",
"Association",
"(",
"APHA",
")",
"and",
"the",
"American",
"Medical",
"Association",
"(",
"AMA",
")",
")",
"have",
"called",
"for",
"restrictions",
"on",
"antibiotic",
"use",
"in",
"food",
"animal",
"production",
"and",
"an",
"end",
"to",
"all",
"nontherapeutic",
"uses.[citation",
"needed",
"]",
"However",
",",
"commonly",
"there",
"are",
"delays",
"in",
"regulatory",
"and",
"legislative",
"actions",
"to",
"limit",
"the",
"use",
"of",
"antibiotics",
",",
"attributable",
"partly",
"to",
"resistance",
"against",
"such",
"regulation",
"by",
"industries",
"using",
"or",
"selling",
"antibiotics",
",",
"and",
"to",
"the",
"time",
"required",
"for",
"research",
"to",
"test",
"causal",
"links",
"between",
"their",
"use",
"and",
"resistance",
"to",
"them",
".",
"Two",
"federal",
"bills",
"(",
"S.742",
"and",
"H.R.",
"2562",
")",
"aimed",
"at",
"phasing",
"out",
"nontherapeutic",
"use",
"of",
"antibiotics",
"in",
"US",
"food",
"animals",
"were",
"proposed",
",",
"but",
"have",
"not",
"passed",
".",
"These",
"bills",
"were",
"endorsed",
"by",
"public",
"health",
"and",
"medical",
"organizations",
",",
"including",
"the",
"American",
"Holistic",
"Nurses",
"'",
"Association",
",",
"the",
"American",
"Medical",
"Association",
",",
"and",
"the",
"American",
"Public",
"Health",
"Association",
"(",
"APHA",
")",
"."
],
"offsets": [
0,
4,
14,
17,
28,
39,
43,
52,
65,
68,
74,
78,
81,
85,
88,
91,
96,
97,
103,
110,
114,
115,
117,
121,
125,
128,
132,
139,
143,
147,
150,
162,
165,
171,
172,
184,
191,
197,
201,
203,
211,
213,
221,
235,
236,
240,
242,
246,
255,
263,
267,
280,
281,
284,
285,
287,
296,
303,
310,
322,
323,
327,
329,
333,
337,
346,
354,
366,
367,
370,
371,
373,
378,
385,
389,
402,
405,
416,
420,
423,
428,
435,
446,
450,
453,
457,
460,
464,
479,
494,
500,
502,
509,
511,
520,
526,
530,
537,
540,
551,
555,
567,
575,
578,
584,
588,
592,
595,
606,
608,
621,
628,
631,
642,
650,
655,
666,
669,
680,
686,
689,
697,
708,
710,
714,
717,
721,
726,
735,
739,
748,
751,
756,
763,
769,
777,
783,
787,
791,
802,
805,
809,
811,
815,
823,
829,
830,
836,
840,
845,
849,
851,
857,
860,
868,
872,
887,
891,
894,
906,
909,
912,
917,
925,
930,
938,
940,
944,
949,
953,
959,
961,
967,
973,
978,
987,
990,
997,
1004,
1008,
1016,
1029,
1031,
1041,
1045,
1054,
1063,
1069,
1071,
1082,
1084,
1088,
1097,
1105,
1116,
1118,
1122,
1126,
1135,
1142,
1149,
1161,
1162,
1166,
1167
]
} | 963996cdb7194012a8dd9278c9332822 | What report caused the UK to worry about resistance? | {
"tokens": [
"What",
"report",
"caused",
"the",
"UK",
"to",
"worry",
"about",
"resistance",
"?"
],
"offsets": [
0,
5,
12,
19,
23,
26,
29,
35,
41,
51
]
} | {
"text": [
"Swann report 1969"
],
"char_spans": [
{
"start": [
97
],
"end": [
113
]
}
],
"token_spans": [
{
"start": [
17
],
"end": [
19
]
}
]
} | [
"Swann report 1969"
] |
SQuAD | The emergence of antibiotic resistance has prompted restrictions on their use in the UK in 1970 (Swann report 1969), and the EU has banned the use of antibiotics as growth-promotional agents since 2003. Moreover, several organizations (e.g., The American Society for Microbiology (ASM), American Public Health Association (APHA) and the American Medical Association (AMA)) have called for restrictions on antibiotic use in food animal production and an end to all nontherapeutic uses.[citation needed] However, commonly there are delays in regulatory and legislative actions to limit the use of antibiotics, attributable partly to resistance against such regulation by industries using or selling antibiotics, and to the time required for research to test causal links between their use and resistance to them. Two federal bills (S.742 and H.R. 2562) aimed at phasing out nontherapeutic use of antibiotics in US food animals were proposed, but have not passed. These bills were endorsed by public health and medical organizations, including the American Holistic Nurses' Association, the American Medical Association, and the American Public Health Association (APHA). | {
"tokens": [
"The",
"emergence",
"of",
"antibiotic",
"resistance",
"has",
"prompted",
"restrictions",
"on",
"their",
"use",
"in",
"the",
"UK",
"in",
"1970",
"(",
"Swann",
"report",
"1969",
")",
",",
"and",
"the",
"EU",
"has",
"banned",
"the",
"use",
"of",
"antibiotics",
"as",
"growth",
"-",
"promotional",
"agents",
"since",
"2003",
".",
"Moreover",
",",
"several",
"organizations",
"(",
"e.g.",
",",
"The",
"American",
"Society",
"for",
"Microbiology",
"(",
"ASM",
")",
",",
"American",
"Public",
"Health",
"Association",
"(",
"APHA",
")",
"and",
"the",
"American",
"Medical",
"Association",
"(",
"AMA",
")",
")",
"have",
"called",
"for",
"restrictions",
"on",
"antibiotic",
"use",
"in",
"food",
"animal",
"production",
"and",
"an",
"end",
"to",
"all",
"nontherapeutic",
"uses.[citation",
"needed",
"]",
"However",
",",
"commonly",
"there",
"are",
"delays",
"in",
"regulatory",
"and",
"legislative",
"actions",
"to",
"limit",
"the",
"use",
"of",
"antibiotics",
",",
"attributable",
"partly",
"to",
"resistance",
"against",
"such",
"regulation",
"by",
"industries",
"using",
"or",
"selling",
"antibiotics",
",",
"and",
"to",
"the",
"time",
"required",
"for",
"research",
"to",
"test",
"causal",
"links",
"between",
"their",
"use",
"and",
"resistance",
"to",
"them",
".",
"Two",
"federal",
"bills",
"(",
"S.742",
"and",
"H.R.",
"2562",
")",
"aimed",
"at",
"phasing",
"out",
"nontherapeutic",
"use",
"of",
"antibiotics",
"in",
"US",
"food",
"animals",
"were",
"proposed",
",",
"but",
"have",
"not",
"passed",
".",
"These",
"bills",
"were",
"endorsed",
"by",
"public",
"health",
"and",
"medical",
"organizations",
",",
"including",
"the",
"American",
"Holistic",
"Nurses",
"'",
"Association",
",",
"the",
"American",
"Medical",
"Association",
",",
"and",
"the",
"American",
"Public",
"Health",
"Association",
"(",
"APHA",
")",
"."
],
"offsets": [
0,
4,
14,
17,
28,
39,
43,
52,
65,
68,
74,
78,
81,
85,
88,
91,
96,
97,
103,
110,
114,
115,
117,
121,
125,
128,
132,
139,
143,
147,
150,
162,
165,
171,
172,
184,
191,
197,
201,
203,
211,
213,
221,
235,
236,
240,
242,
246,
255,
263,
267,
280,
281,
284,
285,
287,
296,
303,
310,
322,
323,
327,
329,
333,
337,
346,
354,
366,
367,
370,
371,
373,
378,
385,
389,
402,
405,
416,
420,
423,
428,
435,
446,
450,
453,
457,
460,
464,
479,
494,
500,
502,
509,
511,
520,
526,
530,
537,
540,
551,
555,
567,
575,
578,
584,
588,
592,
595,
606,
608,
621,
628,
631,
642,
650,
655,
666,
669,
680,
686,
689,
697,
708,
710,
714,
717,
721,
726,
735,
739,
748,
751,
756,
763,
769,
777,
783,
787,
791,
802,
805,
809,
811,
815,
823,
829,
830,
836,
840,
845,
849,
851,
857,
860,
868,
872,
887,
891,
894,
906,
909,
912,
917,
925,
930,
938,
940,
944,
949,
953,
959,
961,
967,
973,
978,
987,
990,
997,
1004,
1008,
1016,
1029,
1031,
1041,
1045,
1054,
1063,
1069,
1071,
1082,
1084,
1088,
1097,
1105,
1116,
1118,
1122,
1126,
1135,
1142,
1149,
1161,
1162,
1166,
1167
]
} | fe4febfe24af40cfb0abec956b8a203c | What 3 US organizations have called for the banning of antibiotics in the production of food animals? | {
"tokens": [
"What",
"3",
"US",
"organizations",
"have",
"called",
"for",
"the",
"banning",
"of",
"antibiotics",
"in",
"the",
"production",
"of",
"food",
"animals",
"?"
],
"offsets": [
0,
5,
7,
10,
24,
29,
36,
40,
44,
52,
55,
67,
70,
74,
85,
88,
93,
100
]
} | {
"text": [
"American Society for Microbiology (ASM), American Public Health Association (APHA) and the American Medical Association (AMA)"
],
"char_spans": [
{
"start": [
246
],
"end": [
370
]
}
],
"token_spans": [
{
"start": [
47
],
"end": [
69
]
}
]
} | [
"American Society for Microbiology (ASM), American Public Health Association (APHA) and the American Medical Association (AMA)"
] |
SQuAD | The emergence of antibiotic resistance has prompted restrictions on their use in the UK in 1970 (Swann report 1969), and the EU has banned the use of antibiotics as growth-promotional agents since 2003. Moreover, several organizations (e.g., The American Society for Microbiology (ASM), American Public Health Association (APHA) and the American Medical Association (AMA)) have called for restrictions on antibiotic use in food animal production and an end to all nontherapeutic uses.[citation needed] However, commonly there are delays in regulatory and legislative actions to limit the use of antibiotics, attributable partly to resistance against such regulation by industries using or selling antibiotics, and to the time required for research to test causal links between their use and resistance to them. Two federal bills (S.742 and H.R. 2562) aimed at phasing out nontherapeutic use of antibiotics in US food animals were proposed, but have not passed. These bills were endorsed by public health and medical organizations, including the American Holistic Nurses' Association, the American Medical Association, and the American Public Health Association (APHA). | {
"tokens": [
"The",
"emergence",
"of",
"antibiotic",
"resistance",
"has",
"prompted",
"restrictions",
"on",
"their",
"use",
"in",
"the",
"UK",
"in",
"1970",
"(",
"Swann",
"report",
"1969",
")",
",",
"and",
"the",
"EU",
"has",
"banned",
"the",
"use",
"of",
"antibiotics",
"as",
"growth",
"-",
"promotional",
"agents",
"since",
"2003",
".",
"Moreover",
",",
"several",
"organizations",
"(",
"e.g.",
",",
"The",
"American",
"Society",
"for",
"Microbiology",
"(",
"ASM",
")",
",",
"American",
"Public",
"Health",
"Association",
"(",
"APHA",
")",
"and",
"the",
"American",
"Medical",
"Association",
"(",
"AMA",
")",
")",
"have",
"called",
"for",
"restrictions",
"on",
"antibiotic",
"use",
"in",
"food",
"animal",
"production",
"and",
"an",
"end",
"to",
"all",
"nontherapeutic",
"uses.[citation",
"needed",
"]",
"However",
",",
"commonly",
"there",
"are",
"delays",
"in",
"regulatory",
"and",
"legislative",
"actions",
"to",
"limit",
"the",
"use",
"of",
"antibiotics",
",",
"attributable",
"partly",
"to",
"resistance",
"against",
"such",
"regulation",
"by",
"industries",
"using",
"or",
"selling",
"antibiotics",
",",
"and",
"to",
"the",
"time",
"required",
"for",
"research",
"to",
"test",
"causal",
"links",
"between",
"their",
"use",
"and",
"resistance",
"to",
"them",
".",
"Two",
"federal",
"bills",
"(",
"S.742",
"and",
"H.R.",
"2562",
")",
"aimed",
"at",
"phasing",
"out",
"nontherapeutic",
"use",
"of",
"antibiotics",
"in",
"US",
"food",
"animals",
"were",
"proposed",
",",
"but",
"have",
"not",
"passed",
".",
"These",
"bills",
"were",
"endorsed",
"by",
"public",
"health",
"and",
"medical",
"organizations",
",",
"including",
"the",
"American",
"Holistic",
"Nurses",
"'",
"Association",
",",
"the",
"American",
"Medical",
"Association",
",",
"and",
"the",
"American",
"Public",
"Health",
"Association",
"(",
"APHA",
")",
"."
],
"offsets": [
0,
4,
14,
17,
28,
39,
43,
52,
65,
68,
74,
78,
81,
85,
88,
91,
96,
97,
103,
110,
114,
115,
117,
121,
125,
128,
132,
139,
143,
147,
150,
162,
165,
171,
172,
184,
191,
197,
201,
203,
211,
213,
221,
235,
236,
240,
242,
246,
255,
263,
267,
280,
281,
284,
285,
287,
296,
303,
310,
322,
323,
327,
329,
333,
337,
346,
354,
366,
367,
370,
371,
373,
378,
385,
389,
402,
405,
416,
420,
423,
428,
435,
446,
450,
453,
457,
460,
464,
479,
494,
500,
502,
509,
511,
520,
526,
530,
537,
540,
551,
555,
567,
575,
578,
584,
588,
592,
595,
606,
608,
621,
628,
631,
642,
650,
655,
666,
669,
680,
686,
689,
697,
708,
710,
714,
717,
721,
726,
735,
739,
748,
751,
756,
763,
769,
777,
783,
787,
791,
802,
805,
809,
811,
815,
823,
829,
830,
836,
840,
845,
849,
851,
857,
860,
868,
872,
887,
891,
894,
906,
909,
912,
917,
925,
930,
938,
940,
944,
949,
953,
959,
961,
967,
973,
978,
987,
990,
997,
1004,
1008,
1016,
1029,
1031,
1041,
1045,
1054,
1063,
1069,
1071,
1082,
1084,
1088,
1097,
1105,
1116,
1118,
1122,
1126,
1135,
1142,
1149,
1161,
1162,
1166,
1167
]
} | 1f061522330148178134328621424358 | Name two US bills that want to ban antibiotics in food production? | {
"tokens": [
"Name",
"two",
"US",
"bills",
"that",
"want",
"to",
"ban",
"antibiotics",
"in",
"food",
"production",
"?"
],
"offsets": [
0,
5,
9,
12,
18,
23,
28,
31,
35,
47,
50,
55,
65
]
} | {
"text": [
"S.742 and H.R. 2562"
],
"char_spans": [
{
"start": [
830
],
"end": [
848
]
}
],
"token_spans": [
{
"start": [
146
],
"end": [
149
]
}
]
} | [
"S.742 and H.R. 2562"
] |
SQuAD | The emergence of antibiotic resistance has prompted restrictions on their use in the UK in 1970 (Swann report 1969), and the EU has banned the use of antibiotics as growth-promotional agents since 2003. Moreover, several organizations (e.g., The American Society for Microbiology (ASM), American Public Health Association (APHA) and the American Medical Association (AMA)) have called for restrictions on antibiotic use in food animal production and an end to all nontherapeutic uses.[citation needed] However, commonly there are delays in regulatory and legislative actions to limit the use of antibiotics, attributable partly to resistance against such regulation by industries using or selling antibiotics, and to the time required for research to test causal links between their use and resistance to them. Two federal bills (S.742 and H.R. 2562) aimed at phasing out nontherapeutic use of antibiotics in US food animals were proposed, but have not passed. These bills were endorsed by public health and medical organizations, including the American Holistic Nurses' Association, the American Medical Association, and the American Public Health Association (APHA). | {
"tokens": [
"The",
"emergence",
"of",
"antibiotic",
"resistance",
"has",
"prompted",
"restrictions",
"on",
"their",
"use",
"in",
"the",
"UK",
"in",
"1970",
"(",
"Swann",
"report",
"1969",
")",
",",
"and",
"the",
"EU",
"has",
"banned",
"the",
"use",
"of",
"antibiotics",
"as",
"growth",
"-",
"promotional",
"agents",
"since",
"2003",
".",
"Moreover",
",",
"several",
"organizations",
"(",
"e.g.",
",",
"The",
"American",
"Society",
"for",
"Microbiology",
"(",
"ASM",
")",
",",
"American",
"Public",
"Health",
"Association",
"(",
"APHA",
")",
"and",
"the",
"American",
"Medical",
"Association",
"(",
"AMA",
")",
")",
"have",
"called",
"for",
"restrictions",
"on",
"antibiotic",
"use",
"in",
"food",
"animal",
"production",
"and",
"an",
"end",
"to",
"all",
"nontherapeutic",
"uses.[citation",
"needed",
"]",
"However",
",",
"commonly",
"there",
"are",
"delays",
"in",
"regulatory",
"and",
"legislative",
"actions",
"to",
"limit",
"the",
"use",
"of",
"antibiotics",
",",
"attributable",
"partly",
"to",
"resistance",
"against",
"such",
"regulation",
"by",
"industries",
"using",
"or",
"selling",
"antibiotics",
",",
"and",
"to",
"the",
"time",
"required",
"for",
"research",
"to",
"test",
"causal",
"links",
"between",
"their",
"use",
"and",
"resistance",
"to",
"them",
".",
"Two",
"federal",
"bills",
"(",
"S.742",
"and",
"H.R.",
"2562",
")",
"aimed",
"at",
"phasing",
"out",
"nontherapeutic",
"use",
"of",
"antibiotics",
"in",
"US",
"food",
"animals",
"were",
"proposed",
",",
"but",
"have",
"not",
"passed",
".",
"These",
"bills",
"were",
"endorsed",
"by",
"public",
"health",
"and",
"medical",
"organizations",
",",
"including",
"the",
"American",
"Holistic",
"Nurses",
"'",
"Association",
",",
"the",
"American",
"Medical",
"Association",
",",
"and",
"the",
"American",
"Public",
"Health",
"Association",
"(",
"APHA",
")",
"."
],
"offsets": [
0,
4,
14,
17,
28,
39,
43,
52,
65,
68,
74,
78,
81,
85,
88,
91,
96,
97,
103,
110,
114,
115,
117,
121,
125,
128,
132,
139,
143,
147,
150,
162,
165,
171,
172,
184,
191,
197,
201,
203,
211,
213,
221,
235,
236,
240,
242,
246,
255,
263,
267,
280,
281,
284,
285,
287,
296,
303,
310,
322,
323,
327,
329,
333,
337,
346,
354,
366,
367,
370,
371,
373,
378,
385,
389,
402,
405,
416,
420,
423,
428,
435,
446,
450,
453,
457,
460,
464,
479,
494,
500,
502,
509,
511,
520,
526,
530,
537,
540,
551,
555,
567,
575,
578,
584,
588,
592,
595,
606,
608,
621,
628,
631,
642,
650,
655,
666,
669,
680,
686,
689,
697,
708,
710,
714,
717,
721,
726,
735,
739,
748,
751,
756,
763,
769,
777,
783,
787,
791,
802,
805,
809,
811,
815,
823,
829,
830,
836,
840,
845,
849,
851,
857,
860,
868,
872,
887,
891,
894,
906,
909,
912,
917,
925,
930,
938,
940,
944,
949,
953,
959,
961,
967,
973,
978,
987,
990,
997,
1004,
1008,
1016,
1029,
1031,
1041,
1045,
1054,
1063,
1069,
1071,
1082,
1084,
1088,
1097,
1105,
1116,
1118,
1122,
1126,
1135,
1142,
1149,
1161,
1162,
1166,
1167
]
} | 8d31e152d7e949fb9ab39e2c1d8e5ec2 | What 3 medical associations supported the bills? | {
"tokens": [
"What",
"3",
"medical",
"associations",
"supported",
"the",
"bills",
"?"
],
"offsets": [
0,
5,
7,
15,
28,
38,
42,
47
]
} | {
"text": [
"American Holistic Nurses' Association, the American Medical Association, and the American Public Health Association (APHA)"
],
"char_spans": [
{
"start": [
1045
],
"end": [
1166
]
}
],
"token_spans": [
{
"start": [
184
],
"end": [
203
]
}
]
} | [
"American Holistic Nurses' Association, the American Medical Association, and the American Public Health Association (APHA)"
] |
SQuAD | In 1939, coinciding with the start of World War II, Rene Dubos reported the discovery of the first naturally derived antibiotic, tyrothricin, a compound of 20% gramicidin and 80% tyrocidine, from B. brevis. It was one of the first commercially manufactured antibiotics universally and was very effective in treating wounds and ulcers during World War II. Gramicidin, however, could not be used systemically because of toxicity. Tyrocidine also proved too toxic for systemic usage. Research results obtained during that period were not shared between the Axis and the Allied powers during the war. | {
"tokens": [
"In",
"1939",
",",
"coinciding",
"with",
"the",
"start",
"of",
"World",
"War",
"II",
",",
"Rene",
"Dubos",
"reported",
"the",
"discovery",
"of",
"the",
"first",
"naturally",
"derived",
"antibiotic",
",",
"tyrothricin",
",",
"a",
"compound",
"of",
"20",
"%",
"gramicidin",
"and",
"80",
"%",
"tyrocidine",
",",
"from",
"B.",
"brevis",
".",
"It",
"was",
"one",
"of",
"the",
"first",
"commercially",
"manufactured",
"antibiotics",
"universally",
"and",
"was",
"very",
"effective",
"in",
"treating",
"wounds",
"and",
"ulcers",
"during",
"World",
"War",
"II",
".",
"Gramicidin",
",",
"however",
",",
"could",
"not",
"be",
"used",
"systemically",
"because",
"of",
"toxicity",
".",
"Tyrocidine",
"also",
"proved",
"too",
"toxic",
"for",
"systemic",
"usage",
".",
"Research",
"results",
"obtained",
"during",
"that",
"period",
"were",
"not",
"shared",
"between",
"the",
"Axis",
"and",
"the",
"Allied",
"powers",
"during",
"the",
"war",
"."
],
"offsets": [
0,
3,
7,
9,
20,
25,
29,
35,
38,
44,
48,
50,
52,
57,
63,
72,
76,
86,
89,
93,
99,
109,
117,
127,
129,
140,
142,
144,
153,
156,
158,
160,
171,
175,
177,
179,
189,
191,
196,
199,
205,
207,
210,
214,
218,
221,
225,
231,
244,
257,
269,
281,
285,
289,
294,
304,
307,
316,
323,
327,
334,
341,
347,
351,
353,
355,
365,
367,
374,
376,
382,
386,
389,
394,
407,
415,
418,
426,
428,
439,
444,
451,
455,
461,
465,
474,
479,
481,
490,
498,
507,
514,
519,
526,
531,
535,
542,
550,
554,
559,
563,
567,
574,
581,
588,
592,
595
]
} | bf0203b4f2014d28bd3dc3bfebd92f7e | What was the first antibiotic developed from nature? | {
"tokens": [
"What",
"was",
"the",
"first",
"antibiotic",
"developed",
"from",
"nature",
"?"
],
"offsets": [
0,
5,
9,
13,
19,
30,
40,
45,
51
]
} | {
"text": [
"tyrothricin"
],
"char_spans": [
{
"start": [
129
],
"end": [
139
]
}
],
"token_spans": [
{
"start": [
24
],
"end": [
24
]
}
]
} | [
"tyrothricin"
] |
SQuAD | In 1939, coinciding with the start of World War II, Rene Dubos reported the discovery of the first naturally derived antibiotic, tyrothricin, a compound of 20% gramicidin and 80% tyrocidine, from B. brevis. It was one of the first commercially manufactured antibiotics universally and was very effective in treating wounds and ulcers during World War II. Gramicidin, however, could not be used systemically because of toxicity. Tyrocidine also proved too toxic for systemic usage. Research results obtained during that period were not shared between the Axis and the Allied powers during the war. | {
"tokens": [
"In",
"1939",
",",
"coinciding",
"with",
"the",
"start",
"of",
"World",
"War",
"II",
",",
"Rene",
"Dubos",
"reported",
"the",
"discovery",
"of",
"the",
"first",
"naturally",
"derived",
"antibiotic",
",",
"tyrothricin",
",",
"a",
"compound",
"of",
"20",
"%",
"gramicidin",
"and",
"80",
"%",
"tyrocidine",
",",
"from",
"B.",
"brevis",
".",
"It",
"was",
"one",
"of",
"the",
"first",
"commercially",
"manufactured",
"antibiotics",
"universally",
"and",
"was",
"very",
"effective",
"in",
"treating",
"wounds",
"and",
"ulcers",
"during",
"World",
"War",
"II",
".",
"Gramicidin",
",",
"however",
",",
"could",
"not",
"be",
"used",
"systemically",
"because",
"of",
"toxicity",
".",
"Tyrocidine",
"also",
"proved",
"too",
"toxic",
"for",
"systemic",
"usage",
".",
"Research",
"results",
"obtained",
"during",
"that",
"period",
"were",
"not",
"shared",
"between",
"the",
"Axis",
"and",
"the",
"Allied",
"powers",
"during",
"the",
"war",
"."
],
"offsets": [
0,
3,
7,
9,
20,
25,
29,
35,
38,
44,
48,
50,
52,
57,
63,
72,
76,
86,
89,
93,
99,
109,
117,
127,
129,
140,
142,
144,
153,
156,
158,
160,
171,
175,
177,
179,
189,
191,
196,
199,
205,
207,
210,
214,
218,
221,
225,
231,
244,
257,
269,
281,
285,
289,
294,
304,
307,
316,
323,
327,
334,
341,
347,
351,
353,
355,
365,
367,
374,
376,
382,
386,
389,
394,
407,
415,
418,
426,
428,
439,
444,
451,
455,
461,
465,
474,
479,
481,
490,
498,
507,
514,
519,
526,
531,
535,
542,
550,
554,
559,
563,
567,
574,
581,
588,
592,
595
]
} | b112d55853294e17916e4bc86fda07cd | When was tyrothricin created? | {
"tokens": [
"When",
"was",
"tyrothricin",
"created",
"?"
],
"offsets": [
0,
5,
9,
21,
28
]
} | {
"text": [
"1939"
],
"char_spans": [
{
"start": [
3
],
"end": [
6
]
}
],
"token_spans": [
{
"start": [
1
],
"end": [
1
]
}
]
} | [
"1939"
] |
SQuAD | In 1939, coinciding with the start of World War II, Rene Dubos reported the discovery of the first naturally derived antibiotic, tyrothricin, a compound of 20% gramicidin and 80% tyrocidine, from B. brevis. It was one of the first commercially manufactured antibiotics universally and was very effective in treating wounds and ulcers during World War II. Gramicidin, however, could not be used systemically because of toxicity. Tyrocidine also proved too toxic for systemic usage. Research results obtained during that period were not shared between the Axis and the Allied powers during the war. | {
"tokens": [
"In",
"1939",
",",
"coinciding",
"with",
"the",
"start",
"of",
"World",
"War",
"II",
",",
"Rene",
"Dubos",
"reported",
"the",
"discovery",
"of",
"the",
"first",
"naturally",
"derived",
"antibiotic",
",",
"tyrothricin",
",",
"a",
"compound",
"of",
"20",
"%",
"gramicidin",
"and",
"80",
"%",
"tyrocidine",
",",
"from",
"B.",
"brevis",
".",
"It",
"was",
"one",
"of",
"the",
"first",
"commercially",
"manufactured",
"antibiotics",
"universally",
"and",
"was",
"very",
"effective",
"in",
"treating",
"wounds",
"and",
"ulcers",
"during",
"World",
"War",
"II",
".",
"Gramicidin",
",",
"however",
",",
"could",
"not",
"be",
"used",
"systemically",
"because",
"of",
"toxicity",
".",
"Tyrocidine",
"also",
"proved",
"too",
"toxic",
"for",
"systemic",
"usage",
".",
"Research",
"results",
"obtained",
"during",
"that",
"period",
"were",
"not",
"shared",
"between",
"the",
"Axis",
"and",
"the",
"Allied",
"powers",
"during",
"the",
"war",
"."
],
"offsets": [
0,
3,
7,
9,
20,
25,
29,
35,
38,
44,
48,
50,
52,
57,
63,
72,
76,
86,
89,
93,
99,
109,
117,
127,
129,
140,
142,
144,
153,
156,
158,
160,
171,
175,
177,
179,
189,
191,
196,
199,
205,
207,
210,
214,
218,
221,
225,
231,
244,
257,
269,
281,
285,
289,
294,
304,
307,
316,
323,
327,
334,
341,
347,
351,
353,
355,
365,
367,
374,
376,
382,
386,
389,
394,
407,
415,
418,
426,
428,
439,
444,
451,
455,
461,
465,
474,
479,
481,
490,
498,
507,
514,
519,
526,
531,
535,
542,
550,
554,
559,
563,
567,
574,
581,
588,
592,
595
]
} | 4d6d5f2825224052a59809a189ac7f57 | What also happened in 1939 besides tyrothricin? | {
"tokens": [
"What",
"also",
"happened",
"in",
"1939",
"besides",
"tyrothricin",
"?"
],
"offsets": [
0,
5,
10,
19,
22,
27,
35,
46
]
} | {
"text": [
"start of World War II,"
],
"char_spans": [
{
"start": [
29
],
"end": [
50
]
}
],
"token_spans": [
{
"start": [
6
],
"end": [
11
]
}
]
} | [
"start of World War II,"
] |
SQuAD | In 1939, coinciding with the start of World War II, Rene Dubos reported the discovery of the first naturally derived antibiotic, tyrothricin, a compound of 20% gramicidin and 80% tyrocidine, from B. brevis. It was one of the first commercially manufactured antibiotics universally and was very effective in treating wounds and ulcers during World War II. Gramicidin, however, could not be used systemically because of toxicity. Tyrocidine also proved too toxic for systemic usage. Research results obtained during that period were not shared between the Axis and the Allied powers during the war. | {
"tokens": [
"In",
"1939",
",",
"coinciding",
"with",
"the",
"start",
"of",
"World",
"War",
"II",
",",
"Rene",
"Dubos",
"reported",
"the",
"discovery",
"of",
"the",
"first",
"naturally",
"derived",
"antibiotic",
",",
"tyrothricin",
",",
"a",
"compound",
"of",
"20",
"%",
"gramicidin",
"and",
"80",
"%",
"tyrocidine",
",",
"from",
"B.",
"brevis",
".",
"It",
"was",
"one",
"of",
"the",
"first",
"commercially",
"manufactured",
"antibiotics",
"universally",
"and",
"was",
"very",
"effective",
"in",
"treating",
"wounds",
"and",
"ulcers",
"during",
"World",
"War",
"II",
".",
"Gramicidin",
",",
"however",
",",
"could",
"not",
"be",
"used",
"systemically",
"because",
"of",
"toxicity",
".",
"Tyrocidine",
"also",
"proved",
"too",
"toxic",
"for",
"systemic",
"usage",
".",
"Research",
"results",
"obtained",
"during",
"that",
"period",
"were",
"not",
"shared",
"between",
"the",
"Axis",
"and",
"the",
"Allied",
"powers",
"during",
"the",
"war",
"."
],
"offsets": [
0,
3,
7,
9,
20,
25,
29,
35,
38,
44,
48,
50,
52,
57,
63,
72,
76,
86,
89,
93,
99,
109,
117,
127,
129,
140,
142,
144,
153,
156,
158,
160,
171,
175,
177,
179,
189,
191,
196,
199,
205,
207,
210,
214,
218,
221,
225,
231,
244,
257,
269,
281,
285,
289,
294,
304,
307,
316,
323,
327,
334,
341,
347,
351,
353,
355,
365,
367,
374,
376,
382,
386,
389,
394,
407,
415,
418,
426,
428,
439,
444,
451,
455,
461,
465,
474,
479,
481,
490,
498,
507,
514,
519,
526,
531,
535,
542,
550,
554,
559,
563,
567,
574,
581,
588,
592,
595
]
} | cfbc5bfdc58940af975af73d67c43db5 | Who discovered tyrothricin? | {
"tokens": [
"Who",
"discovered",
"tyrothricin",
"?"
],
"offsets": [
0,
4,
15,
26
]
} | {
"text": [
"Rene Dubos"
],
"char_spans": [
{
"start": [
52
],
"end": [
61
]
}
],
"token_spans": [
{
"start": [
12
],
"end": [
13
]
}
]
} | [
"Rene Dubos"
] |
SQuAD | In 1939, coinciding with the start of World War II, Rene Dubos reported the discovery of the first naturally derived antibiotic, tyrothricin, a compound of 20% gramicidin and 80% tyrocidine, from B. brevis. It was one of the first commercially manufactured antibiotics universally and was very effective in treating wounds and ulcers during World War II. Gramicidin, however, could not be used systemically because of toxicity. Tyrocidine also proved too toxic for systemic usage. Research results obtained during that period were not shared between the Axis and the Allied powers during the war. | {
"tokens": [
"In",
"1939",
",",
"coinciding",
"with",
"the",
"start",
"of",
"World",
"War",
"II",
",",
"Rene",
"Dubos",
"reported",
"the",
"discovery",
"of",
"the",
"first",
"naturally",
"derived",
"antibiotic",
",",
"tyrothricin",
",",
"a",
"compound",
"of",
"20",
"%",
"gramicidin",
"and",
"80",
"%",
"tyrocidine",
",",
"from",
"B.",
"brevis",
".",
"It",
"was",
"one",
"of",
"the",
"first",
"commercially",
"manufactured",
"antibiotics",
"universally",
"and",
"was",
"very",
"effective",
"in",
"treating",
"wounds",
"and",
"ulcers",
"during",
"World",
"War",
"II",
".",
"Gramicidin",
",",
"however",
",",
"could",
"not",
"be",
"used",
"systemically",
"because",
"of",
"toxicity",
".",
"Tyrocidine",
"also",
"proved",
"too",
"toxic",
"for",
"systemic",
"usage",
".",
"Research",
"results",
"obtained",
"during",
"that",
"period",
"were",
"not",
"shared",
"between",
"the",
"Axis",
"and",
"the",
"Allied",
"powers",
"during",
"the",
"war",
"."
],
"offsets": [
0,
3,
7,
9,
20,
25,
29,
35,
38,
44,
48,
50,
52,
57,
63,
72,
76,
86,
89,
93,
99,
109,
117,
127,
129,
140,
142,
144,
153,
156,
158,
160,
171,
175,
177,
179,
189,
191,
196,
199,
205,
207,
210,
214,
218,
221,
225,
231,
244,
257,
269,
281,
285,
289,
294,
304,
307,
316,
323,
327,
334,
341,
347,
351,
353,
355,
365,
367,
374,
376,
382,
386,
389,
394,
407,
415,
418,
426,
428,
439,
444,
451,
455,
461,
465,
474,
479,
481,
490,
498,
507,
514,
519,
526,
531,
535,
542,
550,
554,
559,
563,
567,
574,
581,
588,
592,
595
]
} | 4dac2b912f684c0494e4bdd2af7ba4e4 | What was tyrothricin used for during the war? | {
"tokens": [
"What",
"was",
"tyrothricin",
"used",
"for",
"during",
"the",
"war",
"?"
],
"offsets": [
0,
5,
9,
21,
26,
30,
37,
41,
44
]
} | {
"text": [
"wounds and ulcers"
],
"char_spans": [
{
"start": [
316
],
"end": [
332
]
}
],
"token_spans": [
{
"start": [
57
],
"end": [
59
]
}
]
} | [
"wounds and ulcers"
] |
SQuAD | Vaccines rely on immune modulation or augmentation. Vaccination either excites or reinforces the immune competence of a host to ward off infection, leading to the activation of macrophages, the production of antibodies, inflammation, and other classic immune reactions. Antibacterial vaccines have been responsible for a drastic reduction in global bacterial diseases. Vaccines made from attenuated whole cells or lysates have been replaced largely by less reactogenic, cell-free vaccines consisting of purified components, including capsular polysaccharides and their conjugates, to protein carriers, as well as inactivated toxins (toxoids) and proteins. | {
"tokens": [
"Vaccines",
"rely",
"on",
"immune",
"modulation",
"or",
"augmentation",
".",
"Vaccination",
"either",
"excites",
"or",
"reinforces",
"the",
"immune",
"competence",
"of",
"a",
"host",
"to",
"ward",
"off",
"infection",
",",
"leading",
"to",
"the",
"activation",
"of",
"macrophages",
",",
"the",
"production",
"of",
"antibodies",
",",
"inflammation",
",",
"and",
"other",
"classic",
"immune",
"reactions",
".",
"Antibacterial",
"vaccines",
"have",
"been",
"responsible",
"for",
"a",
"drastic",
"reduction",
"in",
"global",
"bacterial",
"diseases",
".",
"Vaccines",
"made",
"from",
"attenuated",
"whole",
"cells",
"or",
"lysates",
"have",
"been",
"replaced",
"largely",
"by",
"less",
"reactogenic",
",",
"cell",
"-",
"free",
"vaccines",
"consisting",
"of",
"purified",
"components",
",",
"including",
"capsular",
"polysaccharides",
"and",
"their",
"conjugates",
",",
"to",
"protein",
"carriers",
",",
"as",
"well",
"as",
"inactivated",
"toxins",
"(",
"toxoids",
")",
"and",
"proteins",
"."
],
"offsets": [
0,
9,
14,
17,
24,
35,
38,
50,
52,
64,
71,
79,
82,
93,
97,
104,
115,
118,
120,
125,
128,
133,
137,
146,
148,
156,
159,
163,
174,
177,
188,
190,
194,
205,
208,
218,
220,
232,
234,
238,
244,
252,
259,
268,
270,
284,
293,
298,
303,
315,
319,
321,
329,
339,
342,
349,
359,
367,
369,
378,
383,
388,
399,
405,
411,
414,
422,
427,
432,
441,
449,
452,
457,
468,
470,
474,
475,
480,
489,
500,
503,
512,
522,
524,
534,
543,
559,
563,
569,
579,
581,
584,
592,
600,
602,
605,
610,
613,
625,
632,
633,
640,
642,
646,
654
]
} | c57496efce9547fe8527e8c115ecba6c | What do vaccines need to work? | {
"tokens": [
"What",
"do",
"vaccines",
"need",
"to",
"work",
"?"
],
"offsets": [
0,
5,
8,
17,
22,
25,
29
]
} | {
"text": [
"immune modulation or augmentation"
],
"char_spans": [
{
"start": [
17
],
"end": [
49
]
}
],
"token_spans": [
{
"start": [
3
],
"end": [
6
]
}
]
} | [
"immune modulation or augmentation"
] |
SQuAD | Vaccines rely on immune modulation or augmentation. Vaccination either excites or reinforces the immune competence of a host to ward off infection, leading to the activation of macrophages, the production of antibodies, inflammation, and other classic immune reactions. Antibacterial vaccines have been responsible for a drastic reduction in global bacterial diseases. Vaccines made from attenuated whole cells or lysates have been replaced largely by less reactogenic, cell-free vaccines consisting of purified components, including capsular polysaccharides and their conjugates, to protein carriers, as well as inactivated toxins (toxoids) and proteins. | {
"tokens": [
"Vaccines",
"rely",
"on",
"immune",
"modulation",
"or",
"augmentation",
".",
"Vaccination",
"either",
"excites",
"or",
"reinforces",
"the",
"immune",
"competence",
"of",
"a",
"host",
"to",
"ward",
"off",
"infection",
",",
"leading",
"to",
"the",
"activation",
"of",
"macrophages",
",",
"the",
"production",
"of",
"antibodies",
",",
"inflammation",
",",
"and",
"other",
"classic",
"immune",
"reactions",
".",
"Antibacterial",
"vaccines",
"have",
"been",
"responsible",
"for",
"a",
"drastic",
"reduction",
"in",
"global",
"bacterial",
"diseases",
".",
"Vaccines",
"made",
"from",
"attenuated",
"whole",
"cells",
"or",
"lysates",
"have",
"been",
"replaced",
"largely",
"by",
"less",
"reactogenic",
",",
"cell",
"-",
"free",
"vaccines",
"consisting",
"of",
"purified",
"components",
",",
"including",
"capsular",
"polysaccharides",
"and",
"their",
"conjugates",
",",
"to",
"protein",
"carriers",
",",
"as",
"well",
"as",
"inactivated",
"toxins",
"(",
"toxoids",
")",
"and",
"proteins",
"."
],
"offsets": [
0,
9,
14,
17,
24,
35,
38,
50,
52,
64,
71,
79,
82,
93,
97,
104,
115,
118,
120,
125,
128,
133,
137,
146,
148,
156,
159,
163,
174,
177,
188,
190,
194,
205,
208,
218,
220,
232,
234,
238,
244,
252,
259,
268,
270,
284,
293,
298,
303,
315,
319,
321,
329,
339,
342,
349,
359,
367,
369,
378,
383,
388,
399,
405,
411,
414,
422,
427,
432,
441,
449,
452,
457,
468,
470,
474,
475,
480,
489,
500,
503,
512,
522,
524,
534,
543,
559,
563,
569,
579,
581,
584,
592,
600,
602,
605,
610,
613,
625,
632,
633,
640,
642,
646,
654
]
} | b0e400a4cdb14860a0c3a4f6e96b990a | What type of vaccines have saved millions of lives? | {
"tokens": [
"What",
"type",
"of",
"vaccines",
"have",
"saved",
"millions",
"of",
"lives",
"?"
],
"offsets": [
0,
5,
10,
13,
22,
27,
33,
42,
45,
50
]
} | {
"text": [
"Antibacterial vaccines"
],
"char_spans": [
{
"start": [
270
],
"end": [
291
]
}
],
"token_spans": [
{
"start": [
44
],
"end": [
45
]
}
]
} | [
"Antibacterial vaccines"
] |
SQuAD | Vaccines rely on immune modulation or augmentation. Vaccination either excites or reinforces the immune competence of a host to ward off infection, leading to the activation of macrophages, the production of antibodies, inflammation, and other classic immune reactions. Antibacterial vaccines have been responsible for a drastic reduction in global bacterial diseases. Vaccines made from attenuated whole cells or lysates have been replaced largely by less reactogenic, cell-free vaccines consisting of purified components, including capsular polysaccharides and their conjugates, to protein carriers, as well as inactivated toxins (toxoids) and proteins. | {
"tokens": [
"Vaccines",
"rely",
"on",
"immune",
"modulation",
"or",
"augmentation",
".",
"Vaccination",
"either",
"excites",
"or",
"reinforces",
"the",
"immune",
"competence",
"of",
"a",
"host",
"to",
"ward",
"off",
"infection",
",",
"leading",
"to",
"the",
"activation",
"of",
"macrophages",
",",
"the",
"production",
"of",
"antibodies",
",",
"inflammation",
",",
"and",
"other",
"classic",
"immune",
"reactions",
".",
"Antibacterial",
"vaccines",
"have",
"been",
"responsible",
"for",
"a",
"drastic",
"reduction",
"in",
"global",
"bacterial",
"diseases",
".",
"Vaccines",
"made",
"from",
"attenuated",
"whole",
"cells",
"or",
"lysates",
"have",
"been",
"replaced",
"largely",
"by",
"less",
"reactogenic",
",",
"cell",
"-",
"free",
"vaccines",
"consisting",
"of",
"purified",
"components",
",",
"including",
"capsular",
"polysaccharides",
"and",
"their",
"conjugates",
",",
"to",
"protein",
"carriers",
",",
"as",
"well",
"as",
"inactivated",
"toxins",
"(",
"toxoids",
")",
"and",
"proteins",
"."
],
"offsets": [
0,
9,
14,
17,
24,
35,
38,
50,
52,
64,
71,
79,
82,
93,
97,
104,
115,
118,
120,
125,
128,
133,
137,
146,
148,
156,
159,
163,
174,
177,
188,
190,
194,
205,
208,
218,
220,
232,
234,
238,
244,
252,
259,
268,
270,
284,
293,
298,
303,
315,
319,
321,
329,
339,
342,
349,
359,
367,
369,
378,
383,
388,
399,
405,
411,
414,
422,
427,
432,
441,
449,
452,
457,
468,
470,
474,
475,
480,
489,
500,
503,
512,
522,
524,
534,
543,
559,
563,
569,
579,
581,
584,
592,
600,
602,
605,
610,
613,
625,
632,
633,
640,
642,
646,
654
]
} | 97cf39292977415ca2e4f601a6ec8ed2 | What types of vaccines have been phased out? | {
"tokens": [
"What",
"types",
"of",
"vaccines",
"have",
"been",
"phased",
"out",
"?"
],
"offsets": [
0,
5,
11,
14,
23,
28,
33,
40,
43
]
} | {
"text": [
"Vaccines made from attenuated whole cells or lysates"
],
"char_spans": [
{
"start": [
369
],
"end": [
420
]
}
],
"token_spans": [
{
"start": [
58
],
"end": [
65
]
}
]
} | [
"Vaccines made from attenuated whole cells or lysates"
] |
SQuAD | In Paris, Chopin encountered artists and other distinguished figures, and found many opportunities to exercise his talents and achieve celebrity. During his years in Paris he was to become acquainted with, among many others, Hector Berlioz, Franz Liszt, Ferdinand Hiller, Heinrich Heine, Eugène Delacroix, and Alfred de Vigny. Chopin was also acquainted with the poet Adam Mickiewicz, principal of the Polish Literary Society, some of whose verses he set as songs. | {
"tokens": [
"In",
"Paris",
",",
"Chopin",
"encountered",
"artists",
"and",
"other",
"distinguished",
"figures",
",",
"and",
"found",
"many",
"opportunities",
"to",
"exercise",
"his",
"talents",
"and",
"achieve",
"celebrity",
".",
"During",
"his",
"years",
"in",
"Paris",
"he",
"was",
"to",
"become",
"acquainted",
"with",
",",
"among",
"many",
"others",
",",
"Hector",
"Berlioz",
",",
"Franz",
"Liszt",
",",
"Ferdinand",
"Hiller",
",",
"Heinrich",
"Heine",
",",
"Eugène",
"Delacroix",
",",
"and",
"Alfred",
"de",
"Vigny",
".",
"Chopin",
"was",
"also",
"acquainted",
"with",
"the",
"poet",
"Adam",
"Mickiewicz",
",",
"principal",
"of",
"the",
"Polish",
"Literary",
"Society",
",",
"some",
"of",
"whose",
"verses",
"he",
"set",
"as",
"songs",
"."
],
"offsets": [
0,
3,
8,
10,
17,
29,
37,
41,
47,
61,
68,
70,
74,
80,
85,
99,
102,
111,
115,
123,
127,
135,
144,
146,
153,
157,
163,
166,
172,
175,
179,
182,
189,
200,
204,
206,
212,
217,
223,
225,
232,
239,
241,
247,
252,
254,
264,
270,
272,
281,
286,
288,
295,
304,
306,
310,
317,
320,
325,
327,
334,
338,
343,
354,
359,
363,
368,
373,
383,
385,
395,
398,
402,
409,
418,
425,
427,
432,
435,
441,
448,
451,
455,
458,
463
]
} | 84c8396e32a4404082afbae57f6fd573 | In what city did Frédéric achieve celebrity status? | {
"tokens": [
"In",
"what",
"city",
"did",
"Frédéric",
"achieve",
"celebrity",
"status",
"?"
],
"offsets": [
0,
3,
8,
13,
17,
26,
34,
44,
50
]
} | {
"text": [
"Paris"
],
"char_spans": [
{
"start": [
3
],
"end": [
7
]
}
],
"token_spans": [
{
"start": [
1
],
"end": [
1
]
}
]
} | [
"Paris"
] |
SQuAD | In Paris, Chopin encountered artists and other distinguished figures, and found many opportunities to exercise his talents and achieve celebrity. During his years in Paris he was to become acquainted with, among many others, Hector Berlioz, Franz Liszt, Ferdinand Hiller, Heinrich Heine, Eugène Delacroix, and Alfred de Vigny. Chopin was also acquainted with the poet Adam Mickiewicz, principal of the Polish Literary Society, some of whose verses he set as songs. | {
"tokens": [
"In",
"Paris",
",",
"Chopin",
"encountered",
"artists",
"and",
"other",
"distinguished",
"figures",
",",
"and",
"found",
"many",
"opportunities",
"to",
"exercise",
"his",
"talents",
"and",
"achieve",
"celebrity",
".",
"During",
"his",
"years",
"in",
"Paris",
"he",
"was",
"to",
"become",
"acquainted",
"with",
",",
"among",
"many",
"others",
",",
"Hector",
"Berlioz",
",",
"Franz",
"Liszt",
",",
"Ferdinand",
"Hiller",
",",
"Heinrich",
"Heine",
",",
"Eugène",
"Delacroix",
",",
"and",
"Alfred",
"de",
"Vigny",
".",
"Chopin",
"was",
"also",
"acquainted",
"with",
"the",
"poet",
"Adam",
"Mickiewicz",
",",
"principal",
"of",
"the",
"Polish",
"Literary",
"Society",
",",
"some",
"of",
"whose",
"verses",
"he",
"set",
"as",
"songs",
"."
],
"offsets": [
0,
3,
8,
10,
17,
29,
37,
41,
47,
61,
68,
70,
74,
80,
85,
99,
102,
111,
115,
123,
127,
135,
144,
146,
153,
157,
163,
166,
172,
175,
179,
182,
189,
200,
204,
206,
212,
217,
223,
225,
232,
239,
241,
247,
252,
254,
264,
270,
272,
281,
286,
288,
295,
304,
306,
310,
317,
320,
325,
327,
334,
338,
343,
354,
359,
363,
368,
373,
383,
385,
395,
398,
402,
409,
418,
425,
427,
432,
435,
441,
448,
451,
455,
458,
463
]
} | d70a06ce3d5c4be9b2b966a4f179c859 | Who was the principal of the Polish Literary Society that Frédéric became acquainted with? | {
"tokens": [
"Who",
"was",
"the",
"principal",
"of",
"the",
"Polish",
"Literary",
"Society",
"that",
"Frédéric",
"became",
"acquainted",
"with",
"?"
],
"offsets": [
0,
4,
8,
12,
22,
25,
29,
36,
45,
53,
58,
67,
74,
85,
89
]
} | {
"text": [
"Adam Mickiewicz"
],
"char_spans": [
{
"start": [
368
],
"end": [
382
]
}
],
"token_spans": [
{
"start": [
66
],
"end": [
67
]
}
]
} | [
"Adam Mickiewicz"
] |
Subsets and Splits